Total synthesis of spirofungins A and B and formal synthesis of the C1-C38 fragment of (+)-sorangicin A by OBryan, Elizabeth Anne
 
 
 
Total Synthesis of Spirofungins A and B and Formal Synthesis of the C1-C38 
Fragment of (+)-Sorangicin A 
 
Elizabeth Anne O’Bryan 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
Department of Chemistry. 
 
Chapel Hill 
2011 
 
 
 
Approved by: 
 
Michael T. Crimmins 
Jeffrey S. Johnson 
David S. Lawrence 
Joseph L. Templeton 
Marcey L. Waters  
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2011 
Elizabeth Anne O’Bryan 
ALL RIGHTS RESERVED 
  
iii 
 
 
ABSTRACT 
Elizabeth Anne O’Bryan: Total Synthesis of Spirofungins A and B and Formal Synthesis 
of the C1-C38 Fragment of (+)-Sorangicin A 
(Under the direction of Michael T. Crimmins) 
 
 The enantioselective total synthesis of spirofungins A and B is reported in 14 
steps over the longest linear sequence.  The synthesis of three key fragments in six 
steps or less and excellent overall yield allowed for the assembly of spirofungins A and B 
in a highly efficient manner.  Highlights of the synthesis include the use of 
thiazolidinethione-mediated aldol reactions to install five of the seven stereocenters, and 
the appendage of the C1-C6 unsaturated side chain through a challenging cross 
metathesis reaction. 
 Efforts towards the total synthesis of (+)-sorangicin A resulted in the completion 
of a formal synthesis of the C1-C38 fragment.  The preparation of three orthogonally 
differentiated cyclic ether fragments allowed for the investigation of several coupling 
strategies for assembly of the natural product.  A cross metathesis reaction was 
employed to form the C29-C30 bond and unite the bicyclic ether and tetrahydropyran 
fragments.  It was our intention to utilize a second cross metathesis reaction to install the 
C15-C16 olefin and append the dihydropyran moiety to the rest of the molecule; 
however, a low yield for this cross metathesis reaction prompted us to instead use a 
Julia-Kocienski olefination to arrive at the C1-C38 fragment.  Completion of the total 
synthesis of (+)-sorangicin A can be achieved in six known steps from this advanced 
intermediate.   
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CHAPTER ONE 
 
Background: Spirofungins A and B 
 
1.1 Isolation, structural assignment, and biological activity 
Spiroketal-containing natural products are abundant in nature and have been 
isolated as secondary metabolites from a number of insects, fungi, plants, and marine 
organisms.  The increasing pharmacological importance of these naturally-occurring 
molecules has stimulated intense interest from the chemical community with regard to 
both their synthesis and chemical reactivity.  For several years, our group has been 
interested in the synthesis of spiroketals due to their diverse biological profiles and 
complex architectures.  As such, the spirofungins were identified as ideal targets for total 
synthesis as they possess several synthetically challenging features and important 
biological properties.    
Spirofungins A (1) and B (2) were isolated by Höltzel and co-workers in 1998 as 
secondary metabolites of Streptomyces violaceusniger Tü 4113 as a 4:1 mixture.1  The 
spirofungins are closely related to the reveromycins,2,3 specifically reveromycin A (4), 
which possesses a similar 6,6-spiroketal core (Figure 1.1).2  The spiroketal core for both 
the spirofungins and reveromycin A is flanked on both sides by identical C1-C10 and 
C20-C24 unsaturated acid side chains.  The key difference between these natural 
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products is in the substitution at C18, in which reveromycin A possesses a 
hemisuccinate and n-butyl chain, while the spirofungins have a methyl group at this 
position.   
 
Structural elucidation of spirofungins A and B was carried out primarily by 
utilizing various NMR techniques.  Although a slight difference in retention time between 
spirofungin A and B was observed upon analysis by reverse phase HPLC, determination 
of the structure was carried out on the mixture.1  Spirofungin B was originally assigned 
as the C18 and C19 epimer (3) of the major component, spirofungin A (1).  In 2004, 
Rizzacasa and co-workers completed the synthesis of the proposed structure of 
spirofungin B (3).4  Unfortunately, the spectral data for the synthetically prepared 
spirofungin B did not match what had been reported in the original isolation paper.  
Strong literature evidence led to the reassignment of spirofungin B (2) as the C15 epimer 
of spirofungin A.  The structure and absolute stereochemistry of both spirofungin A and 
B were confirmed by total synthesis by Shimizu in 2005.5   
Spirofungin A, like the structurally related reveromycin A, has emerged as a 
popular target for synthesis due to its significant biological activity.  The spirofungins 
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have been shown to possess high antifungal activity against yeasts, and moderate 
activity against filamentous fungi.1  Cell-based biological assays conducted on the 
mixture of spirofungins A and B determined the minimal inhibition concentration (MIC) to 
be 15 g/mL for the human pathogen Candida albicans.  The Kozmin group recently 
demonstrated that spirofungin A suppresses the growth of several human cancer cell 
lines, including HL-60 (leukemia), HCT116 (colon), PC3 (prostate), and A549 (lung), with 
IC50 values ranging from 0.64-6.4 M.
6  They also determined that spirofungin A 
selectively inhibits isoleucyl-tRNA synthetase in a dose dependent fashion.  The 
biological profile of spirofungin A is consistent with the behavior of reveromycin A, which 
exhibits similar antifungal, antiproliferative, and inhibitory activity towards isoleucyl-tRNA 
synthetase.7-9  The mode of action for spirofungin A has yet to be determined, however, 
it has been suggested that it may be the same as the reveromycins, which inhibit protein 
synthesis in eukaryotic cells.   
1.2 Spirofungins and the anomeric effect 
A major challenge that is often encountered in the synthesis of spiroketal-
containing natural products is formation of the spirocenter in a stereoselective fashion.  
A traditional approach to spiroketals, specifically the 6,6-spiroketals that make up the 
core of the spirofungins, involves acid-catalyzed condensation of a 1,9-dihydroxy ket-5-
one (Figure 1.2).  The stereochemical outcome of the spiroketalization event is 
influenced by a number of factors, including solvent, steric interactions, hydrogen 
bonding, and the anomeric effect.10,11  
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The anomeric effect was first observed by Edward in 1955 in the course of his 
work with pyranose sugars, and has since been extended to a wide range of cyclic and 
linear systems.12  In relation to the spiroketal systems of interest, the anomeric effect is 
defined as the preference for an electronegative substituent at the anomeric carbon (C2) 
to occupy the axial orientation as opposed to the sterically less demanding equatorial 
orientation.  This is illustrated by 2-methoxytetrahydropyran, in which the axial 
configuration is favored in an 80:20 ratio (Figure 1.3). 
 
It has been proposed that the anomeric effect is the result of two contributing 
factors, a stabilizing molecular orbital overlap and a net dipole minimization.12,13  From a 
molecular orbital perspective, the anomeric effect is believed to arise from the overlap of 
the axial lone pair on the endocyclic oxygen with the antibonding * orbital of the 
exocyclic C-O bond (Figure 1.4).  This stabilizing interaction is only possible when the C-
O bond is anti-periplanar to the non-bonding oxygen lone pairs, resulting in 
delocalization of the lone pair of electrons and a decrease in the overall energy of the 
system.   
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The anomeric effect can also be rationalized in terms of a dipole minimization 
argument (Figure 1.5).  The neighboring electronegative atoms result in a local dipole 
moment with a fixed orientation.  When the electronegative substituent at the anomeric 
carbon is in an equatorial orientation there will be a dipole-dipole repulsion; however, in 
the axial orientation, the dipole-dipole interaction and the overall energy of the molecule 
are minimized.   
 
The contribution of the anomeric effect to overall energy has been estimated to 
provide approximately 1.4-2.4 kcal/mol stabilization, depending on the specific substrate.  
Consideration of the 6,6-spiroketal system reveals that there are four possible anomers 
that could be obtained upon acid-catalyzed spiroketalization of a generic 
dihydroxyketone (Figure 1.6).  Without complication from other factors, A is the preferred 
conformation, in which the anti-periplanar relationship is realized for both oxygens.10,11,14   
 
In spiroketal-containing natural products, such as the spirofungins, steric 
interactions and intramolecular hydrogen bonding, among other factors, can reinforce or 
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counteract the stabilization gained by the anomeric effect.  Thus, the most stable 
spiroketal conformation is described as that in which the number of anomeric 
stabilizations is maximized, and unfavorable steric interactions are minimized.14   
Evaluation of spirofungins A and B reveals that spirofungin A possesses two 
anomeric stabilizations, while spirofungin B has a single anomeric stabilization (Figure 
1.7).  Despite the stabilization gained by the anomeric effect in spirofungin A, an 
undesirable steric interaction as a result of the axially oriented C20-C24 side chain 
causes the spirofungins to be very close in energy.  Interestingly, the initially proposed 
structure of spirofungin B would be the most stable, since it is doubly anomeric and lacks 
the steric congestion caused by the C20-C24 side chain in spirofungin A.15   
 
The minimal energy difference between the spirofungins makes the 
stereoselective synthesis of either spirofungin A or B a significant challenge.  As will 
become evident from the synthetic efforts towards these natural products, subtle 
changes in the spiroketal precursor can have a marked effect on the selectivity of the 
spiroketalization. 
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1.3 Previous synthetic efforts 
Due to the unique structure and important biological activity of the spirofungins, 
there has been considerable interest from the synthetic community in these natural 
products.  Approaches toward the 6,6-spiroketal core have been reported by Kiyota,16 
Dias,17,18 Rychnovsky,19 and most recently, Maier.20  Most of the aforementioned 
syntheses of the core feature an acid catalyzed spiroketalization to give rise to a mixture 
spiroketals.  Conversely, Rychnovsky and co-workers have developed a route for the 
selective preparation of the spirofungin B core which employs a highly efficient and 
stereoselective reductive cyclization.19  Total syntheses, which will be discussed herein, 
have been completed by the groups of Shimizu,5 Kozmin,6 and Rizzacasa,15 in addition 
to our own.21    
i. Shimizu’s synthesis of spirofungins A and B 
The Shimizu group achieved the first asymmetric total synthesis of spirofungins A 
and B in 2005.5  This group was also responsible for the first total synthesis of 
reveromycin A,22 and has recently reported the synthesis and biological evaluation of a 
series of reveromycin A and spirofungin A derivatives.23,24  Their approach towards the 
spirofungins takes advantage of the minimal energy difference, allowing for the 
preparation of both spirofungins A and B from a common intermediate.  Their synthetic 
plan involved preparation of three key intermediates: alkyne 10, Weinreb amide 11, and 
vinyl boronate 5, from common intermediate 12 (Scheme 1.1).16,25  Retrosynthetically, 
they envisioned constructing spiroketal cores 7 (15S) and 8 (15R) by an acid-catalyzed 
spiroketalization of ynoate 9.  Appendage of the C20-C24 and C1-C6 unsaturated side 
chains to the spiroketal core would be achieved by a Horner-Wadsworth-Emmons 
olefination with phosphonate 6 and a Suzuki coupling with vinyl boronate 5, respectively.   
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 Common intermediate 12, used for the preparation of the three key fragments, 
was prepared in nine steps and 59% overall yield from p-methoxybenzyl alcohol.5,25  The 
-unsaturated ester was converted into alkyne 10 in six additional steps and Weinreb 
amide 11 in three steps.  Weinreb amide 11 was then treated with the lithiated alkyne to 
arrive at ynoate 9 in 87% yield (Scheme 1.2).  Deprotection of the triethylsilyl (TES) 
protecting groups with pyridinium p-toluenesulfonate (PPTS) in methanol triggered 
spontaneous formation of mixed acetal 13 in 97% yield.  As a consequence of utilizing 
-unsaturated ester 12 as a common intermediate, inversion of the C11 stereocenter 
was required.  Toward this end, mixed acetal 13 was converted to the mesylate, which 
upon cleavage of the p-methoxybenzyl ether and treatment with base effected formation 
of the epoxide with concurrent inversion of the C11 stereocenter.  Subjection of the 
alkyne to hydrogenation conditions and treatment with PPTS in methanol delivered 
mixed acetal 14 as a single stereoisomer.  Epoxide 14 was then treated with lithiated 
propyne to install the alcohol at C11 with the correct stereochemistry.26  Following 
exposure of the mixed acetal to PPTS in methanol for a third time, a thermodynamic 
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mixture of spiroketals 15 and 16 (10:7 15S/15R) was obtained as an inseparable 
mixture.  Regioselective formation of the vinyl iodide27 and silyl deprotection rendered 
the spiroketals separable, allowing for isolation of 7 and 8 in 45% and 30% yield, 
respectively.  Extensive 2-D NMR analysis of spiroketals 7 (15S) and 8 (15R) was 
employed to assign the major product (7) as the spiroketal corresponding to the 
spirofungin A core. 
 
 Spiroketals 7 and 8 were independently carried through the remaining steps in 
the synthesis (Scheme 1.3).  First, the C20-C24 diene was installed via a Horner-
Wadsworth-Emmons olefination of the aldehydes prepared from 7 and 8 with 
phosphonate 6 in 96% and 86% yield, respectively.22,28  The Suzuki coupling29,30 of vinyl 
iodide 17 or 18 with vinyl boronate 5, derived from common intermediate 12 in five steps, 
efficiently installed the C1-C6 side chain and completed the carbon framework of the 
natural product.  Finally, hydrolysis of the diesters with lithium hydroxide and 
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deprotection of the tert-butyldimethylsilyl (TBS) ether provided (+)-spirofungin A (1) in 
74% yield or ()-spirofungin B (2) in 80% yield over the final three steps.  This first total 
synthesis of spirofungins A and B by Shimizu provided the natural products in 31 steps 
over the longest linear sequence, with overall yields of 7.9% and 5.2% for spirofungin A 
and B, respectively. 
 
ii. Kozmin’s synthesis of spirofungin A 
 The Kozmin group devised an elegant approach towards the stereoselective 
synthesis of spirofungin A.6  Similar to Shimizu’s approach, Kozmin and co-workers 
sought to prepare spiroketal core 20 and then install the unsaturated side chains at a 
late stage via a Horner-Wadsworth-Emmons reaction and a palladium catalyzed 
coupling reaction with vinyl stannane 19 (Scheme 1.4).  It was envisioned that spiroketal 
21 could be formed selectively from ketone 22, wherein a temporary silyl tether would 
influence the spatial orientation of the side chains, allowing for exclusive formation of the 
spirofungin A spiroketal.31,32  Ketone 22 would be prepared from terminal olefins 23 and 
24 via the cyclopropenone acetal ring opening/cross metathesis methodology developed 
by Kozmin.33   
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 The synthesis commenced with the ring opening/cross metathesis sequence 
between olefin 23 and cyclopropenone acetal 25.  Upon subsequent cleavage of the 
TBS ether, 26 was obtained in 60% yield over 2 steps (Scheme 1.5).  Introduction of the 
dialkoxysilane tether was achieved upon sequential addition of alcohols 26 and 24 to a 
mixture of dichlorodi-iso-propylsilane.  Subsequent cleavage of the acetal and ring 
closing metathesis with Grubbs 2nd generation catalyst (G2)34 afforded ketone 22 in 55% 
yield over the three step sequence.  Exposure of dienone 22 to hydrogenation conditions 
resulted in reduction of the dienone with concomitant debenzylation and spiroketalization 
to give rise to spiroketal 21 exclusively in 98% yield.   
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 Removal of the temporary silyl tether with tetrabutylammonium fluoride, followed 
by oxidative cleavage of the resultant 1,2-diol, formation of the C20 TBS ether, and 
Wittig olefination provided vinyl dibromide 20 (Scheme 1.6).  Installation of the right hand 
side chain was achieved by successive palladium catalyzed coupling reactions with vinyl 
dibromide 20.  An E-selective Stille coupling35 with vinyl stannane 19 was followed by a 
Negishi coupling36 with dimethylzinc to generate terminal olefin 27 in 60% yield.  A cross 
metathesis reaction with methyl acrylate37 completed the C1-C8 side chain; subsequent 
removal of the C20 TBS ether afforded alcohol 28 in 52% yield over the two steps.  To 
complete the synthesis, appendage of the C20-C24 side chain was accomplished by a 
four step sequence.  After removal of the C20 TBS ether, a similar sequence to that 
described by Shimizu5 was employed to give rise to spirofungin A (1) in 20 steps over 
the longest linear sequence and 2.9% overall yield.   
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iii. Rizzacasa’s synthesis of spirofungin A 
 The most recent synthesis of spirofungin A was disclosed by Rizzacasa shortly 
after our synthesis of spirofungins A and B.15  Rizzacasa and co-workers have shown 
considerable interest in this family of natural products, having reported the total 
synthesis of reveromycin A38,39 and B,40,41 the initially proposed structure of spirofungin 
B,4 and the total synthesis of spirofungin A.15  Their synthesis features a more traditional 
acid-catalyzed spiroketalization strategy, followed by a hydrogen bond controlled 
epimerization to prepare spirofungin A exclusively.  Retrosynthetically, as in the previous 
two syntheses, they planned to append the side chains to an orthogonally substituted 
spiroketal core.  Spiroketal 29 would be prepared from ketone 30, which in turn could be 
accessed from Weinreb amide 31 and terminal olefin 32 (Scheme 1.7).   
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 Spiroketal precursor 30 was prepared from Weinreb amide 314 and alkene 3242 
in three steps via a vinyl addition, cross metathesis, hydrogenation sequence in 
excellent overall yield (Scheme 1.8).  Initial treatment of ketone 30 with PPTS in 
methanol resulted in a 1:2 mixture of spiroketals 34 (15S) and 35 (15R), in which the 
spirofungin B core (15R) was favored.   
 
At this point in their synthesis, considerable effort was directed toward 
epimerization of the spiroacetal center to prepare spirofungin A in a more selective 
manner.  Simply resubjecting undesired spiroketal 35 (15R) to the identical conditions 
resulted in epimerization to the previously obtained 1:2 mixture.  As this was not an 
efficient way to funnel material towards spirofungin A, the mixture of spiroketals was 
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carried forward with the intention of exploring epimerization at a later stage in the 
synthesis.  Spiroketals 34 and 35 were converted to alkynes 36 and 37 in three steps via 
hydrogenolysis of the benzyl ether, Dess-Martin oxidation, and an Ohira-Bestmann 
reaction (Scheme 1.9).43  To remove the TBS ether, the mixture of spiroketals 36 and 37 
was treated with a catalytic amount of CSA in methanol and methylene chloride.  To 
their delight, these conditions not only effected the TBS deprotection, but also increased 
the ratio of spiroketal 29 (15S) to 38 (15R) to 9:1.  The spiroketals were readily 
separated at this point, and after one recycle of the undesired spirofungin B core, 
spiroketal 29 was obtained in a >99:1 ratio.   
 
In an attempt to streamline the synthesis, ketone 30 was treated directly with 
CSA in methanol, from which a disappointing 1:1.4 ratio of spiroketals 39 to 40 was 
obtained in 91% yield (Scheme 1.10).  This result provided convincing evidence that the 
free alcohol alone had little influence on the stereochemical outcome of the 
spiroketalization.  The unique combination of the free alcohol and the axial alkyne allows 
for the thermodynamically favored spiroketal 29 (15S) to be formed with exceptional 
selectivity.   The dramatic increase in thermodynamic preference for the spirofungin A 
core is explained by the decrease in size of the C20 substituent (alkyne vs. benzyl 
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ether), as well as an intramolecular hydrogen bonding interaction (See Scheme 1.9).  As 
both spiroketals 29 and 38 were crystalline, X-ray analysis confirmed the interaction 
between the primary alcohol and the endocyclic oxygen in 29, but there was no evidence 
of intramolecular hydrogen bonding in the minor diastereomer, 38.   
 
With spirofungin A core 29 in hand, installation of the right hand side chain was 
the next task at hand (Scheme 1.11).  A more stepwise approach than in the previous 
syntheses was employed, in which Dess-Martin oxidation of 29 followed by successive 
Wittig reactions appended the C6-C8 diene functionality.  A reduction-oxidation 
sequence afforded aldehyde 42, which was employed in a tin triflate mediated syn aldol 
reaction with oxazolidinethione 43,44 delivering aldol adduct 44 in 75% yield from 41.  
Reductive removal of the chiral auxiliary and protection of the resultant secondary 
alcohol as the TBS ether afforded 45 in 40% yield over the three step sequence.   
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Attention was then turned to introduction of the C20-C24 side chain.  
Hydrostannylation of alkyne 45,45 followed by a Stille coupling46 of vinyl iodide 47 with 
the resultant vinyl stannane 46 generated ester 48 in 82% yield (Scheme 1.12).  To 
complete the total synthesis, Rizzacasa employed a similar four step sequence to that 
utilized by both Shimizu and Kozmin, to arrive at spirofungin A (1) in 23 steps and 3.0% 
overall yield from the previously prepared Weinreb amide 31; 30 steps from 
commercially available starting materials.41     
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CHAPTER TWO 
 
Total Synthesis of Spirofungins A and B 
 
2.1 Retrosynthetic analysis 
As in the previously reported syntheses of spirofungins A and B, we sought to 
divide the molecule into three key fragments: C1-C6 right hand side chain 49, C21-C24 
left-hand side chain 50, and spiroketal core 51 or 52 (Scheme 2.1).  It was envisioned 
that the spirofungins could be constructed in an efficient manner by employing a late 
stage cross metathesis reaction to append the unsaturated acid side chains to the 
spiroketal core.  Spiroketal core 51 or 52 would arise from the acid-catalyzed 
spiroketalization of ketone 53, available from -ketophosphonate 54 and aldehyde 55 via 
a Horner-Wadsworth-Emmons, conjugate reduction sequence.  -Ketophosphonate 54 
and C1-C6 side chain 49 would be prepared from a common intermediate using the 
thiazolidinethione-mediated propionate aldol reaction developed in our laboratories.47  
Aldehyde 55 would be derived from a chiral auxiliary mediated acetate aldol reaction.48 
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2.2 Synthesis of the spiroketal core 
i.   Synthesis of aldehyde 55 
Efforts toward the spiroketal core began with the synthesis of aldehyde 55.  Due 
to the requisite anti substitution of aldehyde 55, this fragment could not be accessed 
directly via a thiazolidinethione-mediated propionate aldol reaction. Instead, aldehyde 55 
was prepared via a diastereoselective acetate aldol reaction followed by a Frater-
Seebach alkylation.49,50  The acetate aldol reaction between mesityl substituted N-
acetylthiazolidinethione 56 and 3-butenal51 gave rise to aldol adduct 57 in 80% yield and 
excellent diastereoselectivity (>20:1) (Scheme 2.2).48  Direct displacement of the chiral 
auxiliary with methanol or iso-butyl alcohol provided ester 58 or 59 in 100% and 98% 
yield, respectively.47   
 
With the iso-butyl and methyl esters in hand, conditions for the Frater-Seebach 
alkylation with methyl iodide were explored.  Initial attempts with methyl ester 58, in 
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which TMEDA was employed as an additive, provided alkylated product 60 with high 
diastereoselectivity, albeit in modest yield (entry 1).52  With iso-butyl ester 59, promising 
results were obtained when the Frater-Seebach alkylation was run in the absence of an 
additive while raising the temperature to 40 °C (entry 2).  After screening a variety of 
other conditions, it was determined that employing DMPU as an additive resulted in the 
highest yields for both the methyl and iso-butyl esters (Table 2.1, entries 3-4).53   
 
Entry R Additive Temperature Yield 
1 Me TMEDA –78 °C 36% 
2 i-Bu  none –78 °C to –40 °C  47% 
3 Me DMPU –78 °C to 0 °C 37-61% 
4 i-Bu  DMPU –78 °C to 0 °C 55-68% 
 
At best, these conditions provided methyl ester 60 in 61% yield or iso-butyl ester 
61 in 68% yield.  As a result of the slightly higher yield obtained for the Frater-Seebach 
alkylation with iso-butyl ester 59, we proceeded with alkylated ester 61 towards aldehyde 
55.  Protection of the secondary alcohol as the triethylsilyl (TES) ether, followed by 
treatment with di-iso-butylaluminum hydride gave rise to aldehyde 55 in 89% yield over 
the two step sequence (Scheme 2.3).  With the optimized conditions, aldehyde 55 could 
be generated in five steps and 46% overall yield.   
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ii.   Synthesis of the -ketophosphonate 
Attention was then turned to the synthesis of the -ketophosphonate via a 
thiazolidinethione mediated propionate aldol reaction.  The synthesis commenced with 
an Evans-syn propionate aldol reaction between N-propionylthiazolidinethione 63 and 
acrolein to deliver aldol adduct 64 in 96% yield and >20:1 diastereomeric ratio (Scheme 
2.4).47  The resultant secondary alcohol was protected as the TES ether and reductive 
removal of the chiral auxiliary with di-iso-butylaluminum hydride furnished aldehyde 65 in 
94% yield over the two steps.   
 
 In the literature, we encountered the seldom used ylide-phosphonate 67,54 which 
seemed perfectly suited for use in our synthesis.  This reagent would allow us to access 
-ketophosphonate 68 in just four steps from acrolein.  Ylide-phosphonate 67 was 
prepared from 1,3-dibromoacetone in 3 steps (Scheme 2.5).  The displacement of one of 
the bromides with triphenylphosphine, followed by ylide formation delivered ylide 66 in 
81% yield.55,56  The phosphonate was installed upon treatment of ylide 66 with diethyl 
phosphite and sodium hydride, generating ylide-phosphonate 67 in 68% yield.   
 
 Limited procedural details were provided in the original publication for use of this 
reagent in olefination reactions;54 thus, it was necessary to investigate conditions for 
promoting the desired bond-forming event between aldehyde 65 and ylide-phosphonate 
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67 (Table 2.2).  With the intent of performing the Wittig reaction prior to the Horner-
Wadsworth-Emmons olefination to arrive at -ketophosphonate 68, we initially ran the 
reaction in refluxing THF for 24 hours, only to recover aldehyde 65 unreacted (entry 1).  
We next turned to higher boiling solvents, such as toluene and chlorobenzene, both of 
which resulted in minimal product formation even at extended reaction times (entries 2-
3).  Concerned that the prolonged reaction times at elevated temperatures were leading 
to ylide decomposition, several reactions were conducted at temperatures ranging from 
50 to 70 °C over several days (entries 4-6).  Despite variation in the reaction time, 
temperature, solvent, and equivalents of aldehyde 65 and ylide-phosphonate 67, at best, 
a 38% yield of -ketophosphonate 68 was obtained.  
 
Entry 65 (equiv) 67 (equiv) solvent temp, time Yield 
1 1.0 1.5 THF 70 °C, 24 h NR 
2 1.0 3.0 Toluene 110 °C, 2 d  38% 
3 1.0 2.0 Chlorobenzene 130 °C, 24 h 26% 
4 2.0 1.0 Toluene 50 °C, 6 d 17% 
5 2.0 1.0 Toluene ))), rt, 6 d 21% 
6 1.0 3.0 THF 70 °C, 5 d 33% 
  
 As this was not an efficient way to advance material, we next turned our attention 
to stabilized ylide 69 to homologate the aldehyde to -unsaturated ester 70 (Scheme 
2.6).  While employing this ylide increased the number of steps necessary to prepare the 
-ketophosphonate, the vast improvement in yield made this route more advantageous.  
Ester 70 also serves as a common intermediate in the synthesis of the -
ketophosphonate and C1-C6 side chain 49.  Finally, the treatment of ester 70 with 
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lithiated dimethylmethyl phosphonate57 generated -ketophosphonate 71 in five steps 
and 65% overall yield.   
 
 With both -ketophosphonate 71 and aldehyde 55 in hand, formation of the 
spiroketal precursor via a modified Horner-Wadsworth-Emmons olefination was explored 
(Scheme 2.7).  Treatment of -ketophosphonate 71 with barium hydroxide followed by 
addition of aldehyde 55 formed the desired C13-14 bond in 73% yield.58  Conjugate 
reduction of dienone 72 was attempted with nickel chloride and sodium borohydride in 
the presence of methanol.59,60  We opted for these conditions anticipating that the 
presence of methanol in the reaction would enable the selective reduction of both of the 
-unsaturated systems in dienone 72.  Unfortunately, a 9:1 ratio of enones 73 and 74 
in 55% yield were the only products obtained.  The spiroketal precursor, ketone 53, 
could be accessed upon resubjection of the mixture of enones to the same conditions, 
albeit in only 38% yield from dienone 72.   
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These results prompted us to take a more stepwise approach toward ketone 53, 
in which conjugate reduction of 70 would be carried out prior to formation of the -
ketophosphonate.  Toward this end, 1,4-reduction of ester 70 with di-iso-butylaluminum 
hydride mediated by MeCu, delivered saturated ester 75 in 93% yield (Scheme 2.8).61  
Subsequent treatment of ester 75 with lithiated dimethyl methylphosphonate furnished -
ketophosphonate 76 in 93% yield and 73% overall yield for the six steps.   
 
It is noteworthy that while this sequence for preparing -ketophosphonate 76 
requires six steps, the 73% overall yield is significantly higher than both the four step 
sequence with ylide-phosphonate 67 and the five step sequence in which the -
ketophosphonate was formed directly from -unsaturated ester 70.   
iii.   Construction of the spiroketal core 
From -ketophosphonate 76 and aldehyde 55, ketone 53 was prepared in 77% 
yield over two additional steps by a Horner-Wadsworth-Emmons olefination, conjugate 
reduction sequence (Scheme 2.9).  To arrive at the spiroketal core, ketone 53 was 
treated with PPTS in methanol to induce cleavage of the triethylsilyl (TES) protecting 
groups and spontaneous spiroketalization, to give rise to a 1:2 mixture of spiroketals 78 
and 79 in a combined 90% yield.   
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Correlation of the characteristic signals for the protons at C11 and C19 of the 1H 
NMR spectrum to similar intermediates from Shimizu’s synthesis,5 in addition to 2-D 
NOESY and COSY NMR analysis, confirmed that the major product corresponded to the 
spiroketal core of spirofungin B.  The 2-D NOESY NMR data of minor spiroketal 78 
showed a strong cross peak between the protons at C11 and C20, while spiroketal 79 
showed a cross peak between the protons at C11 and C19, supporting the assignment 
of the major product as the spirofungin B core (Figure 2.1).     
 
Various acidic conditions were investigated in an effort to increase the selectivity 
for spirofungin A core 78, but all efforts resulted in a similar 1:2 ratio.  Epimerization of 
the C15 spirocenter of the spirofungin B core was also explored; however, when 
spiroketal 79 was exposed to PPTS in methanol or CSA in methylene chloride, no 
change was observed and spiroketal 79 was recovered cleanly.  While it was expected 
that the spirofungin A core would be favored, it was known that these spiroketals would 
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be very similar in energy.  Upon comparison of spiroketals 78 and 79 to the spiroketals 
from Shimizu5 and Rizzacasa’s synthesis,15 it is evident that subtle changes at the 
terminus of the spiroketal precursor can have a dramatic effect on the stereochemical 
outcome of the spiroketalization.   
Despite the poor selectivity for the spirofungin A core, we moved forward with the 
synthesis with the intention of epimerizing the spirocenter at a later stage.  Upon 
separation via flash column chromatography, spiroketals 78 (15S) and 79 (15R) were 
obtained in 30% and 60% yield, respectively, and carried on separately for introduction 
of the unsaturated side chains.  We opted to install the diene via a sequential cross 
metathesis/methylene Wittig olefination (Scheme 2.10).62  The treatment of 78 or 79 with 
methacrolein and 5 mol % Grubbs 2nd generation catalyst (G2) gave rise to an 
intermediate enal, which upon methylene Wittig olefination63 introduced the terminal 
olefin, providing dienes 51 and 52 in 49% and 65% yield, respectively.   
 
2.3 Installation of the C1-C6 side chain 
i.   Literature precedent for the key cross metathesis reaction 
 Having developed an efficient route to the spiroketal core, focus was shifted to 
the synthesis and appendage of the unsaturated side chains to spiroketal 51 or 52 via 
cross metathesis.  Attention was first turned to installation of C1-C6 side chain 49.  Over 
the years, cross metathesis has been widely used in total synthesis; however, few 
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examples exist in which a similarly substituted diene, a Type III olefin, and an allylic 
alcohol, a Type II olefin, undergo a cross metathesis reaction.64  One example of a 
comparable cross metathesis comes from the synthesis of apoptolidinone completed by 
our group.65,66  The synthesis features a highly selective cross metathesis between diene 
82 and trienoate 83 to arrive at advanced intermediate 84 in 63% yield (Scheme 2.11).   
 
ii.   Model studies on the key cross metathesis reaction 
Based on this strong literature precedent, we proceeded with a model system to 
optimize conditions for our proposed cross metathesis.  Previously prepared ester 62 
was identified as a suitable model system, as upon installation of the C6-C8 diene, this 
fragment maps onto the right-hand portion of the spiroketal core (Scheme 2.12).  The 
same cross metathesis/methylene Wittig sequence was employed to arrive at model 
diene system 86 in 50% yield.   
 
  The desired C1-C6 side chain could be generated in one step from unsaturated 
ester 70, an intermediate from the synthesis of -ketophosphonate 76, in 92% yield 
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(Scheme 2.13).  Thus, C1-C6 side chain 49 was prepared in five steps and 76% overall 
yield.   
 
With both C1-C6 side chain 49 and model diene 86 in hand, optimization of the 
key cross metathesis reaction was carried out.  Our first task was identification of the 
optimal metathesis catalyst.  Exposure of diene 86 and C1-C6 side chain 49 to Grubbs 
2nd generation catalyst (G2) or Hoveyda-Grubbs 2nd generation catalyst (HG2) in 
methylene chloride at room temperature resulted in a modest 28% and 17% yield of 
cross metathesis adduct 87, respectively (Table 2.3, entries 1-2).   Encouragingly, a 
majority of diene 86 was recovered unreacted, an indication that the poor yields could be 
attributed to low conversion, not decomposition of the starting material.  Since a higher 
yield was obtained with G2, we decided to focus on this catalyst for the remainder of our 
optimization studies.  In an effort to improve the rate of conversion, we opted to add the 
ruthenium catalyst to the reaction via syringe pump over several hours.  This strategy 
would allow us to introduce active catalyst over the course of the reaction, thereby 
circumventing low conversion as a result of catalyst decomposition.  Without changing 
any other experimental parameters, this simple procedural modification increased the 
yield to 48% (entry 3).  A 62% yield of cross metathesis adduct 87 was obtained when 
the reaction was run at an elevated temperature, comparable to the yield from the similar 
cross metathesis in the apoptolidinone synthesis (entry 4).   
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Entry Catalyst Rate of catalyst addition Conditions Yield 
1 G2 1 portion 23 °C, 24 h 28% (68% brsm) 
2 HG2 1 portion 23 °C, 24 h 17% (98% brsm) 
3 G2 syringe pump addition (8 h) 23 °C, 24 h 48% 
4 G2 syringe pump addition (8 h) 40 °C, 24 h 62% 
 
iii.   Cross metathesis to install the C1-C6 side chain 
Pleased with the yield obtained with the model system, our focus returned to the 
cross metathesis between spiroketals 51 or 52 and C1-C6 side chain 49.  Unlike the 
model system, in which the diene was the only olefin functionality present, the 
spiroketals necessary for the synthesis possess two terminal olefins.  It was expected 
that the diene would be more reactive towards cross metathesis with C1-C6 side chain 
49 than the allylic alcohol embedded in the tetrahydropyran at C19; unfortunately, this 
proved not to be the case (Scheme 2.14).  When a mixture of C1-C6 side chain 49 and 
spiroketal core 51 was treated with 20 mol % Grubbs 2nd generation catalyst (G2) in 
methylene chloride, a disappointing 20% yield of the desired cross metathesis product 
was obtained.  More discouraging was the discovery that this material was actually a 1:1 
of mixture of desired cross metathesis product 88 and undesired cross metathesis 
adduct 89, formed as a result of a non-selective cross metathesis reaction.   
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 The lack of discrimination between the terminal olefins at C7 and C20 in 
spiroketal 51 led us to consider an alternative substrate for the installation of the C1-C6 
side chain, in which there would be a stronger bias for reaction with the terminal olefin at 
C7.  We envisaged that ketone 90, derived from the spiroketal precursor, would fulfill this 
role as the triethylsilyl protecting group of the allylic alcohol at C19 would hinder the 
cross metathesis reaction from occurring at this site (Scheme 2.15).  Upon installation of 
the C6-C8 diene to ketone 53 via the sequential cross metathesis/Wittig reaction, diene 
90 was obtained in 57% yield.  Unlike the previous cross metathesis substrate, in which 
the spiroketal was formed prior to installation of the C6-C8 diene, ketone 53 required 
addition of precisely one equivalent of methylene triphenylphosphorane to avoid 
olefination of the C15 ketone.  Using the previously optimized conditions in which 
Grubbs 2nd generation catalyst (G2) was added dropwise to diene 90 and allylic alcohol 
49, the desired cross metathesis product was obtained exclusively in 70% yield, with no 
evidence of the product from the reaction of C1-C6 side chain 49 with the terminal olefin 
at C20.    
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2.4. Installation of the C21-C24 unsaturated side chain 
i.   Attempts to append the C21-C24 fragment via cross metathesis 
 From ketone 91, three steps remained in the total synthesis of the spirofungins, 
including introduction of the C21-C24 fragment.  The C21-C24 side chain was available 
in three steps from pyruvic aldehyde dimethyl acetal (Scheme 2.16).  A Horner-
Wadsworth-Emmons olefination, followed by acetal hydrolysis unveiled an intermediate 
aldehyde, which upon a methylene Wittig reaction furnished diene 50 in 55% overall 
yield.67-69   
 
Our initial attempt to append the C21-C24 diene involved a cross metathesis 
reaction between diene 50 and ketone 91.  Not surprisingly, as the triethylsilyl ether at 
C19 had been utilized in the previous cross metathesis to inhibit reaction from occurring 
at this site, no reaction between diene 50 and ketone 91 occurred in the presence of 
either Grubbs 2nd generation catalyst (G2) or the more reactive Hoveyda-Grubbs 2nd 
generation catalyst (HG2) (Scheme 2.17).   
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As the olefin at C20 had exhibited reactivity towards allylic alcohol 49 when 
embedded in the spiroketal core, we next turned our attention to the spiroketal derived 
from ketone 91 as a suitable cross metathesis substrate.  Exposure of ketone 91 to 
PPTS in methanol resulted in a 90% yield of a 1:2 mix of spiroketals 94 and 95, in which 
the spirofungin B core was favored (Scheme 2.18).  The mixture of spiroketals 94 and 95 
and diene 50 was then treated with either G2 or HG2; disappointingly, no product 
formation was observed.  Variation of the temperature and catalyst loading was also 
explored; however, these efforts were unproductive as none of the desired product was 
obtained.   
 
In order to determine if diene 50 was a competent cross metathesis partner, we 
attempted the cross metathesis with C1-C6 side chain 49, which maps onto the left-hand 
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portion of the spiroketal core (Scheme 2.19).  To our delight, the cross metathesis 
between diene 50 and allylic alcohol 49 proceeded smoothly in the presence of 5 mol % 
Grubbs 2nd generation catalyst to generate dienoate 98 in 83% yield.   
 
It was thought that this model could be applied to our synthesis if we could arrive 
at a derivative of ketone 91 bearing a free alcohol at C20.  Straightforward removal of 
the triethylsilyl protecting groups was not a feasible option as spontaneous 
spiroketalization would occur.  Consequently, the ketone needed to be converted to a 
masked form prior to deprotection of the triethylsilyl groups.  The first option we chose to 
explore was masking the ketone as a thioketal (Scheme 2.20).  Unfortunately, attempts 
to install the thioketal from ketone 90 with ethanethiol and zinc triflate resulted in a 1:2 
ratio of spiroketals 51 and 52, providing evidence that the triethylsilyl groups were too 
acid labile to withstand the Lewis acidic conditions required to effect thioketal formation. 
 
As a result, ketone 99, bearing the more robust tri-iso-propylsilyl (TIPS) 
protecting groups, was prepared using a sequence analogous to that developed for the 
synthesis of ketone 53.  With bis-TIPS ketone 99 in hand, formation of the thioketal 
could be realized using the previous conditions to afford thioketal 100 in 75% yield 
(Scheme 2.21).  Disappointingly, when thioketal 132 was utilized in the key cross 
metathesis reaction, cross metathesis adduct 100 was obtained in an unacceptable 16% 
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yield.  We speculate that the low yield may be a result of the presence of the thioketal, 
as sulfur is capable of coordinating to the catalyst, rendering it inactive.  
 
We next considered an acetal strategy for masking the ketone.  With the acid 
stable TIPS protecting groups in place, we were optimistic that ketone 102 could 
withstand the conditions necessary for acetal formation (Scheme 2.22).  This indeed 
proved to be the case, as acetal 103 was prepared in 68% yield upon treatment of 
ketone 102 and 2,2-dimethyl-1,3-propanediol with PPTS in the presence of molecular 
sieves.  Introduction of the C6-C8 diene was achieved by the previously used cross 
metathesis/Wittig sequence to give rise to diene 104 in 70% yield.  The cross metathesis 
with the C1-C6 side chain was then carried out to give rise to cross metathesis adduct 
105 in a modest 35% yield.   
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 Prior to investing the time to address the low yield obtained for the key cross 
metathesis between acetal 104 and C1-C6 side chain 49, we wanted to ensure that the 
subsequent reactions could be carried out as planned.  We intended to remove the silyl 
protecting groups from acetal 105 to reveal the free alcohol at C20, perform the cross 
metathesis with C21-C24 diene 50, and subsequently reveal the ketone to effect 
spiroketalization.  Toward this end, deprotection of the TIPS protecting groups was 
explored (Scheme 2.23).  Due to the acid sensitivity of the acetal, we were limited to 
using fluoride sources to cleave the TIPS ethers.  With tetrabutylammonium fluoride 
(TBAF) and tris(dimethylamino) sulfonium difluorotrimethylsilicate (TASF), an anhydrous 
fluoride source, none of the desired triol 106 was obtained.   
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ii.   Incorporation of the C21-C24 side chain via aldol reaction 
 As a result of these unsuccessful attempts to install C21-C24 side chain 50 via 
cross metathesis, we decided to incorporate this fragment at an earlier stage in the 
synthesis.  We deemed the most straightforward manner for installing the C21-C24 side 
chain would be during the aldol reaction, in which we would employ known aldehyde 109 
instead of acrolein.70-72  Appending this fragment at the beginning of the synthesis would 
minimize deviation from the original synthetic plan.   
Aldehyde 109 was prepared in three steps from 107, available from an allylic 
oxidation of the tert-butyldimethylsilyl ether of 3-methyl-2-buten-1-ol (Scheme 2.24).73  
The treatment of aldehyde 107 with ylide 69 gave rise to dienoate 108 in 83% yield.  
Reduction of the ester with di-iso-butylaluminum hydride and subsequent manganese 
dioxide oxidation delivered aldehyde 109 in quantitative yield.   
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Gratifyingly, aldehyde 109 performed well in the Evans syn aldol reaction with 
thiazolidinethione 63 to give rise to aldol adduct 110 in 88% yield and >20:1 
diastereomeric ratio (Scheme 2.25).  As before, the resultant secondary alcohol was 
protected as the triethylsilyl ether, and the chiral auxiliary reductively cleaved to deliver 
aldehyde 111 in 81% yield over the two steps.  The aldehyde was converted to -
ketophosphonate 112 via the three step sequence utilized for the preparation of -
ketophosphonate 76.  Thus, the revised -ketophosphonate, to which the C21-C24 chain 
has already been incorporated, was obtained in six steps and 48% overall yield from 
known aldehyde 109.   
 
2.5 Completion of the total synthesis of spirofungins A and B 
With revised -ketophosphonate 112 and aldehyde 55 in hand, formation of the 
spiroketal precursor via a modified Horner-Wadsworth-Emmons olefination was 
explored.  Treatment of 112 with barium hydroxide followed by addition of aldehyde 55 
formed the desired C13-14 bond (Scheme 2.26).  Conjugate reduction of the resultant 
enone generated ketone 113 in 94% yield.61   
38 
 
 
Initially, we sought to append C1-C6 side chain 49 to the rest of the molecule by 
a cross metathesis reaction with the diene derived from ketone 113, as this sequence 
had provided the best results with the previous substrates.  Additionally, this route would 
offer the advantage of postponing the spiroketalization until the final steps, minimizing 
the number of transformations which would have to be carried out on the independent 
spiroketals.  Introduction of the C6-C8 diene to ketone 113 was achieved via the two 
step cross metathesis/methylene Wittig sequence (Scheme 2.27).  With this particular 
substrate, the methylene Wittig reaction proved quite problematic.  After initially 
obtaining diene 115 in 60% yield, these same results could not be obtained consistently, 
with yields ranging from 8-40%.  As a consequence of requiring precisely one equivalent 
of methylene triphenylphosphorane, the reaction was plagued by low rates of 
conversion, despite taking extensive measures to exclude moisture from the reaction.  
When a slight excess of methylene triphenylphosphorane was employed in the reaction, 
bis-olefinated product 116 was obtained; in addition, unreacted aldehyde 114 was also 
recovered from the reaction mixture.  Crystallized, salt-free methylene 
triphenylphosphorane, which can be added as a solution throughout the course of the 
reaction, was also explored.74  Significant variation in the yield for the methylene Wittig 
was also observed with the salt-free ylide, with yields ranging from 20-69%.   
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Although we were not satisfied with these results, we decided to push forward 
and investigate the cross metathesis reaction, with the intention of optimizing the Wittig 
after assessing the viability of the remaining steps in the synthesis.  Toward this end, the 
cross metathesis reaction between ketone 115 and C1-C6 side chain 49 was carried out 
using the previously optimized conditions to afford cross metathesis adduct 117 in 50% 
yield (Scheme 2.28).  Ketone 117 contains the entire carbon skeleton of the natural 
product with spiroketalization, adjustment of the oxidation state at C24, and hydrolysis 
the ethyl ester as the only remaining steps.    
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Exposure of ketone 117 to PPTS in methanol resulted in facile cleavage of the 
three silyl protecting groups and spontaneous spiroketalization to generate a 2:1 ratio of 
spiroketals 118 and 119 in a moderate 50% yield.  Upon correlation of the characteristic 
signals corresponding to protons at C11 and C19 to the 1H NMR spectra of spiroketals 
51 and 52, it was determined that the major product corresponded to the spirofungin A 
core.  Intrigued by the reversal of selectivity, we wanted to probe whether these results 
could be attributed to the presence of the C1-C6 side chain or the C21-C24 side chain in 
the spiroketal precursor.  Toward this end, ketone 113, which bears the C21-C24 side 
chain, but not the C1-C6 side chain, was subjected to the identical spiroketalization 
conditions (Scheme 2.29).  Cleavage of the silyl protecting groups with concomitant 
formation of a 2:1 mixture of spiroketals 120 and 121 resulted.  The spiroketals were 
readily separated by flash column chromatography to give 120 and 121 in 56% and 26% 
yields, respectively.   
 
NOESY and COSY NMR analysis determined that the major product 
corresponded to the spiroketal core of spirofungin A (Figure 2.2).   A strong correlation 
between the proton at C11 and those at C20 and C21 was observed, confirming the 
assignment of 120 as the spirofungin A core.  Upon comparison of the various 
spiroketals prepared during the course of our synthetic efforts, it was evident that the 
presence of the C21-C24 side chain, not the C1-C6 side chain, in the spiroketal 
precursor has a greater influence on the stereochemical outcome of the 
spiroketalization.   
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The significantly higher yield obtained for the spiroketalization of ketone 113 
compared to 117, in combination with the inconsistency of the methylene Wittig reaction, 
caused us reconsider our endgame strategy.  We decided to pursue our original 
synthetic plan, in which we would construct the spiroketal core prior to installation of C1-
C6 side chain 49.  With the C20-24 side chain already in place, competition between the 
two terminal olefins during the cross metathesis was no longer an issue.   
Moving forward with the synthesis, spiroketals 120 and 121 were independently 
carried through the remaining steps.  Introduction of the desired oxidation state of C24 
was achieved by a manganese dioxide oxidation employing sodium cyanide and 
methanol to deliver methyl esters 122 and 123 directly from allylic alcohols 120 and 121, 
each in 78% yield (Scheme 2.30).75,76 To arrive at the desired cross metathesis partner, 
installation of the C6-C8 diene was accomplished via the previously utilized two-step 
sequence.  Treatment of 122 or 123 with methacrolein and Grubbs 2nd generation 
catalyst gave rise to enals 124 and 125 each in 74% yield. A methylene Wittig olefination 
introduced the terminal olefin, providing dienes 126 and 127 in 86% and 75% yield, 
respectively. 
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The major bond forming event that remained was introduction of the C6-C7 bond 
via the key cross metathesis reaction between diene 126 or 127 and C1-C6 side chain 
49 (Scheme 2.31).  The previously optimized conditions for the cross metathesis, in 
which Grubbs 2nd generation catalyst (G2) was added as a solution over several hours, 
delivered the cross metathesis products 128 and 129 in 83% and 71% yield respectively, 
based on recovered diene.  Finally, employing conditions used in Shimizu’s synthesis of 
the spirofungins,5 hydrolysis of diesters 128 and 129 with lithium hydroxide provided ()-
spirofungin A (1) in 87% yield and (+)-spirofungin B (2) in 88% yield. 
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2.6. Summary 
 A highly convergent total synthesis of spirofungins A and B was completed in 14 
steps as the longest linear sequence from known aldehyde 109, 19 steps from 
commercially available 3-methyl-2-buten-1-ol. The three key fragments: aldehyde 55, -
ketophosphonate 112, and C1-C6 side chain 49, were all prepared in six steps or less in 
46%, 48%, and 76% overall yield, respectively.  A highlight of the synthesis is the use of 
the thiazolidinethione mediated propionate and acetate aldol reactions developed in our 
laboratories to install five of the seven stereocenters of the natural product.  The 
synthesis also features a demanding cross metathesis reaction, which proved to be an 
efficient strategy for appending the C1-C6 side chain to the spiroketal core.   
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CHAPTER THREE 
 
Background: (+)-Sorangicin A 
 
3.1 Isolation 
In 1985 (+)-sorangicin A (130) was isolated by Höfle and Reichenbach from 
Sorangium cellulosum strain So ce12 (Figure 3.1).77,78  The producing strain was 
originally isolated from a soil sample collected in Xcaret, Mexico in 1978.  The gliding 
bacteria (myxobacteria) Sorangium cellulosum, from which sorangicin A was isolated, 
has been identified as a rich source of structurally diverse secondary metabolites 
possessing a broad range of bioactivity.79  Sorangicin A has shown promise as a broad 
spectrum antibiotic, as it is active against both Gram-positive and Gram-negative 
bacteria.78  As a result of its significant biological properties and unique structure, 
sorangicin A was identified as an attractive target for total synthesis.   
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3.2 Structural determination 
Structural elucidation of sorangicin A was carried out primarily using high-
resolution mass spectroscopy in combination with extensive 1-D and 2-D NMR analysis.   
The molecular formula of C47H66O11 and molecular weight of 806 g/mol were determined 
by negative ion fast atom bombardment (FAB) and high resolution electron impact (EI) 
mass spectroscopy, and confirmed by elemental analysis.77,80   
With the molecular formula as a basis for structural assignment, several 1H-1H 
and 1H-13C 2-D NMR experiments were conducted to elucidate the structure of 
sorangicin A.  X-ray crystal analysis later confirmed the connectivity and absolute 
configuration of the natural product.80  While the structure and stereochemical 
assignments originally reported by Höfle and Reichenbach were correct, contradictory 
reports of the configuration of the C10 stereocenter resulted in several publications in 
which the stereochemistry at this position was inverted.81-89  The stereogenicity at C10 
as S, as had been originally reported, was clarified by Jansen in 2008 (See Figure 3.1).90  
Sorangicin A contains 15 stereocenters and features a signature bicyclic ether, a tetra-
substituted tetrahydropyran, and a tri-substituted dihydropyran all embedded in a 31-
membered macrolactone.  Additionally, the macrocyclic skeleton is highly unsaturated 
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and contains a sensitive (Z,Z,E)-trienoate, to which the instability of the natural product 
toward several reagents  has been attributed.81   
3.3  Biological activity 
Prior to the isolation of any myxobacterial antibiotics from Sorangium cellulosum, 
the important role of these bacteria in cellulose degradation in the soil had long been 
recognized.91  Reports of the production of antibacterial substances by myxobacteria 
date back to 1946; however, it was not until the mid-1970s that the structure of a 
myxobacterial antibiotic was first described.  At this time there was a renewed interest in 
myxobacterial antibiotics, resulting in the characterization of a significant number of 
biologically active secondary metabolites over the next decade, amongst them, 
sorangicin A.79   
Sorangicin A was identified as the main bioactive component of Sorangium 
cellulosum strain So ce12, exhibiting potent activity against both Gram-positive and 
Gram-negative bacteria.  Sorangicin A is especially active towards Gram-positive 
bacteria, such as Staphylococcus aureus, with minimal inhibitory concentration (MIC) 
values ranging from 0.01 to 0.1 g/mL.  At higher concentrations (3-30 g/mL) Gram-
negative bacteria, such as Escherichia coli, are also inhibited, while yeasts and molds 
are resistant.77  Interestingly, sorangicin A is active against several myxobacteria (MIC 
0.1-3 g/mL), however, against the producing strain So ce12, higher concentrations (50 
g/mL) were required for inhibition.  The exceptional antibiotic activity displayed by 
sorangicin A makes it the most potent myxobacterial antibiotic isolated to date.79   
Sorangicin A was found to be an inhibitor of RNA polymerase (RNAP), the 
enzyme responsible for transcription of DNA into RNA.  This mechanism of action is 
identical to the ansamycin antibiotic rifampin, a known RNAP inhibitor commonly used 
for the treatment of tuberculosis.82,92  In the case of sorangicin A and rifampin, inhibition 
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of RNA polymerization is the result of a steric clash between the RNAP-bound antibiotic 
and the path of the elongating RNA transcript, resulting in a build-up of RNA transcripts 
no longer than 2-3 nucleotides.  Studies by Jansen and Darst82 revealed that sorangicin 
A and rifamycin bind in the same RNAP -subunit pocket, despite the fact that these 
natural products are structurally dissimilar.  Interestingly, an X-ray crystal structure of a 
bacterial RNAP in complex with sorangicin established that the overall shape of 
sorangicin compared to rifampin in the binding pocket is very similar.  In fact, all 12 
residues which interact with rifampin also interact with sorangicin.   
Jansen and Darst were also responsible for a cross-resistance study which 
helped illustrate the differences in the way these antibiotics interact with RNAP.  Known 
rifampin-resistant E. coli mutants were employed in the cross-resistance study in an 
effort to determine if these same mutations also resulted in sorangicin resistance.  While 
several mutations led to strong resistance to both sorangicin A and rifampin, in a number 
of cases, mutations which led to strong resistance against rifampin, showed little or no 
change in sorangicin binding affinity.  This class of mutants, which saw a different 
response from sorangicin A compared to rifampin, contained residues which were 
expected to introduce unfavorable steric interactions or alter the shape of the binding 
pocket.  The results of the cross-resistance study indicate a distinct difference between 
these RNAP inhibitors is the ability of sorangicin to adapt to fluctuations in the shape of 
the binding pocket, while rifampin is extremely sensitive to changes in conformation.  It is 
speculated that this is a result of the structural rigidity of rifampin as compared to 
conformational flexibility of sorangicin A.  The ability of sorangicin to accommodate 
distortion of the binding pocket has implications for the further exploration of sorangicin 
A as an antibiotic.   
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3.4 Previous synthetic efforts 
 As one would expect, the complex architecture and important biological activity of 
(+)-sorangicin A have drawn the attention of the synthetic community.  To date, Smith 
and co-workers have completed the only total synthesis of sorangicin A,90 with the 
groups of Schinzer,86 Lee,85 Mohapatra,89 and Srihari,88 in addition to our own,87 having 
published progress towards key fragments of this natural product.   
i. Smith’s total synthesis of (+)-sorangicin A 
Smith and co-workers divided (+)-sorangicin A (130) into three key fragments: 
C16-C29 tetrahydropyran 131, C1-C15 dihydropyran 132, and C30-C38 bicyclic ether 
core 133 (Scheme 3.1).90  They envisioned that these three fragments could be 
assembled by a Julia-Kocienski olefination to form the C15-C16 and C29-C30 bonds.  
Incorporation of the sensitive (Z,Z,E)-trienoate linkage would be achieved via a late 
stage Stille reaction with vinyl stannane 134.   
 
 In a 2005 communication, the Smith group disclosed their routes towards C16-
C29 tetrahydropyran (THP) 131 and C1-C15 dihydropyran (DHP) 132.84  For 
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tetrahydropyran 131, initially a Petasis-Ferrier union/rearrangement93,94 was explored, an 
approach which has been implemented in several total syntheses published by the 
Smith group.95-97  Formation of dioxanone 137 from -hydroxy acid 135 and aldehyde 
136 was readily accomplished in near quantitative yield by employing TMSOTf as a 
Lewis acid (Scheme 3.2).98  Despite the success of the Petasis-Ferrier 
union/rearrangement, in which ketone 138 was prepared in 56% yield from dioxanone 
137, subsequent installation of the C25 stereocenter in a selective manner could not be 
realized.   
 
Unable to install the C25 alcohol in a stereoselective fashion, they turned their 
attention towards an aldol approach for the preparation of tetrahydropyran 131.  Toward 
this end, ketone 140 and aldehyde 141 were prepared and utilized in a boron-mediated 
aldol reaction, giving rise to -hydroxy ketone 142 in 93% yield as a separable mixture of 
diastereomers (Scheme 3.3).  Each diastereomer was subjected to acidic conditions to 
cleave the triethylsilyl (TES) ether and induce formation of mixed methyl ketal 143 or 144 
in 82% or 92% yield, respectively.  At this point, the moderate selectivity of the aldol 
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reaction could be addressed, as the minor diastereomer could be converted to 143 by 
means of a high yielding oxidation-reduction sequence.   
 
Introduction of the C16-C18 fragment to alkyne 143 was the next task at hand.  
The reduction of mixed methyl ketal 143 by triethylsilane mediated by TMSOTf, followed 
by protection of the C25 alcohol as the methoxymethyl (MOM) ether delivered 
tetrahydropyran 145 in 93% yield over the two steps (Scheme 3.4).  Alkyne 145 was 
converted to an intermediate vinyl iodide via a hydrozirconation/iodination sequence.27  
Suzuki-Miyaura99 coupling with alkyl boronate 146 generated the carbon skeleton of the 
C16-C29 fragment in quantitative yield over the two steps.  Protecting group 
manipulation of tetrahydropyran 147 generated alcohol 148 in 59% yield over the three 
steps.  Finally, conversion of the alcohol to the sulfone100 under standard conditions 
afforded tetrahydropyran 131 in 17 steps and 17% overall yield.   
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Their approach toward the dihydropyran fragment hinged on the success of a 
conjugate addition/-oxygenation sequence with dihydropyrone 150 and vinyl bromide 
155 (Scheme 3.5).  The requisite dihydropyrone was prepared via a hetero Diels-Alder 
reaction between the Danishefsky diene and aldehyde 149, available from 1,3-
propanediol in two steps.  The hetero Diels-Alder reaction proceeded with both high yield 
and enantioselectivity (20:1 er) in the presence of a catalytic amount of chromium (III) 
complex 151, initially developed by Jacobsen.101,102  Vinyl bromide 155 was prepared in 
five steps, with the lone stereocenter installed via a Myers alkylation with ephedrine-
derived auxiliary 152.103   
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Upon generation of the higher order cuprate derived from vinyl bromide 155 and 
addition of dihydropyrone 150, the enolate formed in situ was trapped as the silyl enol 
ether to give rise to 156 in 61% yield (Scheme 3.6).  Rubottom oxidation104 and 
protection of the resultant alcohol as the TBS ether provided -hydroxy ketone 157 in 
46% yield over the three steps.  Formation of the vinyl triflate105 derived from the kinetic 
enolate, followed by reduction106 afforded dihydropyran 158 in 71% yield.  The alcohol at 
C1 was converted to the tert-butyl ester upon cleavage of the p-methoxybenzyl ether 
followed by a three step oxidation sequence to deliver tert-butyl ester 160.107  As a result 
of the ambiguous representation of the C10 stereocenter, Smith and co-workers initially 
targeted ester 160 in their efforts towards sorangicin A, in which the C10 stereocenter is 
inverted.  Upon confirmation of the C10 stereochemistry by Jansen, ester 160 was 
converted to dihydropyran 162 by a five step sequence.  Unfortunately, attempts to 
correct the stereochemistry by means of a Mitsunobu reaction were met with failure due 
to the predominance of the SN2´ pathway. Upon inversion of the C10 stereocenter, 
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cleavage of the primary TBS ether from dihydropyran 162 and conversion of the alcohol 
to sulfone 132 was accomplished using standard conditions in 70% yield over the three 
steps.  This route developed by Smith and coworkers enables the preparation of the 
dihydropyran fragment, sulfone 132, in 25 steps and 4.0% overall yield.   
 
A route towards the final fragment, dioxabicyclo[3.2.1]octane core 133, was first 
reported by Smith in 2004.83  Their synthesis featured a kinetically controlled, regio- and 
stereoselective epoxide ring opening to arrive at the desired fragment in 15 steps and 
2.4% overall yield.  The lessons learned from their synthesis of the dihydropyran led to 
54 
 
the publication of a second generation synthesis of bicyclic aldehyde 133 in 2009.108  
The revised approach was more efficient both in terms of number of steps and overall 
yield than the original route.   
 The second generation route towards bicyclic ether 133 begins with a hetero 
Diels-Alder reaction between the Danishefsky diene and aldehyde 163 in the presence 
of previously used chromium-Schiff base 151.109  Under these conditions, dihydropyrone 
164 was prepared in 86% yield and a 33:1 diastereomeric ratio (Scheme 3.7).  
Conjugate addition followed by trapping of the in situ generated enolate was explored.  
Bromostyrene was selected as a suitable nucleophile, wherein the styrene component 
would serve as a masked aldehyde.  Lithium halogen exchange of the bromine with tert-
butyllithium followed by addition of dimethylzinc and subsequent addition to 
dihydropyrone 164 effected the desired conjugate addition.110  Quenching of the enolate 
with methyl iodide in the presence of HMPA led to the desired product, albeit in a 
moderate 51% yield.  Further optimization of this reaction revealed that addition of 
CuI·PBu3 prior to addition of methyl iodide attenuated the reactivity of the zinc enolate, 
allowing for formation of ketone 165 in 73% yield.  Selective reduction of the ketone with 
L-selectride followed by cleavage of the acetonide revealed triol 166 in 80% yield.  The 
triol could be converted to bicyclic ether 168, an intermediate from our synthesis of the 
C29-C37 bicyclic ether fragment, directly upon addition of potassium 
hexamethydisilazide and trisyl chloride in 33% yield.  Alternatively, a two-step protocol 
involving selective sulfonylation of the primary hydroxyl followed by treatment with 
KHMDS, furnished 168 in a much improved 70% yield over the two steps.  Parikh-
Doering oxidation111 of the resultant alcohol and subsequent Takai olefination112,113 
delivered the E- and Z-vinyl iodides in 52% and 16% yields, respectively.  Finally, 
chemoselective dihydroxylation of the electron rich olefin followed by oxidative cleavage 
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of the diol generated bicyclic aldehyde 133 in 10 steps from aldehyde 163 and 11.3% 
overall yield.   
 
In this publication, Smith and co-workers also demonstrated the viability of the 
proposed Stille coupling for installing the (Z,Z,E)-trienoate (Scheme 3.8).  The palladium 
catalyzed reaction between vinyl iodide 133 and vinyl stannane 134 furnished trienoate 
170 in 96% yield, which upon treatment with lithium hydroxide, could be converted to 
acid 171.  Most notably, these conditions delivered the acid with complete preservation 
of the olefin geometry.   
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 With the three key fragments in hand, and precedent for the installation of the 
sensitive trienoate moiety, investigation of the Julia-Kocienski olefination114 for forming 
the C15-C16 and C28-C29 bonds was the next task at hand.  Development of conditions 
for the union of tetrahydropyran 131 and bicyclic aldehyde 133 was not trivial (Scheme 
3.9).  Investigation of several different solvent and base combinations revealed that tert-
butylithium in a 3:1 ratio of DMF and HMPA provided the best yields of coupled adduct 
172, as exclusively the E-olefin.115  Several recycles of the recovered starting material 
allowed for the advancement of the coupled material in around 65% yield.  In two steps, 
C1-C38 fragment 172 was converted to aldehyde 173, setting up the second Julia-
Kocienski reaction.  They were pleased to find that the second key fragment coupling 
between sulfone 132 and aldehyde 173 proceeded in 88% yield with complete 
conversion and olefin selectivity when the reaction was run in DME with KHMDS as the 
base.   
 
57 
 
At this point, all that remained was installation of the C39-C43 trienoate and 
global deprotection.  After cleavage of the C25 TBS ether from the C1-C38 fragment 
174, a Stille coupling with vinyl stannane 134116 was achieved in 88% yield using the 
conditions from the model system (Scheme 3.10).  The excess Ph2PO2NBu4 suppressed 
E/Z isomerization allowing for the isolation of (Z,Z,E)-trienoate 175 with minimal 
isomerization.117  Hydrolysis of the ester was quickly followed by macrolactonization 
using the Evans-modified Mukaiyama protocol118,119 to deliver macrocycle 177, 
containing the entire carbon skeleton of the natural product.  Identification of conditions 
for the global deprotection was nontrivial, as it was known that the (Z,Z,E)-trienoate was 
extremely sensitive to isomerization.81  Thus, mild conditions which effected the 
cleavage of the methoxymethyl ether, acetonide, and tert-butyl protecting groups were 
eventually realized after a considerable amount of experimentation, to deliver (+)-
sorangicin A (130) in 70% yield over the final two steps.   
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ii.    Schinzer’s synthesis of the C8-C15, C21-C28, and C29-C37 fragments 
 Besides the total synthesis by Smith and co-workers, the Schinzer group has 
reported the most progress towards the natural product.86  Their retrosynthetic approach 
involves a similar disconnection strategy to that employed by Smith, in which they would 
target tetrahydropyran 178, bicyclic ether 179, dihydropyran 180, and alcohol 181 
(Scheme 3.11).  In 2004, Schinzer and co-workers published their approach towards 
each of these orthogonally functionalized fragments, although no indication of their 
coupling strategy was divulged in this paper, and no progress has since been reported.   
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 A key feature of their synthetic approach is exploitation of the similar structures of 
the bicyclic ether and tetrahydropyran (THP) portions of the natural product.  These 
fragments differ only in the stereochemistry at C27 and C31 allowing for the preparation 
of tetrahydropyran (THP) 178 and bicyclic ether 179 from a common starting material 
(Scheme 3.12).  Beginning with aldehyde 149, also utilized as a starting material in 
Smith’s synthesis of the dihydropyran, asymmetric crotylation120 followed by protection of 
the resultant alcohol as the TIPS ether generated terminal olefin 183 in 60% yield over 
the two steps.  Osmium tetraoxide mediated dihydroxylation delivered a mixture of 1,2-
diols 184 and 185 in 48% and 24% yield, respectively.  Upon separation of the 
diastereomers, diol 184 was taken on to bicyclic ether 179, while diol 185 was advanced 
to tetrahydropyran 178.    
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 Efforts were first directed towards the synthesis of tetrahydropyran 178 from diol 
185, the minor diastereomer from the dihydroxylation reaction.  Protection of diol 185 as 
the acetonide with concurrent cleavage of the primary TBS ether, followed by TPAP 
oxidation121 furnished aldehyde 186 in 62% yield over the two steps (Scheme 3.13).  
Homologation of the aldehyde to Z--unsaturated ester 187 was accomplished via a 
Horner-Wadsworth-Emmons olefination with the Still-Gennari reagent122 in 91% yield.  A 
three step reduction, epoxidation, and protection sequence afforded benzyl ether 188 in 
44% yield over the three steps.  Finally, exposure of epoxide 188 to CSA effected 
formation of tetrahydropyran 178 via a ring closingepoxide opening cascade.    
 
 Diol 184 was carried through the identical seven step sequence to deliver 
tetrahydropyran 189 in 16% yield (Scheme 3.14).  In order to convert tetrahydropyran to 
the desired bicyclic ether, several steps of protecting group manipulations were carried 
out to give rise to alcohol 190 in 49% yield over the four step sequence.  Upon treatment 
of secondary alcohol 190 with mesyl chloride, a 59% yield of mesylate 191, along with 
28% of the desired bicyclic ether 179 were obtained.  From the mesylate, bicyclic ether 
179 could be accessed in 45% yield over two additional steps via removal of the p-
methoxybenzyl ether and treatment with base.  This synthetic approach, which takes 
advantage of the similarities between the THP and bicyclic ether fragments, allowed for 
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the preparation of THP 178 in 10 steps and 6% overall yield and bicyclic ether 179 in 17 
steps and less than 1% overall yield.  
 
 For the remaining dihydropyran subunit, Schinzer and co-workers opted to use a 
starting material from the chiral pool, namely L-glucose, which bears the requisite 
stereochemistry at C9 and C10 (Scheme 3.15).  From L-glucose (192), a known one-pot, 
three-step procedure developed by Koreeda123 was employed to prepare a tri-O-acetyl-L-
glucal, which upon deprotection yielded dihydropyran 193 in 81% yield over the two 
steps.  Treatment of triol 193 with allyltrimethyl silane and TMSOTf delivered allylated 
product 194 in 84% yield with excellent diastereoselectivity (>99%).  Protection of diol 
194 as the bis-TBS ether followed by chemoselective cleavage of the terminal olefin 
generated aldehyde 195 in 70% yield.  The aldehyde was converted to the dimethyl 
acetal and the primary TBS ether was selectively cleaved to give rise to acetal 196 in 
69% yield over the two steps.  Finally, the C8 methyl ketone was installed by a three-
step oxidation, Grignard addition, oxidation sequence in 78% yield, completing C8-C15 
fragment 180 in 10 steps and 25.5% overall yield.  Efforts by the Schinzer group to 
couple these key fragments and complete the total synthesis are currently underway.   
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iii.   Lee’s synthesis of the C8-C15 fragment 
 The Lee group has reported two pathways for accessing C8-C15 dihydropyran 
203, both of which utilize a ring-closing metathesis for assembly of the six-membered 
ring.85  The first route features the aldol/ ring closing metathesis approach which was 
developed in our laboratories for the preparation of medium ring ethers124 (Scheme 
3.16).  Beginning with allylic alcohol 197, initial treatment with bromoacetic acid gave 
rise to glycolic acid 198 in near quantitative yield.  Conversion of the acid to the mixed 
anhydride followed by addition of lithiated oxazolidinone 199 delivered acylated product 
200 in 81% yield.  An aldol reaction between glycolate 200 and acrolein provided aldol 
adduct 201 in 73% yield with excellent diastereoselectivity (93:7 dr).125  Protection of the 
resultant secondary alcohol as the TBS ether followed by lithium borohydride reduction 
afforded diene 202 in 80% yield over the two steps.  Formation of the six-membered ring 
was realized upon treatment of diene 202 with Grubbs 1st generation catalyst (G1), 
generating C8-C15 dihydropyran 203 in 86% yield.  The aldol/ring closing metathesis 
approach provided C8-C15 dihydropyran 203 in six steps and 40% overall yield.   
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 The Lee group also investigated a more novel approach towards C8-C15 
dihydropyran 203 which features an enantioselective rhodium catalyzed allylic 
etherification reaction (Scheme 3.17).126,127  This route towards the desired intermediate 
commences with an Evans syn aldol reaction between p-methoxybenzyl glycolate 204 
and acrolein, to generate aldol adduct 205 in 84% yield in a 92:8 diastereomeric ratio.  A 
four step sequence converted aldol adduct 205 to bis-TBS alcohol 207 in 70% yield.  
The Rh-catalyzed allylic etherification reaction between homoallylic alcohol 207 and tert-
butyl carbonate 208 afforded diene 209 in 67% yield.  Upon removal of the primary TBS 
ether and ring-closing metathesis, previously prepared dihydropyran 203 was obtained 
in eight steps and 26% overall yield.   
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iv.   Srihari’s synthesis of the C16-C29 fragment 
 The Srihari group recently reported a Prins cyclization approach towards C16-
C28 fragment 148, an intermediate from Smith’s total synthesis of (+)-sorangicin A.88  
The carbohydrate-based approach begins with opening of lactol 210,128 available in one 
step from D-ribose (Scheme 3.18).  The treatment of lactol 210 under Wittig conditions 
effected opening of the lactol with concurrent methylene Wittig olefination to deliver 
terminal olefin 211.129  The primary alcohol was converted to the tosylate in the presence 
of dibutyltin oxide; subsequent treatment of the tosylate with sodium hydride resulted in 
formation of epoxide 212 in 61% yield from acetonide 210.  Upon addition of lithiated 
propyne to epoxide 212,130 an intermediate alkyne was generated, which after Lindlar 
reduction delivered Prins cyclization precursor 213 in 97% yield.   
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 With cyclization precursor 213 in hand, formation of the tetrahydropyran by a 
Prins cyclization was explored.  Initially, a Prins cyclization between homoallylic alcohol 
213 and 3-benzyloxy propionaldehyde was investigated.  Unfortunately, under these 
conditions, none of the cyclized product was obtained; thus, a segment coupled Prins 
cyclization with -acetoxy ether 215 was pursued (Scheme 3.19).131  Esterification of 
alcohol 213 with 3-benzyloxy propanoic acid in the presence of DCC, followed by 
reduction and acetate formation, afforded cyclization precursor 387 in 98% yield.  The 
treatment of -acetoxy ether 215 with boron trifluoride diethyl etherate and acetic acid 
initiated the Prins cyclization to give rise to tetrahydrofuran 216 as a 9:1 mixture of 
diastereomers, epimeric at the C26 methyl group.  Fortuitously, the major product 
featured the necessary stereochemistry at the methyl position; unfortunately, the same 
was not true for the C25 alcohol, also formed during the Prins cyclization.  Upon 
cleavage of the acetate followed by oxidation to ketone 217, several conditions for the 
selective introduction of the C25 alcohol were explored.  Disappointingly, all attempts 
resulted in a separable 1:1 mixture of diastereomers.  The best yields were obtained with 
di-iso-butylaluminum hydride, which gave rise to a 1:1 diastereomeric mixture of alcohols 
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218a and 218b in 46% and 50% yield, respectively.  The diastereomers were separated 
and only alcohol 218a, bearing the appropriate stereochemistry at C25, was carried 
forward.  A cross metathesis with TBS-protected 4-pentenol was envisioned for 
installation of the C16-C19 fragment.  Initial attempts were made to effect the cross 
metathesis in the presence of the acetonide protecting group; however, disappointing 
results prompted them to remove the acetonide protecting group prior to the cross 
metathesis reaction.  Toward this end, after protection of the C25 alcohol as the 
methoxymethyl ether, the acetonide was exposed to strongly acidic conditions to reveal 
diol 219 in 88% yield over the two steps.  The subsequent cross metathesis reaction 
between TBS protected 4-pentenol and diol 219 proceeded in 65% yield.64  With cross 
metathesis adduct 220 in hand, access to Smith’s C16-C28 intermediate 148 was 
attained upon re-protection of the cross metathesis adduct as the acetonide and 
cleavage of the benzyl ether.  This route described by Srihari enables the preparation of 
Smith’s C16-C28 intermediate in 17 steps and 7.7% overall yield from D-ribose.   
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v.   Mohapatra’s synthesis of the C30-C37 bicyclic ether 
 The most recent publication regarding the synthesis of (+)-sorangicin A was 
published by Mohapatra and co-workers, detailing the implementation of methodology 
developed in their group for accessing trans-2,6-disubstituted-3,4-dihydropyrans from 
-unsaturated aldehydes.89  This novel iodine-catalyzed reaction for the preparation of 
dihydropyrans in a highly diastereoselective manner was applied toward the synthesis of 
the signature C30-C37 bicyclic ether core.   
Unsaturated aldehyde 221, available from benzyloxyacetaldehyde in two steps 
via an asymmetric crotylation,120 cross metathesis sequence,132 was exposed to allyl 
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trimethyl silane and iodine to form trans-2,6-disubstituted-3,4-dihydropyran 222 in 90% 
yield (Scheme 3.20).  A two step oxidative cleavage of the terminal olefin delivered 
aldehyde 223 in 80% yield.  Asymmetric -aminoxylation, with proline as the catalyst 
and nitrosobenzene as the oxygen source, followed by in situ sodium borohydride 
reduction gave rise to 1,2-diol 224 in 61% yield.133,134  The primary alcohol was 
selectively protected as the tert-butyldiphenylsilyl (TBDPS) ether and subsequently 
treated with N-iodosuccinimide to furnish iodo-ether 225 as the only regioisomer.  
Finally, reduction with azobis-iso-butyronitrile (AIBN) and tributyltin hydride afforded 
C30-C37 bicyclic ether 226 in 95% yield, and 21% overall yield for the eight step 
sequence.   
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CHAPTER FOUR 
 
Formal Synthesis of the C1-C38 Fragment of (+)-Sorangicin A 
 
4.1 Synthetic approach towards (+)-sorangicin A 
 As in the previously reported approaches towards (+)-sorangicin A (130), we 
sought to divide the molecule into three key fragments: bicyclic ether 227, 
tetrahydropyran 228, and dihydropyran 229.  It was envisioned that the preparation of 
these orthogonally differentiated fragments would allow us to investigate several 
coupling strategies (Scheme 4.1).  Our initial focus was devoted to the development of 
efficient and high-yielding routes towards each of the core synthetic fragments.   
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4.2   Synthesis of the Core Fragments 
i.   Synthesis of bicyclic ether 227 
 Our synthetic approach towards bicyclic ether 227 by was reported by Crimmins 
and Haley in 2006.87,135  The route features an epoxide opening cascade with epoxy 
tosylate 236 to form the unique dioxabicyclo[3.2.1]octane skeleton.  The synthesis of 
cyclization precursor 236 commenced with an anti-aldol reaction between N-
propionylthiazolidinethione 230 and cinnamaldehyde (Scheme 4.2).136  The resultant 
alcohol was protected in situ as the trimethylsilyl (TMS) ether to afford the protected 
aldol adduct in one step.  Reductive removal of the chiral auxiliary with di-iso-
butylaluminum hydride furnished aldehyde 231 in 63% yield over the two steps.  
Aldehyde 231 was subsequently employed in an asymmetric Brown allylation with (+)-B-
allyldiisopinocampheyl borane to deliver diol 232 in 90% yield and excellent 
diastereoselectivity (>95:5 dr).137  Formation of p-methoxyphenyl (PMP) acetal 233 was 
achieved upon exposure of diol 232 to 4-methoxybenzaldehyde dimethyl acetal and 
PPTS.  Homologation of the carbon backbone by a cross metathesis reaction between 
ethyl acrylate and PMP-acetal 233 delivered an intermediate -unsaturated ester,64 
which upon di-iso-butylaluminum hydride reduction gave rise to allylic alcohol 234 in 
88% yield over the two steps.  The selection of a cyclic acetal for protection of the diol 
was critical, as the six-membered ring fixes the olefin side chains into a bis-equatorial 
relationship, such that ring closing metathesis is strongly disfavored.  The conversion of 
allylic alcohol 234 to the requisite epoxide was accomplished via a Sharpless 
asymmetric epoxidation138 to deliver epoxide 235 in 83% yield as a single diastereomer.  
Epoxide 235 was swiftly converted to the cyclization precursor, epoxy tosylate 236, in 
85% yield under standard conditions.      
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With epoxy tosylate 236 in hand, the epoxide opening cascade to form the 
signature bicyclic ether was explored (Scheme 4.3).  Initially, a stepwise approach 
towards bicyclic ether 227 was investigated in which treatment of epoxy tosylate 236 
with 5% HCl in THF/methanol facilitated cleavage of the p-methoxyphenyl (PMP) acetal 
and opening of the epoxide with concomitant formation of tetrahydropyran 237.139,140  
While the option for formation of a 5-membered tetrahydrofuran by a 5-endo-ring closure 
was possible, it was expected that the 6-exo-cyclization to form tetrahydropyran 406 
would be favored due to better overall orbital overlap.141  Next, tetrahydropyran 237 was 
exposed to potassium carbonate in methanol which upon displacement of the tosylate 
triggered rapid formation of epoxide 238.  Attempts to purify epoxide 238 resulted in 
decomposition; alternatively, the crude epoxide could be treated directly with 5% HCl in 
THF/MeOH to initiate the 5-exo-cyclization/epoxide opening cascade, generating bicyclic 
ether 227 in 84% yield over the two steps.  Upon further experimentation, Haley 
determined that this three step sequence could be accomplished in a more convenient 
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one-pot procedure in approximately the same overall yield.  The one-pot procedure was 
achieved by first treating epoxy tosylate 236 with 10% HCl in THF/methanol.  Upon 
consumption of the starting material, as observed by thin layer chromatography (TLC), 
10% aqueous NaOH was added until the reaction was basic.  The conversion of 
tetrahydrofuran 237 to epoxide 238 occurred immediately, at which time the reaction 
mixture was acidified with a second portion of 10% HCl.  The three step, one-pot 
procedure afforded bicyclic ether 227 in 62% yield, essentially the same as the 63% 
overall yield obtained for the stepwise procedure.  This synthetic approach, which 
features a regioselective epoxide opening cascade to form both rings of the bicyclic 
ether, provided the C29-C37 fragment of sorangicin A in nine steps and 16% overall 
yield.      
 
ii. Synthesis of tetrahydropyran 228 
Attention was then turned to the synthesis of tetrahydropyran 228.  As evidenced 
by Schinzer’s approach to the bicyclic ether and tetrahydropyran fragments, these cyclic 
ethers are structurally very similar.  Schinzer exploited this similarity by preparing both of 
these fragments from a common intermediate.86  Comparison of tetrahydropyran 228 to 
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THP-diol 237, an intermediate from the epoxide-opening cascade to form bicyclic ether 
227, reveals that these intermediates differ only in the orientation about two 
stereocenters (Scheme 4.4).  Crimmins and Haley intended to take advantage of this 
relationship by using a sequence analogous to that employed for the synthesis of 
bicyclic ether 227 to access tetrahydropyran 228.135  As bicyclic ether 227 was derived 
from epoxy tosylate 236, tetrahydropyran 228 would arise from epoxide 239, which 
would serve as the cyclization precursor.   
 
The synthesis of tetrahydropyran 228 began with an Evans syn aldol addition 
between N-propionylthiazolidinethione 63 and 3-butenal51 to deliver the aldol adduct in 
95% yield (Scheme 4.5).142  The resultant secondary alcohol was protected as the TBS 
ether to furnish protected aldol adduct 240 in 98% yield.  Elongation of the carbon 
backbone was achieved by a cross metathesis with ethyl acrylate to afford -
unsaturated ester 241 in 88% yield.  The treatment of cross metathesis adduct 241 with 
approximately six equivalents of di-iso-butylaluminum hydride effected reduction of the 
-unsaturated ester, while also cleaving the thiazolidinethione auxiliary.  The resultant 
alcohol was protected as the acetate to furnish aldehyde 242 in 68% yield over the two 
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steps.  Subsequent Brown asymmetric allylation137 of aldehyde 242 with (+)-Ipc2B-allyl 
gave rise to diol 243 in 77% yield after basic workup.    
 
 As in the synthesis of the bicyclic ether fragment, cyclization to form the 6-
membered tetrahydropyran would be facilitated by treatment of the corresponding epoxy 
alcohol 239 with acid.  It was postulated that by utilizing an acidic workup for the 
Sharpless asymmetric epoxidation,138 tetrahydropyran 244 could be prepared directly 
from allylic alcohol 243 by a 6-exo-cyclization of intermediate epoxy alcohol 239 
(Scheme 4.6).  In this case, the opportunity to form a seven-membered cyclic ether by a 
7-endo-ring closure exists; however, the 6-exo-cyclization to form the desired 
tetrahydropyran was expected to be highly favored.  This proved to be the case as upon 
acidic workup of the Sharpless asymmetric epoxidation, tetrahydropyran 244 was 
obtained in 82% yield.  Protection of the diol as the bis-TES ether afforded 
tetrahydropyran 228 in 90% yield.  This route towards the tetrahydropyran fragment, 
which parallels our approach towards bicyclic ether 227, delivered tetrahydropyran 228 
in eight steps and 32% overall yield.   
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iii. Synthesis of dihydropyran 229 
With bicyclic ether 227 and tetrahydropyran 228 in hand, we shifted our focus 
towards the synthesis of the remaining core fragment, dihydropyran 229.  Due to the 
unsaturation of the 6-membered ring, dihydropyran 229 required a significantly different 
approach than the acid-catalyzed epoxide-opening cascade employed for the previous 
two fragments.  With inspiration from the aldol/ring closing metathesis approach to 
medium ring ethers developed in our group,124 it was envisioned that dihydropyran 229 
could be prepared in a similar fashion through an alkoxy-allylation/ring closing 
metathesis sequence. 
The synthesis of dihydropyran 229 began with aldehyde 154, also utilized by 
Smith en route to vinyl bromide 155, which was employed in their synthesis of the 
dihydropyran fragment (Scheme 4.7).84  A Wittig olefination with stabilized ylide 245 
installed the requisite tri-substituted olefin, giving rise to an intermediate -unsaturated 
ester.  After a reduction, oxidation sequence, -unsaturated aldehyde 246 was 
obtained in 78% yield over the three steps.  Aldehyde 246 was converted to differentially 
protected syn-1,2-diol 247 via a Brown asymmetric alkoxyallylation with the [(Z)--
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alkoxyallyl]diisopinocampheyl borane  generated in situ from methoxymethyl allyl ether 
and (+)-B-methoxydiisopinocampheyl borane.143  The conversion of the resultant 
secondary alcohol to diene 248 was accomplished in 87% yield by subjecting allylation 
adduct 247 to a catalytic amount of PPTS in neat acrolein diethyl acetal.144  With diene 
248 in hand, conditions for the ring closing metathesis to form the dihydropyran were 
explored.37  Initial attempts at the ring closing metathesis were plagued by low 
conversion and inconsistent yields.  After screening a number of conditions, Haley 
determined that running the reaction in refluxing methylene chloride (0.015 M) in the 
presence of 10 mol % Grubbs 2nd generation catalyst provided the most consistent 
results, to give rise to cyclized product 249 in 59% yield as an inconsequential mixture of 
diastereomers.  We later determined that the yield for the ring closing metathesis could 
be improved to 83% by running the reaction in toluene at 80 °C at a slightly more dilute 
concentration (0.01 M).  Installation of the allyl side chain was accomplished by a 
Sakurai reaction with mixed acetal 249 and allyltrimethyl silane to deliver trans-2,6-
disubstituted-3,4-dihydropyran 250 in 92% yield as a single diastereomer.   
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The Sakurai reaction proceeds through an SN1 pathway, in which two possible 
oxocarbenium transition states can be accessed (conformer A or B) upon treatment of 
mixed acetal 249 with Lewis acid (Scheme 4.8).145,146  The excellent diastereoselectivity 
for dihydropyran 250 is rationalized by well precedented pseudoaxial addition to the 
more populated oxocarbenium conformer B from the top face (path C).  Conformer B is 
the favored transition state due to the minimization of steric interactions as a result of the 
large alkyl substituent (RL) occupying an equatorial orientation and the lone pair 
stabilization provided by the axially oriented methoxymethyl (MOM) ether, which is not 
available in conformer A.  Addition from the bottom face of conformer A (path B) is highly 
disfavored as a result of the developing syn-pentane interaction between the large alkyl 
substituent (RL) and the allyl group in the product.  A similar steric interaction would 
result between the allyl group and the MOM ether upon nucleophilic addition to the 
bottom face of conformer B (path D), making path C, which delivers the product with the 
requisite stereochemistry at C13, the most favorable pathway for addition to the 
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oxocarbenium ion.  The stereochemical outcome of the Sakurai reaction with mixed 
acetal 249 was confirmed by 2-D NOESY NMR analysis.135  A strong correlation 
between the proton at C9 with the proton at C10 and the protons of the allyl side chain 
was observed, while the absence of a cross peak between the protons at C9 and C13 
confirmed the stereochemical assignment of dihydropyran 250 as the 2,6-trans product.   
 
Introduction of the desired oxidation state of C1 was achieved by an analogous 
four step sequence to that employed by Smith and co-workers in their synthesis of the 
dihydropyran fragment (Scheme 4.9).84  Cleavage of the PMB ether from dihydropyran 
250 under oxidative conditions with DDQ delivered alcohol 251 in 83% yield.  A Dess-
Martin oxidation147 gave rise to aldehyde 252, which after a Pinnick oxidation to the 
intermediate acid,148 was swiftly converted to tert-butyl ester 229 upon treatment of the 
crude acid with tert-butyl isourea 159.107  This sequence provided dihydropyran 229 in 
11 steps from aldehyde 154 and 22% overall yield. 
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4.3 Cross metathesis approach toward assembly of the natural product 
Upon development of synthetic routes towards each of the core fragments, 
assembly of the natural product was the next task at hand.  A distinct advantage of the 
modular approach developed by Haley and Crimmins towards bicyclic ether 227, 
tetrahydropyran 228, and dihydropyran 229 is the opportunity to investigate a number of 
coupling strategies with only slight modification of these key intermediates.   
Haley quickly determined that a cross metathesis reaction was a viable approach 
towards uniting the elaborated bicyclic ether and tetrahydropyran fragments; however, 
the design of a consistent and high yielding approach for introducing the dihydropyran 
moiety proved to be a considerable challenge (Figure 4.1).135  The absence of the C16-
C20 fragment from the three key intermediates provides additional flexibility, such that 
introduction of the dihydropyran could be achieved via formation of either the C20-C21, 
C19-C20, or C15-C16 bond.  Both the acetylide addition to form the C20-C21 bond and 
the vinylzinc addition/cross metathesis approach to form the C19-C20 bond were 
investigated by Haley, and provided disappointing results.  We were pleased to find that 
the cross metathesis reaction to form the C15-C16 bond gave rise to the coupled 
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adduct; therefore, we decided to pursue a cross metathesis approach to unite the three 
core synthetic fragments.   
 
Retrosynthetically, we envisioned using a similar endgame strategy to Smith, in 
that the C39-C43 trienoate would be installed at a late stage by a Stille coupling between 
the vinyl iodide derived from C1-C37 fragment 253 and vinyl stannane 134 (Scheme 
4.10).  We sought to prepare advanced C1-C37 intermediate 253 by a cross metathesis 
reaction between dihydropyran 229 and bicyclic ether/THP fragment 254.  Bicyclic 
ether/THP fragment 254 was envisioned arise from a cross metathesis reaction with 
protected bicyclic ether 255 and tetrahydropyran 256, to which the C16-C20 fragment 
has been incorporated.   
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i.  Cross metathesis to form the C29-C30 bond 
Efforts towards bicyclic ether/THP fragment 254 began with preparation of cross 
metathesis partner 255, available from bicyclic ether 227 via a three step sequence 
(Scheme 4.11).  The protection of the alcohol of bicyclic ether 227 as the pivalate 
proceeded in 91% yield.  Next, a two step ozonolysis, methylene Wittig sequence was 
employed to convert the styrene component to the terminal olefin, thus giving rise to 
cross metathesis partner 255 in 90% yield over the two steps.135 
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 Attention was then turned to incorporation of the C16-C20 fragment to 
tetrahydropyran 228.  The conversion of tetrahydropyran 228 to aldehyde 258 was 
realized upon subjection of bis-TES ether 258 to modified Swern conditions which are 
known to convert primary TMS and TES ethers directly to the aldehyde in the presence 
of secondary silyl ethers (Scheme 4.12).149  The vinylzinc species, generated in situ from 
C16-C20 vinyl iodide 259, underwent a Felkin-Anh controlled addition to aldehyde 258 to 
give rise to alcohol 260 in 68% yield as an 8:1 mixture of diastereomers.150  Subsequent 
conversion of the vinyl addition product to the acetonide by a two step sequence 
afforded dihydropyran 256 in 93% yield.  The configuration of the major product as the 
desired diastereomer was confirmed by 2-D NMR analysis. 
 
With both bicyclic ether 255 and acetonide 256 in hand, cross metathesis to form 
the C29-C30 bond was explored.  Initial cross metathesis attempts were plagued by low 
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yields due to dimerization of the tetrahydropyran fragment; conversely, unreacted 
bicyclic ether 255 could be recovered cleanly from the reaction mixture (Scheme 4.13).  
In order to minimize consumption of the starting material by dimerization, the 
tetrahydropyran was added via syringe pump over several hours to a solution of bicyclic 
ether 255 and Grubbs 2nd generation catalyst (G2) in refluxing methylene chloride.  
Under these conditions, cross metathesis adduct 261 was obtained in 40% yield, with 
55% of bicyclic ether 255 recovered unreacted.135  Despite the moderate yield obtained 
for the first coupling reaction, cross metathesis adduct 261 was advanced to terminal 
olefin 254 to assess the viability of the second cross metathesis with dihydropyran 229.  
Due to the presence of the tert-butyl ester in the dihydropyran fragment, cleavage of the 
pivalate ester was necessary.  The treatment of cross metathesis adduct 261 with di-iso-
butylaluminum hydride reduced the pivalate ester to afford alcohol 262 in 88% yield.  
Removal of the TIPS protecting group, followed by hydrogenation of the alkyne in the 
presence of Lindlar’s catalyst,151 gave rise to terminal olefin 254 in 74% yield over the 
two steps.  
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ii. Cross metathesis to form the C15-C16 bond 
  Having developed a convergent route toward bicyclic ether/THP fragment 254, 
focus was shifted to formation of the C15-C16 via cross metathesis.  Initial attempts by 
Haley to unite bicyclic ether/THP fragment 254 and dihydropyran 229 were met with 
some success (Scheme 4.14).135  Cross metathesis adduct 253 was obtained in 30-40% 
yield when the reaction was run in the presence of Hoveyda-Grubbs 2nd generation 
catalyst (HG2); however, unreacted alcohol 254 and dihydropyran 229 were only 
recovered in approximately 30% yield as a mixture with their homodimers.  Despite the 
poor conversion and mass recovery, we opted to pursue this route further.  We 
speculated that the low conversion could be attributed to the fact that these coupling 
reactions were conducted on a very small scale. 
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 4.4 Optimization of the route towards the C16-C37 fragment 
In light of the promising results obtained for cross metathesis reactions to form 
the C29-C30 and C15-C16 bonds, my initial focus was optimization of the yield for both 
of these major bond forming events.  In addition, we were also interested in revising our 
protecting group strategy.  It has been reported that sorangicin A is unstable to a number 
of reagents, including fluoride sources, which are often utilized for the cleavage of silyl 
ethers.  Insight gained from the total synthesis completed by Smith and co-workers 
suggested that exchange of several of our protecting groups early in the synthesis could 
prevent late stage protecting group compatibility issues.  As a result, we decided to 
employ an identical protecting group strategy to that successfully used by Smith in the 
only total synthesis of (+)-sorangicin A to date.   
i. Modification of the protecting group strategy 
We opted to modify the protecting groups on the bicyclic ether and 
tetrahydropyran fragments prior to optimization of the coupling reaction, as even a minor 
change in the cross metathesis substrate can have an effect on the outcome of the 
reaction.  Turning our attention to the bicyclic ether fragment, we were interested in 
preparing p-methoxybenzyl (PMB) protected bicyclic ether 264 instead of pivalate 255.  
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Thus, bicyclic ether 227, the product of the epoxide opening cascade, was treated with 
p-methoxybenzyl bromide and sodium hydride to give rise to PMB-protected bicyclic 
ether 263 in 94% yield (Scheme 4.15).  As a consequence of this protecting group 
modification, ozonolysis could no longer be employed for cleavage of the carbon-carbon 
double bond.  Instead, the Johnson-Lemieux protocol152 was called upon to convert the 
styrene component to an intermediate aldehyde by a one-pot dihydroxylation, oxidative 
cleavage sequence.  Subsequent methylene Wittig olefination63 delivered bicyclic ether 
264 in 87% yield over the two steps.   
 
Next, we wanted to replace the TBS ether of tetrahydropyran 228 with a 
methoxymethyl (MOM) ether in order to parallel the protecting group strategy employed 
by Smith.  This protecting group modification could be achieved by either a 
deprotection/protection sequence with tetrahydropyran 228 or introduction of the MOM 
ether at the beginning of the tetrahydropyran synthesis.  It was quickly realized that 
protecting group manipulation of tetrahydropyran 228 would not deliver the desired 
MOM-protected tetrahydropyran (Scheme 4.16).  We had envisioned that after removal 
of the three silyl ethers from tetrahydropyran 228, we could selectively protect the C21 
and C22 alcohols as triethylsilyl ethers; subsequent formation of the C25 MOM ether 
would give rise to the desired tetrahydropyran fragment.  Upon treatment of 
tetrahydropyran 228 with several equivalents of TBAF, diol 265, with the C25 TBS ether 
still intact, was obtained in 90% yield.  Unfortunately, even when diol 265 was subjected 
to more forcing conditions, none of the desired triol 266 was obtained. 
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We next turned our attention toward identifying methods for incorporation of the 
MOM ether at an earlier stage in the synthesis.  Conversion of aldol adduct 268 to MOM 
ether 269 proceeded smoothly in 83% yield, a pleasing result since the MOM ether is 
seldom used in conjunction with the thiazolidinethione auxiliary (Scheme 4.17).153  Upon 
elongation of the carbon backbone via cross metathesis with ethyl acrylate, MOM ether 
270 was treated with di-iso-butylaluminum hydride to effect reduction of the ester and 
cleavage of the thiazolidinethione auxiliary.  To our surprise, none of desired allylic 
alcohol 271 was obtained from the reaction mixture.  Instead, alcohol 272, formed upon 
elimination of the MOM ether, was obtained in 44% yield.    
 
This unexpected result prompted us to explore an alternative approach towards 
MOM-protected tetrahydropyran 267, in which the cross metathesis would be postponed 
until after cleavage of the auxiliary to prevent elimination.  As a result of reordering these 
steps, the cross metathesis would need to be performed with diacetate 274 to allow for 
differentiation between C21 and C27 (Scheme 4.18).  Toward this end, MOM-protected 
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aldol adduct 269 was treated with di-iso-butylaluminum hydride to effect reductive 
removal of the thiazolidinethione auxiliary, giving rise to aldehyde 273 in 76% yield.  The 
cross metathesis between aldehyde 273 and diacetate 274 proceeded as planned to 
give rise to aldehyde 275 in 71% yield.  The use of diacetate 274 as the cross 
metathesis partner also eliminates a step from the synthesis of the tetrahydropyran 
fragment.  Aldehyde 275 could be advanced to MOM-protected tetrahydropyran 267 via 
the allylation, epoxidation, TES protection sequence, albeit in only 25% yield for the 
three steps.  Tetrahydropyran 267 was prepared in seven steps and 10% overall yield 
from 3-butenal; on the other hand, TBS-protected tetrahydropyran 228 was available in 
32% overall yield by the previously discussed eight step sequence.  Based on the 
significantly lower overall yield with MOM-protected tetrahydropyran 267, we decided to 
proceed with originally prepared tetrahydropyran 228 with the intention of swapping the 
C25 TBS ether for a MOM ether upon completion of the bicyclic ether/THP fragment.   
 
 While we did not end up using tetrahydropyran 267 in our efforts towards 
sorangicin A, the preparation of this intermediate resulted in the development of a more 
convenient seven step synthesis of the tetrahydropyran fragment.  The reduction, cross 
metathesis sequence could also be applied toward the synthesis of TBS-protected 
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tetrahydropyran 228 (Scheme 4.19).  From protected aldol adduct 240, reductive 
removal of the chiral auxiliary delivered aldehyde 278 in 83% yield.  Subsequent cross 
metathesis with diacetate 274 furnished aldehyde 242 in 71% yield.  Aldehyde 242 can 
be carried through the remaining three steps to arrive at tetrahydropyran 228 in seven 
steps and 31% overall yield, essentially the same as the eight step route involving the 
cross metathesis with ethyl acrylate.   
 
ii. Optimization of the cross metathesis to form the C29-C30 bond 
Upon realization that we would need to replace the C25 TBS ether at a later 
stage in the synthesis, we turned our attention toward optimization of the cross 
metathesis to form the C29-C30 bond.  Several conditions were explored for the cross 
metathesis reaction between PMB-protected bicyclic ether 264 and previously prepared 
tetrahydropyran 256 (Scheme 4.20).  The initial conditions developed by Haley involved 
syringe pump addition of tetrahydropyran 256 to a solution of the bicyclic ether and 
Grubbs 2nd generation catalyst.  With Piv-protected bicyclic ether 255, the desired 
product was obtained in 40% yield, with 55% recovered bicyclic ether 255.  These 
results could be replicated with PMB-protected bicyclic ether 264 when the reaction was 
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run with a 1:1 ratio of tetrahydropyran 256 and bicyclic ether 264 in the presence of 20 
mol % Hoveyda-Grubbs 2nd generation catalyst (HG2) in toluene at 60 °C.  We were 
encouraged to find that using an excess of bicyclic ether 264 (2.0 equiv) under otherwise 
identical conditions increased the yield to 47%.  Unfortunately, separation of cross 
metathesis adduct 279 from bicyclic ether 264 was problematic.  In all of the cross 
metathesis attempts between bicyclic ether 264 and tetrahydropyran 256 we noticed the 
formation of a byproduct which closely resembled bicyclic ether 264 by NMR.  Even 
when the cross metathesis reactions were conducted at room temperature, a 
considerable amount of this undesired product was formed.  Upon isolation and further 
evaluation of the NMR, we able to assign the structure as alkyne 280, formed as a result 
of a cross metathesis reaction between bicyclic ether 264 and the internal C19-C20 
olefin of tetrahydropyran 256.  As the internal olefin participating in this unwanted cross 
metathesis reaction is present in both the tetrahydropyran starting material and desired 
cross metathesis adduct 279, there was no way to suppress the formation of alkyne 280.    
 
As a result of the isolation of byproduct 280, we decided to pursue an alternative 
route towards bicyclic ether/THP fragment 279.  Instead of introducing the C16-C20 
fragment prior to the cross metathesis reaction, we would perform the cross metathesis 
91 
 
between bicyclic ether 264 and tetrahydropyran 228 before the vinyl addition of iodide 
259 (Scheme 4.21).  Interestingly, the cross metathesis reaction between bicyclic ether 
264 and tetrahydropyran 228 was far more efficient than the cross metathesis with 
tetrahydropyran 256, even when run under nearly identical conditions.  As before, the 
tetrahydropyran was added dropwise via syringe pump over several hours to a solution 
of bicyclic ether 264 and Grubbs 2nd generation catalyst in toluene.  The metathesis 
catalyst was added in three portions over the same period of time to ensure that active 
catalyst was present in the reaction mixture.  To our delight, these conditions provided a 
77% yield of cross metathesis adduct 281.  Another advantage of this cross metathesis 
reaction, as compared to those discussed previously, is the ease with which cross 
metathesis adduct 281 was separated from excess bicyclic ether 264.  With bicyclic 
ether/THP fragment 281 in hand, installation of the C16-C20 alkyne was explored.  Bis-
TES ether 281 was converted to aldehyde 282 under the modified Swern conditions in 
78% yield.149  Unfortunately, the addition of aldehyde 282 to the transmetallated species 
derived from vinyl iodide 259 did not effect the desired bond forming event.  The 
recovery of 87% of the unreacted aldehyde provided evidence that the lack of reactivity 
was not a result of aldehyde decomposition.  Despite several attempts to arrive at C16-
C37 fragment 283 by this approach, none of the desired product was ever obtained.   
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In order to determine if aldehyde 282 was a competent electrophile, an 
alternative vinyl iodide was prepared and employed in the addition reaction.  Vinyl iodide 
285 was chosen as a suitable C16-C20 surrogate as the terminal olefin, necessary for 
the second cross metathesis reaction, could be readily accessed from the C16 primary 
alcohol.  In addition, having an alcohol at this position instead of an alkyne offers the 
flexibility to explore alternative coupling strategies for introducing the dihydropyran 
moiety.  Thus, vinyl iodide 285, available from 4-pentynol in two steps via a TBS 
protection,154 hydrozirconation/iodination sequence, was prepared in 76% yield (Scheme 
4.22).155,156  To our delight, upon in situ generation of the vinylzinc species from iodide 
285 followed by addition of aldehyde 282, vinyl addition product 286 was obtained in 
78% yield with only one diastereomer detectable by NMR.    
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4.5 C1-C20 Vinyl iodide approach towards assembly of the natural product 
With a viable route towards C16-C37 fragment 286, attention could be turned to 
introduction of the dihydropyran fragment.  However, based on the success of the vinyl 
addition with iodide 285, we first wanted to investigate whether the entire dihydropyran 
fragment could be installed in a similar fashion.  In our revised retrosynthetic analysis, 
we envisioned preparing C1-C37 fragment 287 by the addition of C1-C20 vinyl iodide 
288 into aldehyde 282, available by the previously discussed cross metathesis between 
tetrahydropyran 228 and bicyclic ether 264 (Scheme 4.23).   
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In order to explore this revised synthetic approach, the preparation of C1-C20 
vinyl iodide 288 was necessary.  Elongation of the carbon backbone of alcohol 251, an 
intermediate from the synthesis of dihydropyran 229, was accomplished by a cross 
metathesis with diyne 289 in an unoptimized 62% yield (Scheme 4.24).  Deprotection of 
the TIPS alkyne was achieved upon exposure of cross metathesis adduct 290 to TBAF.  
The primary alcohol was protected as the TBS ether under standard conditions, 
furnishing alkyne 291 in 76% yield over the two steps.  Finally, a 
hydrozirconation/iodination sequence generated vinyl iodide 288 in 72% yield.156  
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The addition reaction of vinyl iodide 288 to aldehyde 282 was run under the 
previously optimized conditions (Scheme 4.25).  Disappointingly, only unreacted 
aldehyde 282 and terminal olefin 292, formed upon quenching of the in situ generated 
vinylzinc species, were obtained from the reaction.  Isolation of terminal olefin 292 in 
60% yield provided evidence that the vinyl iodide was undergoing transmetallation, but 
not addition into the aldehyde.  Several unsuccessful attempts to effect the desired 
transformation prompted us to explore an alternative coupling strategy. 
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4.6 Julia olefination approach towards assembly of the natural product 
 At this point we shifted our focus to the advancement of bicyclic ether/THP 
fragment 286 towards the completion of the natural product.  An advantage of this C16-
C37 fragment over the previously prepared intermediate bearing a terminal olefin at C16 
is the opportunity to easily explore other coupling reactions as a result of the added 
flexibility of the C16 alcohol.  While the cross metathesis approach toward appendage of 
the dihydropyran fragment had provided some promising results, upon careful 
consideration of this coupling strategy several concerns arose.  Most notably, the 
selectivity of the cross metathesis reaction which features two Type I olefins in 
dihydropyran 229 and the olefin derived from bicyclic ether/THP fragment 286.  In 
addition, the number of steps necessary to prepare the terminal olefin from C16-C37 
fragment 286 would require an extra step when compared to olefination strategies which 
feature an aldehyde coupling partner.  For these reasons, we decided to pursue a Julia 
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olefination to unite the dihydropyran unit with the rest of the molecule.  An analogous 
strategy was successfully employed by Smith and co-workers in the only total synthesis 
of (+)-sorangicin A to date.  For the Julia olefination strategy, we sought to prepare the 
same C16-C38 aldehyde 173 and C1-C15 sulfone 132 coupling partners as those 
prepared by Smith (Scheme 4.26).  Aldehyde 173 would be accessed from bicyclic 
ether/THP fragment 286, which was prepared in an efficient manner by a cross 
metathesis between bicyclic ether 264 and tetrahydropyran 228.  The synthesis of 
sulfone 132 would require significant modification of our synthesis of dihydropyran 229 in 
order to accommodate the sulfone at C15 as opposed to a terminal olefin.   
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i. Synthesis of C1-C15 sulfone 132 
In order to access sulfone 132 in an efficient manner, modification of the original 
approach towards dihydropyran 229 was necessary, as we now required a sulfone at 
C15 instead of a terminal olefin.  Upon evaluation of the route developed by Haley for 
accessing dihydropyran 229, we determined that employing TBS-vinyl ether instead of 
allyltrimethyl silane would facilitate preparation of the requisite sulfone in an efficient 
manner.  Thus, mixed acetal 249 (See Scheme 4.7) would serve as a common 
intermediate between dihydropyran 229 and sulfone 132.  With mixed acetal 249 in 
hand, Lewis acid mediated addition of TBS-vinyl ether157 was explored (Scheme 4.27).  
Gratifyingly, in the presence of lithium perchlorate, TBS-vinyl ether underwent facile 
addition into the oxocarbenium ion generated in situ from mixed acetal 249, affording 
aldehyde 293 in 82% yield as a single diastereomer.158  Subsequent sodium borohydride 
reduction delivered alcohol 294 in 97% yield.  In order to intercept the sulfone 
intermediate prepared in Smith’s total synthesis, replacement of the methoxymethyl 
(MOM) ether with a TBS ether was necessary.  The MOM ether was effectively cleaved 
with 15% hydrochloric acid in tert-butanol to deliver an intermediate diol, which was 
converted to bis-TBS dihydropyran 295 in 80% yield over the two step sequence.  
Introduction of the desired oxidation state at C1 was achieved by the four step sequence 
developed by Smith.84  Removal of the p-methoxybenzyl (PMB) ether with DDQ, 
followed by Dess-Martin oxidation gave rise to aldehyde 296 in 77% yield over the two 
steps.  Further oxidation to the acid was achieved under Pinnick conditions; the crude 
acid was subsequently exposed to tert-butyl isourea 159 to afford tert-butyl ester 162 in 
83% yield.    
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Ester 162 is a common intermediate from Smith’s synthesis of the dihydropyran 
fragment.  Thus, the same three step sequence employed by Smith could be utilized to 
convert tert-butyl ester 162 to sulfone 132, beginning with selective removal of the 
primary TBS ether (Scheme 4.28).  The treatment of ester 162 with TBAF at 0 °C 
effected cleavage of the primary TBS ether, in the presence of the secondary TBS ether, 
to deliver alcohol 297 in 76% yield.  The resultant primary alcohol underwent a 
Mitsunobu reaction100 with 1-phenyltetrazole-5-thiol to give rise to an intermediate 
thioether, which was oxidized under standard conditions to sulfone 162 in 68% yield over 
the two steps.  This route enables the preparation of C1-C15 sulfone 162 in 17 steps 
and 11.4% overall yield from known aldehyde 154.   
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ii.   Completion of Smith’s C1-C38 fragment of (+)-sorangicin A 
Having developed an efficient route towards sulfone 132, the preparation of the 
aldehyde coupling partner was the next task at hand.  In order to prepare aldehyde 173 
from bicyclic ether/THP fragment 286, several protecting group manipulations were 
necessary.  It was envisioned that the most efficient manner for arriving at the desired 
C16-C37 substrate was to remove all of the silyl protecting groups from bicyclic 
ether/THP fragment 286 and systematically reprotect the resultant tetraol.  To our 
delight, tetraol 299 was readily obtained in 75% yield upon treatment of the previously 
discussed vinyl addition product 286 with several equivalents of TBAF (Scheme 4.29).  
The protection strategy devised for tetraol 299 involved initial formation of the C21-C22 
acetonide, followed by selective protection of the primary alcohol as the TBS ether, and 
finally formation of the C25 MOM ether.  Toward this end, tetraol 299 was exposed to a 
catalytic amount of camphorsulfonic acid (CSA) in neat 2, 2-dimethoxypropane.  These 
conditions not only form the C21-C22 acetonide, but also protect the primary alcohol as 
the 2-methoxy-2-propyl (MOP) ether.  Acidic workup effectively cleaved the MOP ether 
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to deliver acetonide 300 in 95% yield.  Selective protection of the primary alcohol as the 
TBS ether in the presence of the C25 secondary alcohol was readily accomplished with 
tert-butyldimethylsilyl chloride and imidazole as the base.  Even in the presence of 
excess silylating reagent, the primary TBS ether was obtained exclusively in 78% yield.  
The remaining unprotected alcohol at C25 was converted to the MOM ether with 
methoxymethyl iodide, generated in situ from methoxymethyl chloride and sodium 
iodide,159 affording fully protected C16-C37 fragment 301 in 95% yield.   
 
Introduction of the C37-C38 vinyl iodide by a Takai olefination was pursued.112 
Oxidative removal of the p-methoxybenzyl (PMB) ether was effected upon treatment of 
p-methyoxybenzyl ether 301 with DDQ to give rise to alcohol 302 in 83% yield (Scheme 
4.30).  Subsequent Dess-Martin oxidation proceeded smoothly to deliver aldehyde 303 
in 95% yield.  The aldehyde was exposed to chromium chloride and iodoform in a 4:1 
mixture of dioxane and THF to effect the Takai olefination.113  The requisite vinyl iodide 
was obtained as a 4:1 of mixture of E/Z olefin isomers, which were readily separated by 
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flash column chromatography to afford E-vinyl iodide 172 in 40% yield and Z-vinyl iodide 
304 in 11% yield.   
 
Vinyl iodide 172 is a common intermediate from Smith’s total synthesis of (+)-
sorangicin A, serving as a precursor to aldehyde 173.  With an efficient route towards 
vinyl iodide 172 in hand, we carried out the three step sequence described by Smith to 
arrive at the coupled C1-C38 fragment (Scheme 4.31).  To arrive at the aldehyde 
required for the Julia olefination, the TBS ether was cleaved and subjected to Dess-
Martin oxidation.  Finally, with both coupling partners in hand, the Julia olefination 
between aldehyde 173 and sulfone 132 to form the C15-C16 bond was achieved to 
deliver C1-C38 fragment 174 in 79% yield.   
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4.7 Summary 
 In summary, a formal synthesis of the C1-C38 fragment prepared by Smith en 
route to the total synthesis of (+)-sorangicin A was completed in 25 steps over the 
longest linear sequence.  The three key fragments: bicyclic ether 264, tetrahydropyran 
228, and dihydropyran 132 were prepared in 12, 7, and 19 steps respectively.  Cross 
metathesis proved to be an efficient strategy for coupling the bicyclic ether and 
tetrahydropyran fragments.  The identification of a consistent and high-yielding approach 
for uniting the C1-C15 dihydropyran fragment to the rest of the molecule proved to be a 
considerable challenge.  Our modular approach towards sorangicin A allowed us to 
explore several coupling strategies; ultimately, a Julia olefination to form the C15-C16 
bond, also employed in Smith’s total synthesis, resulted in the formal synthesis of the 
C1-C38 fragment of (+)-sorangicin A.  
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CHAPTER FIVE 
 
Experimental and NMR Spectra: Spirofungins A and B 
 
5.1 Materials and Methods 
  Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform 
infrared spectrometer and values reported in cm-1.  Proton and carbon nuclear magnetic 
resonance spectra (NMR) were acquired on a Bruker model Avance 400 (1H at 400 
MHz; 13C at 100 MHz, CDCl3) or Bruker model Avance 500 (
1H at 500 MHz; 13C at 125 
MHz, CDCl3). Chemical shifts are reported relative to chloroform,  7.26 for 
1H NMR 
spectra and  77.2 for 13C NMR spectra. Optical rotations were determined using a 
Jasco P1010 polarimeter. Mass spectra were obtained using a Bruker BioTOF II mass 
spectrometer with electrospray ionization (ESI).  Thin layer chromatography (TLC) was 
conducted on silica gel F254 TLC plates purchased from Scientific Adsorbents, Inc.  
Flash column chromatography was carried out using Ultra Pure Silica Gel Silia-P (40 to 
63 m) purchased from SiliCycle Inc.  The second generation Grubbs precatalyst (G2) is 
defined as [Ru=CHPh(Cl)2(PCy3)(DHIMes)]. Diethyl ether (Et2O), tetrahydrofuran (THF), 
dichloromethane (CH2Cl2), and toluene were dried by being passed through a column of 
neutral alumina under nitrogen immediately prior to use.  Alkylamines were distilled from 
calcium hydride immediately prior to use.  All other reagents and solvents were used as 
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received from the manufacturer, unless otherwise specified.  All air and water sensitive 
reactions were performed in flasks flame dried under positive flow argon and conducted 
under an argon atmosphere. 
5.2 Experimental Procedures 
 
Aldol adduct 57: To a dry round bottom flask under argon was added N-
acetylthiazolidinethione 56 (5.01 g, 17.93 mmol) in 85 mL CH2Cl2.  The solution was 
cooled to 78 °C and titanium tetrachloride (1.92 mL, 17.93 mmol) was added dropwise.  
The thick suspension was stirred 10 minutes, upon which diisopropylethylamine (3.13 
mL, 17.93 mmol) was added dropwise.  The solution was stirred at 78 °C for 45 
minutes at which time freshly prepared 3-butenal (in CH2Cl2, 1.14 g, 16.31 mmol) was 
added dropwise.  The reaction was stirred at 78 °C for 1 h then quenched with half 
saturated ammonium chloride and warmed to room temperature.  The layers were 
separated and the aqueous layer extracted twice with CH2Cl2.  The combined organic 
layers were dried over Na2SO4, filtered, and concentrated under reduced pressure.  The 
crude product was purified by flash column chromatography (10-15% EtOAc/Hex) to 
provide the product (4.6 g, 81%) as a yellow oil.  1H NMR (500 MHz, CDCl3)  2.14-2.29 
(m, 2H), 2.25 (s, 3H), 2.39 (br. s., 6H), 2.85 (d, J= 4.1 Hz, 1H), 3.19 (dd, J= 17.4, 2.8 Hz, 
1H), 3.33 (dd, J= 11.2, 9.6 Hz, 1H), 3.51-3.60 (m, 2H) 3.95 (m, 1 H) 5.09 (m, 2H) 5.76 
(dddd, J= 16.7, 14.0, 9.4, 7.3 Hz, 1H), 6.37 (t, J= 9.8 Hz, 1H), 6.85 (br. s., 2H); 13C NMR 
(125 MHz, CDCl3):  20.5, 21.0, 32.7, 41.0, 46.1, 67.9, 68.2, 118.3, 132.8, 134.1, 138.1, 
174.8, 201.9; IR (film): 3447 (br), 3074, 3006, 2971, 2921, 2868, 2734, 1705, 1610, 
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1371, 1260, 1177, 1049, 912, 731; ESI-MS: C18H23NO2S2 [M+Na]
 calc. 372.10, found 
372.10; []24D = 112.1° (c = 0.95, CH2Cl2). 
 
Iso-butyl ester 59: To a dry round bottom flask were added aldol adduct 57 (1.85 g, 
5.29 mmol), imidazole (0.72 g, 10.58 mmol), iso-butyl alcohol (4.8 mL, 52.88 mmol) and 
10 mL CH2Cl2.  The reaction mixture was stirred for 12 hours at room temperature, then 
diluted with CH2Cl2 and quenched with water.  The aqueous layer was extracted twice 
with CH2Cl2.  The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  To remove the free auxiliary, the crude product 
was taken up in hexanes and the minimum amount of ethyl acetate and washed twice 
with 1 M NaOH.  The organic layer was dried over Na2SO4, filtered, and concentrated 
under reduced pressure.  The crude ester was purified by flash column chromatography 
(3% Et2O/CH2Cl2) to give the product (0.964 g, 98%) as a light yellow oil.   
1H NMR (400 
MHz, CDCl3)  0.93 (d, J= 6.8 Hz, 6H), 1.94 (q, J= 6.6 Hz, 1H), 2.22-2.35 (m, 2H), 2.44 
(dd, J= 16.7, 9.1 Hz, 1H), 2.53 (dd, J= 16.3, 3.0 Hz, 1H), 2.92 (br. s., 1H), 3.90 (d, J= 6.5 
Hz, 2H), 4.09 (br. s., 1H), 5.09-5.18 (m, 2H), 5.82 (dq, J= 17.1, 7.2 Hz, 1H); 13C NMR 
(125 MHz, CDCl3):  19.2, 27.8, 40.7, 41.1, 67.5, 71.0, 118.4, 134.1, 173.1; IR (film): 
3440, 2964, 2876, 1734, 1381, 1172, 1055, 998, 917 cm-1; ESI-MS: C10H18O3 [M+Na] 
calc. 209.12, found 209.10; []25D = 17.6° (c = 0.70, CH2Cl2). 
 
Alkylated iso-butyl ester 61: To a dry, 3-neck round bottom flask equipped with an 
internal thermometer was added di-iso-propylamine (1.80 mL, 12.9 mmol) and 12 mL 
THF.  The solution was cooled to 78 °C upon which n-butylithium (1.6M in hexanes, 8.0 
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mL, 12.9 mmol) was added dropwise.  The solution was allowed to come to 0 °C, stirred 
for 30 minutes, then cooled back to 78 °C.  Ester 59 (0.80 g, 4.30 mmol) in 3.3 mL THF 
was added dropwise.  The solution was then warmed slowly to 25 °C over 30 minutes.  
A solution of methyl iodide (0.67 mL, 10.8 mmol) and 1,3-Dimethyl-3,4,5,6-tetrahydro-
2(1H)-pyrimidinone (DMPU) (2.0 mL, 16.8 mmol) was added to the reaction mixture.  
Over the next 30 minutes, the solution was warmed to 0 °C and then stirred for 1 hour.  
The reaction was quenched with water and extracted three times with diethylether.  The 
combined organic layers were dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography (8% 
EtOAc/Hex) to provide the product (0.54 g, 63%) as a light yellow oil.  1H NMR (500 
MHz, CDCl3)  0.92 (d, J= 6.6 Hz, 6H), 1.20 (d, J= 7.1 Hz, 3H), 1.93 (dddd, J= 13.5, 6.6 
Hz, 1H), 2.15-2.25 (m, 1H), 2.28-2.37 (m, 1H), 2.56 (quin, J= 7.0 Hz, 1H), 3.70-3.78 (m, 
1H), 3.85-3.91 (m, 2H), 5.08-5.16 (m, 2H), 5.84 (dq, J= 17.0, 7.1 Hz, 1H); 13C NMR (125 
MHz, CDCl3):  14.3, 19.2, 27.8, 39.2, 44.7, 70.8, 72.6, 118.2, 134.4, 176.0; IR (film): 
3462, 2965, 2876, 1733, 1468, 1381, 1186, 1042, 993, 915 cm-1; ESI-MS: C11H20O3 
[M+Na] calc. 223.13, found 223.11; []25D = 11.2° (c = 0.08, CH2Cl2). 
 
TES-protected iso-butyl ester 62: To a dry round bottom flask under argon was added 
ester 61 (0.52 g, 2.60 mmol) in 22 mL CH2Cl2.  The solution was cooled to 0 °C and 2,6-
lutidine (0.90 mL, 7.8 mmol) was added, followed by dropwise addition of TESOTf (0.90 
mL, 3.9 mmol).  The reaction was stirred at 0 °C for 1 hour.  The reaction was quenched 
with saturated NaHCO3 and extracted twice with CH2Cl2.   The combined organic layers 
were dried over Na2SO4, filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography (3% EtOAc/Hex) to provide the 
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product (0.78 g, 96%) as a colorless oil.  1H NMR (400 MHz, CDCl3)  0.59 (q, J= 7.8 Hz, 
6H), 0.89-0.98 (m, 15H), 1.10 (d, J= 6.8 Hz, 3H), 1.93 (dddd, J= 13.3, 6.6 Hz, 1H), 2.18-
2.32 (m, 2H), 2.63 (quin, J= 6.9 Hz, 1 H), 3.85 (d, J= 6.8 Hz, 2H), 4.03 (q, J= 5.7 Hz, 
1H), 4.98-5.12 (m, 2H, 5.78-5.92 (m, 1 H); 13C NMR (100 MHz, CDCl3):  5.2, 7.0, 12.3, 
19.3, 27.9, 38.6, 45.9, 70.6, 73.5, 117.4, 134.8, 174.9; IR (film): 2958, 2913, 2877, 1738, 
1461, 1380, 1175, 1087, 1004, 912 cm-1; ESI-MS: C17H34O3Si [M+Na] calc. 337.22, 
found 337.19; []25D = 30.8° (c = 1.03, CH2Cl2). 
 
Aldehyde 55: To a dry mL round bottom flask under argon was added TES-protected 
ester 62 (0.64 g, 2.05 mmol) in 17 mL CH2Cl2.  The solution was cooled to 78 °C and 
DIBAL (1M in hexanes, 2.1 mL, 2.1 mmol) was added dropwise via syringe.  The 
reaction was stirred 20 minutes and then quenched with saturated potassium sodium 
tartrate.  Upon warming to room temperature, the quenched reaction was vigorously 
stirred for 2 hours.  The layers were separated and the aqueous layer extracted twice 
with CH2Cl2.  The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (4% EtOAc/Hex) to provide the product (0.46g, 93%) as a colorless oil.  
1H NMR (400 MHz, CDCl3)  0.63 (q, J= 7.8 Hz, 6H), 0.98 (t, J= 8.0 Hz, 9 H), 1.10 (d, J= 
6.8 Hz, 3H), 2.25-2.43 (m, 2H), 2.49-2.60 (m, 1H), 4.00 (q, J= 5.3 Hz, 1H), 5.02-5.19 (m, 
2H, 5.76-5.91 (m, 1H), 9.79 (s, 1H); 13C NMR (100 MHz, CDCl3):  5.2, 7.0, 10.7, 40.0, 
51.0, 73.5, 118.3, 133.9, 205.1; IR (film): 2956, 2913, 2877, 1725, 1459, 1239, 1005, 
914 cm-1; ESI-MS: C13H26O2Si [M+Na] calc. 265.16, found 265.14; []
25
D = 37.5° (c = 
0.88, CH2Cl2). 
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Aldol adduct 64: To a dry round bottom flask under argon was added thiazolidinethione 
63 (2.65 g, 10.0 mmol) in 60 mL CH2Cl2.  The solution was cooled to 0 °C and titanium 
tetrachloride (1.15 mL, 10.5 mmol) was added dropwise.  The thick suspension was 
stirred five minutes, upon which ()-sparteine (2.3 mL, 10.0 mmol) was added dropwise.  
After 10 minutes stirring, the solution was cooled to 78 °C and N-methyl pyrrolidinone 
(0.96 mL, 10.0 mmol) was added.  After stirring for 20 minutes, acrolein (neat, 0.74 mL, 
11.0 mmol) was added dropwise.  The reaction was stirred for 1 hour at 78 °C then 
warmed slowly to 0 °C for 1 hour.  The reaction was quenched with half saturated 
ammonium chloride and warmed to room temperature.  The layers were separated and 
the aqueous layer extracted twice with CH2Cl2.  The combined organic layers were dried 
over Na2SO4, filtered, and concentrated under reduced pressure.  The crude product 
was purified by flash column chromatography (25% EtOAc/Hex) to provide the product 
(3.10 g, 96%) as a yellow oil.  1H NMR (500 MHz, CDCl3)  ppm 1.22 (d, J= 6.6 Hz, 3H, 
2.59 (br. s., 1 H), 2.87 (d, J= 11.5 Hz, 1 H), 3.02 (dd, J= 11.0, 12.6 Hz, 1 H), 3.20 (dd, J= 
13.1, 3.4 Hz, 1 H), 3.36 (dd, J= 11.5, 7.1 Hz, 1 H), 4.45 (br. s., 1 H), 4.53 (ddd, J= 13.5, 
10.8, 6.6 Hz, 1 H), 5.18 (d, J= 10.5 Hz, 1 H), 5.24-5.33 (m, 2H, 5.80 (ddd, J= 16.90, 
10.83, 5.50 Hz, 1 H), 7.21-7.34 (m, 5 H); 13C NMR (125 MHz, CDCl3):  11.2, 32.4, 36.9, 
43.9, 69.1, 73.7, 116.5, 127.5, 129.1, 129.6, 136.5, 137.7, 177.6, 201.6; IR (film): 3443, 
3062, 3027, 2981, 2936, 2876, 1695, 1454, 1342, 1262, 1192, 1167, 1137 cm-1; ESI-MS: 
C16H19NO2S2 [M+Na] calc. 344.08, found 344.07; []
25
D = 152.4° (c = 1.95, CH2Cl2). 
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Protected aldol adduct: To a dry round bottom flask under argon was added aldol 
adduct 64 (1.40 g, 4.4 mmol) in 45 mL CH2Cl2.  The solution was cooled to 0 °C and 2,6-
lutidine (1.5 mL, 13.2 mmol) was added, followed by dropwise addition of TESOTf (1.5 
mL, 6.6 mmol).  The reaction was stirred at 0 °C for 1 hour.  The reaction was quenched 
with saturated NaHCO3 and extracted twice with CH2Cl2.   The combined organic layers 
were dried over Na2SO4, filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography (5% EtOAc/Hex) to provide the 
product (1.76 g, 92%) as a yellow oil.  1H NMR (500 MHz, CDCl3)  ppm 0.61 (q, J= 7.9, 
6 H), 0.96 (t, J= 7.9 Hz, 9 H), 1.27 (d, J= 6.6 Hz, 3H, 2.91 (d, J= 11.5 Hz, 1 H), 3.07 (dd, 
J= 12.9, 11.11 Hz, 1 H), 3.28-3.36 (m, 2H, 4.33 (t, J= 6.8 Hz, 1 H), 4.62 (quin, J= 6.6 Hz, 
1 H), 5.05-5.16 (m, 2H, 5.20 (d, J= 17.2 Hz, 1 H), 5.89 (ddd, J= 17.2, 10.1, 7.2 Hz, 1 H), 
7.27-7.40 (m, 5 H); 13C NMR (125 MHz, CDCl3):  5.0, 7.0, 13.0, 32.6, 36.6, 46.0, 69.7, 
76.8, 116.0, 127.3, 129.0, 129.6, 136.8, 139.2, 176.6, 201.3; IR (film): 2921, 1691, 1364, 
1341, 1263, 1165, 1138, 1044 cm-1; ESI-MS: C22H33NO2S2Si [M+Na] calc.458.16, found 
458.13; []25D = 152.3° (c = 1.80, CH2Cl2). 
 
Aldehyde 65: To a dry mL round bottom flask under argon was added the protected 
aldol adduct (1.30 g, 3.0 mmol) in 30 mL CH2Cl2.  The yellow solution was cooled to 78 
°C and DIBAL (1M in hexanes) was added dropwise via syringe until the reaction 
mixture became colorless (4.5 mL, 4.5 mmol).  The reaction mixture was immediately 
quenched with saturated potassium sodium tartrate, warmed to room temperature, and 
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vigorously stirred for 2 hours.  The layers were separated and the aqueous layer 
extracted twice with CH2Cl2.  The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under reduced pressure.  The crude product was purified by 
flash column chromatography (4% EtOAc/Hex) to provide the product (0.685 g, 100%) 
as a colorless oil.  1H NMR (500 MHz, CDCl3)  ppm 0.58 (q, J= 8.0 Hz, 6 H), 0.93 (t, J= 
8.0 Hz, 9 H), 1.06 (d, J= 6.8 Hz, 3H, 2.43 - 2.52 (m, 1 H), 4.51 (t, J= 5.3 Hz, 1H), 5.17 (d, 
J= 10.5 Hz, 1 H), 5.25 (d, J= 17.0 Hz, 1 H), 5.83 (ddd, J= 17.0, 10.5, 6.5 Hz, 1 H), 9.77 
(s, 1 H); 13C NMR (125 MHz, CDCl3):   5.0, 7.0, 8.6, 52.7, 73.9, 116.2, 138.4, 205.0; IR 
(film): 2956, 2912, 2878, 1726, 1459, 1415, 1240, 1081, 1034, 1017 cm-1; ESI-MS: 
C12H24O2Si [M+Na] calc. 251.14, found 251.13; []
24
D = 51.8° (c = 1.43, CH2Cl2). 
 
-unsaturated ester 70: To a dry round bottom flask equipped with a condenser was 
added aldehyde 65 (0.684 g, 3.0 mmol), ylide 69 (1.57 g, 4.5 mmol), and 30 mL THF.  
The reaction was stirred at reflux for 12 hours then cooled to room temperature and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (5% EA/Hex) to provide the product (0.805 g, 91%) as a colorless oil.  
1H NMR (400 MHz, CDCl3)  0.58 (q, J= 7.7 Hz, 6H), 0.94 (t, J= 8.0 Hz, 9H), 1.03 (d, J= 
6.8 Hz, 3H), 1.28 (t, J= 7.2 Hz, 3H) 2.38 - 2.49 (m, 1H) 4.03 (t, J= 5.9 Hz, 1 H) 4.18 (q, 
J= 7.2 Hz, 2H) 5.10 (d, J= 10.2 Hz, 1H), 5.15 (d, J= 17.2 Hz, 1H) 5.75 (ddd, J= 17.2, 
10.2, 6.5 Hz, 1H), 5.78 (d, J= 15.9 Hz, 1H), 6.98 (dd, J= 15.8, 7.4 Hz, 1H); 13C NMR 
(125 MHz, CDCl3):  5.1, 6.6, 7.0, 14.4, 43.3, 60.3, 77.0, 115.9, 121.3, 139.1, 151.3, 
166.9; IR (film): 2957, 2911, 2877, 1722, 1654, 1459, 1367, 1269, 1181, 1035 cm-1; ESI-
MS: C16H30O3Si [M+Na] calc. 321.19, found 321.16; []
25
D = 21.5° (c = 1.18, CH2Cl2). 
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Allylic alcohol 49: To a dry round bottom flask under argon was added -unsaturated 
ester 70 (0.35 g, 1.17 mmol) and 11.7 mL THF.  The solution was cooled to 0 °C upon 
which TBAF (1 M in THF) was added dropwise (2.35 mL, 2.35 mmol).  After 30 minutes, 
the reaction was quenched with saturated NaHCO3 then extracted twice with CH2Cl2.  
The combined organic layers were dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography (10-
20% EtOAc/Hex) to provide the product (0.205 g, 95%) as a colorless oil.  1H NMR (400 
MHz, CDCl3)   1.09 (d, J= 6.8 Hz, 3H) 1.29 (t, J= 7.2 Hz, 3H) 1.59 (br. s., 1H) 2.48 - 
2.59 (m, 1H) 4.11 (m, 1H) 4.19 (q, J= 7.2 Hz, 2H) 5.21 (d, J= 10.3 Hz, 1H) 5.27 (d, J= 
17.2 Hz, 1H) 5.84 (ddd, J= 17.2, 10.3, 6.1 Hz, 1H) 5.87 (d, J= 16.3 Hz, 1H) 6.96 (dd, J= 
15.6, 7.6 Hz, 1H); 13C NMR (125 MHz, CDCl3):  14.37, 14.39, 42.3, 60.5, 75.9, 116.7, 
122.1, 138.3, 150.2, 166.7; IR (film): 3434, 2980, 1718, 1652, 1370, 1276, 1183, 1035 
cm-1; ESI-MS: C10H16O3 [2M+Na] calc. 391.21, found 391.22; []
24
D = 0.36° (c = 12.4, 
CH2Cl2). 
 
Dienoate 108: To a dry round bottom flask equipped with a condenser was added 
aldehyde 107 (1.80 g, 8.39 mmol), ylide 69 (3.89 g, 10.91 mmol), and 42 mL THF.  The 
reaction was stirred at reflux for 12 hours then cooled to room temperature and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (5% EA/Hex) to provide the product (2.10 g, 88%) as a colorless oil.  1H 
NMR (400 MHz, CDCl3)  0.07 (s, 6H), 0.90 (s, 9H), 1.30 (t, J= 7.0 Hz, 3H), 1.76 (s, 3H), 
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4.21 (q, J= 7.2 Hz, 2H), 4.36 (d, J= 5.7 Hz, 2H), 5.84 (d, J= 15.9 Hz, 1H), 5.95 (t, J= 5.9, 
1H) 7.30 (d, J= 15.9 Hz, 1H); 13C NMR (125 MHz, CDCl3):  -5.0, 12.6, 14.5, 18.5, 26.1, 
60.4, 60.5, 117.3, 132.7, 140.4, 148.7, 167.4.   
 
Aldehyde 109: To a dry round bottom flask equipped with an addition funnel was added 
dienoate 108 (2.10 g, 7.37 mmol) and 74 mL CH2Cl2.  The solution was cooled to 78 °C 
and DIBAL (1M in hexanes, 18.4 mL, 18.4 mmol) was added dropwise via addition 
funnel.  After 30 minutes stirring, the reaction was quenched with saturated potassium 
sodium tartrate, warmed to room temperature, and vigorously stirred for 2 hours.  The 
layers were separated and the aqueous layer extracted twice with CH2Cl2.  The 
combined organic layers were dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The crude alcohol was used in the next reaction without further 
purification.  1H NMR (500 MHz, CDCl3)  0.06 (s, 6H), 0.89 (s, 9H), 1.74 (s, 3H), 4.20 
(d, J= 5.7 Hz, 2H), 4.31 (d, J= 6.2 Hz, 2H), 5.58 (t, J= 6.1 Hz, 1H) 5.78 (dt, J= 15.7, 6.0 
Hz, 1H), 6.25 (d, J= 15.6 Hz, 1H); 13C NMR (125 MHz, CDCl3):  -5.0, 12.8, 18.5, 26.1, 
60.4, 63.9, 127.1, 132.2, 133.5, 135.9. 
To a dry round bottom flask was added the alcohol (1.79 g, 7.37 mmol) and 49 mL 
CH2Cl2.  Manganese dioxide (7.69 g, 88.4 mmol) was added and the reaction stirred at 
room temperature for 12 hrs.  The reaction was filtered over Celite, washing with CH2Cl2 
then concentrated under reduced pressure.  Aldehyde 109 was used immediately in the 
next reaction without further purification.  1H NMR (400 MHz, CDCl3)  0.09 (s, 6H), 0.91 
(s, 9H), 1.81 (s, 3H), 4.40 (d, J= 5.7 Hz, 2H), 6.08 (t, J= 5.7 Hz, 1H), 6.14 (dd, J= 15.8, 
7.8 Hz, 1H), 7.11 (d, J= 15.6 Hz, 1H), 9.58 (d, J= 8.0 Hz, 1H); 13C NMR (125 MHz, 
CDCl3):  -5.0, 12.8, 18.5, 26.0, 60.7, 128.0, 132.9, 143.0, 157.0, 194.4. 
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Aldol adduct 110: To a dry round bottom flask under argon was added 
thiazolidinethione 63 (1.76 g, 6.65 mmol) in 50 mL CH2Cl2.  The solution was cooled to 0 
°C and titanium tetrachloride (0.74 mL, 7.0 mmol) was added dropwise.  The thick 
suspension was stirred five minutes, upon which ()-sparteine (1.5 mL, 6.65 mmol) was 
added dropwise.  The dark red solution was stirred for 20 min at 0 °C, then cooled to 78 
°C and N-methyl pyrrolidinone (0.64 mL, 6.65 mmol) was added.  The mixture was 
stirred 10 min at 78 °C then aldehyde 109 (in CH2Cl2, 1.75 g, 7.30 mmol) was added 
dropwise.  The reaction was stirred for 1 hour at 78 °C then warmed slowly to 0 °C for 1 
hour.  The reaction was quenched with half saturated ammonium chloride and warmed 
to room temperature.  The layers were separated and the aqueous layer extracted twice 
with CH2Cl2.  The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (10-20% EtOAc/Hex) to provide the product (2.95 g, 88%) as a yellow 
oil.  1H NMR (500 MHz, CDCl3)  0.04 (s, 6H), 0.88 (s, 9H), 1.28 (d, J= 6.5, 3H), 1.73 (s, 
3H), 2.45 (br. s., 1H), 2.87 (d, J= 11.5 Hz, 1H), 3.03 (dd, J= 10.5, 13.0 Hz, 1H), 3.23 (dd, 
J= 3.5, 13.3 Hz, 1H), 3.32 (dd, J= 7.2, 11.4 Hz, 1H), 4.29 (d, J= 6.0 Hz, 2H), 4.48 (t, J= 
5.5 Hz, 1H), 4.59 (m, 1H), 5.24 (ddd, J= 4.0, 6.5, 10.5 Hz, 1H), 5.59-5.63 (m, 2H), 6.28 
(d, J= 16.0 Hz, 1H), 7.27-7.35 (m, 5H); 13C NMR (125 MHz, CDCl3):  −5.0, 11.7, 12.9, 
18.5, 26.1, 32.4, 36.8, 44.6, 60.3, 69.1, 74.2, 127.4, 127.5, 129.1, 129.6, 132.9, 133.3, 
136.1, 136.5, 177.6, 201.5; IR (film): 3414, 2953, 2928, 2856, 1696, 1342, 1260, 1165, 
1059, 836 cm-1; ESI-MS: C26H39NO3S2Si [M+Na] calc. 528.20, found 528.16; []
25
D = 
104.6° (c = 1.31, CH2Cl2). 
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TES-protected aldol adduct: To a dry round bottom flask under argon was added aldol 
adduct 110 (0.54 g, 1.07 mmol) in 10 mL CH2Cl2.  Upon cooling the solution to 0 °C, 2,6-
lutidine (0.37 mL, 3.20 mmol) was added, followed by dropwise addition of TESOTf (0.36 
mL, 1.60 mmol).  The reaction was stirred at 0 °C for 1 hour.  The reaction was 
quenched with saturated NaHCO3 and extracted twice with CH2Cl2.   The combined 
organic layers were dried over Na2SO4, filtered, and concentrated under reduced 
pressure.  The crude product was purified by flash column chromatography (5% 
EtOAc/Hex) to provide the product (0.654 g, 99%) as a yellow oil.  1H NMR (400 MHz, 
CDCl3)  0.04 (s, 6H), 0.55 (q, J= 8.2 Hz, 6H), 0.85 (s, 9H), 0.92 (t, J= 8.0 Hz, 9H), 1.25 
(d, J= 6.5 Hz, 3H), 1.72 (s, 3H), 2.82 (d, J= 11.4 Hz, 1H) 3.01 (dd, J= 12.9, 11.0 Hz, 1H), 
3.16 (dd, =11.4, 6.8 Hz, 1H), 3.26 (dd, J= 13.3, 3.0 Hz, 1H), 4.21-4.32 (m, 3H), 4.61 (t, 
J= 6.8 Hz, 1 H), 4.99 (m, 1H), 5.54 (t, J= 6.1 Hz, 1H), 5.63 (dd, J= 15.8, 7.8 Hz, 1H), 
6.11 (d, J= 15.6 Hz, 1H), 7.21-7.38 (m, 5H); 13C NMR (125 MHz, CDCl3):  −5.0, 5.1, 
7.0, 12.9, 13.3, 18.5, 26.1, 32.5, 36.7, 46.6, 60.3, 69.6, 76.9, 127.3, 129.1, 129.4, 129.6, 
132.4, 133.5, 135.3, 136.8, 176.8, 201.3; IR (film): 2954, 2876, 2856, 1696, 1456, 1341, 
1259, 1164, 1031, 969, 836 cm-1; ESI-MS: C32H53NO3S2Si2 [M+Na] calc. 642.29, found; 
[]24D = 95.8° (c = 1.35, CH2Cl2). 
 
Aldehyde 111: To a dry mL round bottom flask under argon was added the protected 
aldol adduct (3.0 g, 4.88 mmol) in 48 mL CH2Cl2.  The yellow solution was cooled to 78 
°C and DIBAL (1M in hexanes) was added dropwise via syringe until the reaction 
116 
 
mixture became colorless (9.8 mL, 9.8 mmol).  The reaction mixture was immediately 
quenched with saturated potassium sodium tartrate, warmed to room temperature, and 
vigorously stirred for 2 hours.  The layers were separated and the aqueous layer 
extracted twice with CH2Cl2.  The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under reduced pressure.  The crude product was purified by 
flash column chromatography (5% EtOAc/Hex) to provide the product (1.62 g, 81%) as a 
colorless oil.  1H NMR (400 MHz, CDCl3)  0.07 (s, 6H), 0.57 (q, J= 7.8 Hz, 6H), 0.88-
0.97 (m, 18 H), 1.06 (d, J= 6.8 Hz, 3H) 1.71 (s, 3H), 2.45-2.55 (m, 1H), 4.31 (d, J= 6.1 
Hz, 2H), 4.55 (dd, J= 6.8, 5.0 Hz, 1H), 5.52-5.63 (m, 2H), 6.20 (d, J= 15.6 Hz, 1H) 9.78 
(s, 1H); 13C NMR (125 MHz, CDCl3):  −5.0, 5.1, 7.0, 8.9, 12.9, 18.6, 26.1, 53.3, 60.4, 
74.0, 128.2, 132.5, 133.3, 135.7, 205.1; IR (film): 2955, 2877, 2857, 1727, 1462, 1254, 
1103, 1065, 1007 cm-1; ESI-MS: C22H44O3Si2 [M+Na] calc. 435.27, found 435.27; []
24
D = 
23.5° (c = 1.22, CH2Cl2). 
 
-unsaturated ester: To a dry round bottom flask equipped with a condenser was 
added aldehyde 111 (1.62 g, 3.93 mmol), ylide 69 (2.05 g, 5.9 mmol), and 39 mL THF.  
The reaction was stirred at reflux for 12 hours then cooled to room temperature and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (5% EA/Hex) to provide the product (1.78, 94%) as a colorless oil.  1H 
NMR (400 MHz, CDCl3)  0.07 (s, 6H), 0.56 (q, J= 7.7 Hz, 6H), 0.88-0.96 (m, 18H), 1.02 
(d, J= 6.8 Hz, 3H), 1.28 (t, J= 7.2 Hz, 3H), 1.70 (s, 3H), 2.40-2.51 (m, 1H) 4.08 (t, J= 6.3 
Hz, 1H), 4.18 (q, J= 7.1 Hz, 2H), 4.31 (d, J= 6.1 Hz, 2H) 5.47-5.58 (m, 2H) 5.78 (d, J= 
16.0 Hz, 1H) 6.12 (d, J= 15.6 Hz, 1H) 6.99 (dd, J= 15.6, 7.2 Hz, 1H); 13C NMR (125 
MHz, CDCl3):  −5.0, 5.1, 7.0, 13.0, 14.4, 14.6, 18.6, 26.1, 43.8, 60.3, 60.5, 76.9, 121.3, 
117 
 
129.1, 131.8, 133.6, 135.5, 151.4, 166.9; IR (film): 2955, 2877, 2858, 1722, 1652, 1462, 
1255, 1179, 1062, 967, 837 cm-1; ESI-MS: C26H50O4Si2 [M+Na] calc. 505.31, found 
505.31; []24D = 9.14° (c = 1.36, CH2Cl2). 
 
Ethyl ester: To a dry, 2-neck round bottom flask equipped with an internal thermometer 
was added copper iodide (0.072 g, 0.38 mmol) and 10 mL THF.  The solution was 
cooled to 50 °C at which time MeLi (1.6 M in Et2O, 0.24 mL, 0.38 mmol), 
hexamethylphoshphoramide (1.9 mL, 1.90 mmol), and DIBAL (1M in hexanes, 3.8 mL, 
3.8 mmol) were added successively while maintaining an internal temperature below 40 
°C.  The brown solution was stirred 30 minutes at 50 °C upon which the -
unsaturated ester (0.92 g, 1.9 mmol) in 3.0 mL THF was added dropwise.  The reaction 
was stirred for 1.5 hours at 50 °C, then diluted with ether and quenched with cold 10% 
HCl.  The layers were separated and the organic layer washed twice with cold 10% HCl, 
then twice with water.  The organic layer was dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (5% EtOAc/Hex) to provide the product (0.768 g, 83%) as a colorless 
oil.  1H NMR (400 MHz, CDCl3)  0.08 (s, 6H), 0.56 (q, J= 8.5 Hz, 6H), 0.85-0.97 (m, 
21H), 1.25 (t, J= 7.2 Hz, 3H), 1.29 - 1.41 (m, 1H), 1.54 (m, 1H), 1.72 (s, 3H, 1.76-1.89 
(m, 1H), 2.26 (s, 2H), 3.98 (m, J= 5.7 Hz, 1H), 4.11 (q, J= 7.2 Hz, 2H), 4.32 (d, J= 6.1 
Hz, 2H), 5.54 (m, 2H), 6.11 (d, J= 15.6 Hz, 1H); 13C NMR (125 MHz, CDCl3):  -5.0, 5.1, 
7.0, 12.9, 14.4, 15.0, 18.6, 26.1, 27.8, 32.7, 39.8, 60.36, 60.44, 77.7, 129.9, 131.2, 
133.8, 134.9, 174.2; IR (film): 2955, 2877, 2858, 1738, 1463, 1255, 1100, 1061, 837 cm-
1; ESI-MS: C26H52O4Si2 [M+Na] calc. 507.33, found 507.32; []
24
D = +0.9° (c = 0.88, 
CH2Cl2). 
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-ketophosphonate 112: To a dry, round bottom flask equipped with a jacketed addition 
funnel was added dimethyl methylphosphonate (0.69 mL, 6.3 mmol) and 12 mL THF.  
The solution was cooled to 78 °C, at which time n-butyllithium (1.6 M in hexanes, 3.9 
mL, 6.4 mmol) was added dropwise via the jacketed addition funnel.  After the reaction 
was stirred for 1 hour at 78 °C, the ethyl ester  (0.77 g, 1.58 mmol) in 3.0 mL THF was 
added dropwise via the jacketed addition funnel.  The reaction was stirred for 1 hour at 
78 °C then quenched with sat. ammonium chloride and warmed to room temperature.  
The layers were separated, and the aqueous layer was extracted three times with ethyl 
acetate.  The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (60% EtOAc/Hex) to provide the product (0.774 g, 87%) as a light 
yellow oil.  1H NMR (400 MHz, CDCl3)  0.07 (s, 6H), 0.55 (q, J= 8.0 Hz, 6H), 0.85 (d, J= 
6.8 Hz, 3H), 0.89-0.96 (m, 18H), 1.22-1.38(m, 1H), 1.47-1.58 (m, 1H), 1.72 (s, 3H), 1.76-
1.81 (m, 1H), 2.53-2.72 (m, 2H), 3.00-3.15 (m, 2H), 3.76 (s, 3H), 3.79 (s, 3H), 3.97 (dd, 
J= 7.2, 5.7 Hz, 1H), 4.31 (d, J= 6.1 Hz, 2H), 5.50-5.60 (m, 2H), 6.11 (d, J= 15.6 Hz, 1H); 
13C NMR (125 MHz, CDCl3):  -5.0, 5.1, 7.0, 12.9, 15.3, 18.6, 26.1, 39.7, 40.8, 41.8, 
42.6, 53.2, 60.5, 77.8, 129.7, 131.4, 133.8, 135.0, 202.3; IR (film): 2955, 2877, 2857, 
1717, 1462, 1257, 1056, 837 cm-1; ESI-MS: C27H55O6PSi2 [M+Na] calc. 585.32, found 
585.30; []25D = 1.8° (c = 1.13, CH2Cl2). 
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-unsaturated ketone: To a dry round-bottom flask was added -ketophosphonate 
112 (0.835 g, 1.48 mmol) in 3.6 mL THF. To the solution was added anhydrous barium 
hydroxide (0.195 g, 1.13 mmol) and the mixture was stirred 30 minutes at room 
temperature.  Aldehyde 55 (0.327 g, 1.35 mmol) was added in 4.0 mL of 40:1 THF: H2O, 
followed by an additional 3.7 mL of 40:1 THF: H2O. The reaction mixture was stirred 1 h 
at room temperature and was then diluted with EtOAc, filtered over Celite, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (3% EtOAc/Hex) to provide the product (0.798 g, 87%) as a colorless 
oil.  1H NMR (500 MHz, CDCl3)  0.07 (s, 6H) 0.51-0.63 (m, 12H), 0.85-0.99 (m, 30H), 
1.06 (d, J= 6.9 Hz, 3H), 1.29-1.40 (m, 1H), 1.49-1.60 (m, 2H), 1.71 (s, 3H), 1.75-1.85 (m, 
2H), 2.10-2.26 (m, 2H), 2.40-2.48 (m, 1H), 2.49-2.65 (m, 2H), 3.67 (m, 1H), 3.97 (t, J= 
6.1 Hz, 1H), 4.31 (d, J= 6.2 Hz, 2H) 5.01-5.07 (m, 2H), 5.53 (t, J= 6.1 Hz, 1H), 5.57 (dd, 
J= 15.7, 7.2 Hz, 1H), 5.70-5.81 (m, 1H), 6.05 (d, J= 16.0 Hz, 1H), 6.11 (d, J= 15.8 Hz, 
1H), 6.82 (dd, J= 16.0, 8.3 Hz, 1H);  13C NMR (125 MHz, CDCl3):  -5.0, 5.2, 5.3, 7.1, 
7.2, 13.0, 15.3, 16.1, 18.6, 26.2, 27.3, 38.4, 39.9, 40.1, 42.0, 60.5, 75.4, 77.9, 117.6, 
130.1, 130.6, 131.3, 133.8, 134.8, 134.9, 149.0, 201.3; IR (film): 2955, 2877, 1676, 
1630, 1462, 1415, 1254, 1101, 1064, 1007, 837 cm-1; ESI-MS: C38H74O4Si3 [M+Na] calc 
701.48, found 701.32; []25D = 6.0° (c = 1.09, CH2Cl2). 
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Ketone 113: To a dry, 2-neck round bottom flask equipped with an internal thermometer 
was added copper iodide (0.052 g, 0.26 mmol) and 12 mL THF.  The solution was 
cooled to 50 °C at which time MeLi (1.6 M in Et2O, 0.16 mL, 0.26 mmol), 
hexamethylphoshphoramide (1.32 mL, 7.6 mmol), and DIBAL (1M in hexanes, 3.4 mL, 
3.4 mmol) were added successively while maintaining an internal temperature below 40 
°C.  The brown solution was stirred 30 minutes at 50 °C.  The enone (0.896 g, 1.32 
mmol) in 1.5 mL THF was added dropwise.  The reaction was stirred for 1.5 hours at 50 
°C, then diluted with ether and quenched with cold 10% HCl.  The layers were separated 
and the organic layer washed twice with cold 10% HCl, then twice with water.  The 
organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure.  
The crude product was purified by flash column chromatography (3% EtOAc/Hex) to 
provide the product (0.845 g, 94%) as a colorless oil.  1H NMR (400 MHz, CDCl3)  0.07 
(s, 6H), 0.51-0.61 (m, 12H), 0.85 (d, J= 6.6 Hz, 3H), 0.89-0.98 (m, 30 H), 1.23-1.37 (m, 
2H), 1.45-1.55 (m, 2H), 1.68-1.79 (m, 5H), 2.13-2.23 (m, 2H), 2.28-2.51 (m, 4H), 3.56 (q, 
J= 5.3 Hz, 1H), 3.96 (t, J= 6.0 Hz, 1H), 4.31 (d, J= 6.2 Hz, 2H), 4.98-5.08 (m, 2H), 5.49-
5.61 (m, 2H), 5.76-5.87 (m, 1H), 6.11 (d, J= 15.8 Hz, 1H); 13C NMR (125 MHz, CDCl3):  
-4.9, 5.2, 5.3, 7.1, 7.2, 12.9, 15.0, 15.3, 18.6, 26.1, 26.2, 26.7, 38.1, 38.2, 40.0, 41.0, 
41.1, 60.5, 76.1, 77.9, 116.7, 129.9, 131.3, 133.8, 135.0, 136.0, 211.8; IR (film): 2955, 
2877, 1715, 1462, 1415, 1254, 1065, 1007, 837 cm-1; ESI-MS: C38H76O4Si3 [M+Na] calc. 
703.49, found 703.48; []24D = 3.3° (c = 0.78, CH2Cl2). 
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Spiroketals 120 and 121: To a dry round bottom flask was added ketone 113 (0.196 g, 
0.29 mmol) and 5.8 mL anhydrous methanol.  Pyridinium p-toluenesulfonate (PPTS) 
(0.014 g, 0.06 mmol) was added and the reaction mixture stirred at room temperature for 
3 hours.  The solution was concentrated under reduced pressure and the crude product 
purified by flash column chromatography (10-30% EA/Hex) to give 120 (0.052 g, 56%) 
and 121 (0.0238 g, 26%) as colorless oils.   
120 (15S): 1H NMR (500 MHz, CDCl3)  0.74 (d, J= 6.8 Hz, 3H), 0.78 (d, J= 6.4 Hz, 3H), 
1.22-1.58 (m, 8H), 1.66-1.78 (m, 2H), 1.81 (s, 3H), 1.83-1.91 (m, 1H), 2.19-2.35 (m, 2H), 
3.46 (ddd, J= 9.2, 4.6, 4.6 Hz, 1H), 4.12 (dd, J= 8.9, 5.3 Hz, 1H), 4.29 (br. s., 2H), 4.97-
5.08 (m, 2H) 5.66 (t, J= 6.6 Hz, 1H), 5.89 (dddd, J= 17.2, 10.0, 8.2, 6.0 Hz, 1H), 6.07 
(dd, J= 16.5, 10.3 Hz, 1H), 6.19 (d, J= 15.8 Hz, 1H); 13C NMR (125 MHz, CDCl3):  13.2, 
17.5, 17.6, 24.0, 27.8, 33.5, 33.6, 36.1, 36.4, 37.7, 59.6, 74.0, 79.5, 95.7, 116.4, 128.2, 
130.0, 135.2, 136.2, 137.3; IR (film): 3416, 2953, 2929, 2870, 1640, 1457, 1381, 1147, 
1015, 985 cm-1; ESI-MS: C20H32O3 [M+Na] calc. 343.22, found 343.22; []
24
D = 79.6° (c 
= 1.10, CH2Cl2).   
 
Note: 2-D NOESY NMR indicated a strong cross peak between H1(3.46 ppm)-H2 (6.07 
ppm) and H1 (3.47 ppm)-H3 (6.19 ppm) supporting assignment of the major product as 
the spiroketal corresponding to spirofungin A. 
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121 (15R): 1H NMR (500 MHz, CDCl3)  0.85 (d, J= 6.6 Hz, 3H), 0.93 (d, J= 6.8 Hz, 3H), 
1.18-1.34 (m, 2H), 1.35-1.47 (m, 3H), 1.55-1.74 (m, 4H), 1.78 (s, 3H), 1.87-2.04 (m, 2H), 
2.22 (m, 1H), 2.39 (dd, J= 12.1, 6.8 Hz, 1H), 3.09 (td, J= 9.1, 9.1, 2.6 Hz, 1H), 4.26 (d, 
J= 6.8 Hz, 2H), 4.81 (d, J= 4.1 Hz, 1H), 5.03-5.09 (m, 2H), 5.59-5.70 (m, 2H), 5.99 
(dddd, J= 17.0, 9.9, 7.1 Hz, 1H), 6.23 (d, J= 15.8 Hz, 1H); 13C NMR (125 MHz, CDCl3):  
11.7, 12.7, 17.6, 22.5, 25.6, 29.4, 32.1, 34.8, 36.6, 38.3, 59.6, 73.1, 78.5, 97.8, 116.1, 
129.5, 129.8, 134.0, 136.3, 136.5; IR (film): 3407, 2929, 2870, 1641, 1454, 1380, 1222, 
1058, 1020, 966 cm-1; ESI-MS: C20H32O3 [M+Na] calc. 343.22, found 343.22; []
24
D = 
+46.1° (c = 0.38, CH2Cl2). 
 
Methyl ester 122: To a dry round bottom flask was added spiroketal 120 (0.052 g, 0.16 
mmol) and 1.6 mL acetone.  Manganese dioxide (0.56 g, 6.5 mmol) was added and the 
reaction stirred for two hours.  The reaction mixture was filtered over Celite, washing 
with CH2Cl2, then concentrated under reduced pressure.  The intermediate aldehyde 
(~0.16 mmol) was taken up in 1.6 mL MeOH.  Sodium cyanide (0.040 g, 0.81 mmol) and 
acetic acid (0.018 mL, 0.32 mmol) were added.  After 2 hours of stirring at room 
temperature, the reaction was filtered over Celite, washing with ethyl acetate.  The 
organic layer was washed with brine, dried over Na2SO4, filtered, and concentrated 
under reduced pressure.  The crude product was purified by flash column 
chromatography (5-10% EtOAc/Hex) to give the product (0.044 g, 78%) as a colorless 
oil.  1H NMR (500 MHz, CDCl3)  0.75 (d, J= 7.2 Hz, 3H), 0.78 (d, J= 6.0 Hz, 3H), 1.32-
1.57 (m, 6H), 1.67-1.81 (m, 3H), 1.89 (m, 1H), 2.19-2.34 (m, 5H), 3.41 (dt, J= 9.2, 4.3 
Hz, 1H), 3.71 (s, 3H), 4.15 (dd, J= 8.9, 5.1 Hz, 1H), 4.99-5.08 (m, 2H), 5.79 (s, 1H), 5.88 
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(dddd, J= 17.1, 9.9, 8.0, 6.0 Hz, 1H), 6.22 (d, J= 16.0 Hz, 1H), 6.47 (dd, J= 15.6, 9.0 Hz, 
1H); 13C NMR (125 MHz, CDCl3):  14.5, 17.2, 17.6, 24.0, 27.6, 33.3, 33.4, 35.8, 36.2, 
37.6, 51.2, 74.2, 78.8, 95.8, 116.6, 119.0, 134.9, 135.1, 136.5, 152.4, 167.7; IR (film): 
2929, 2871, 1718, 1640, 1435, 1235, 1159, 1018, 985 cm-1; ESI-MS: C21H32O4 [M+Na] 
calc. 371.22, found 371.22; []25D = 72.7° (c = 0.95, CH2Cl2). 
 
Methyl ester 123: To a dry round bottom flask was added spiroketal 121 (0.014, 0.04 
mmol) and 0.4 mL acetone.  Manganese dioxide (0.15 g, 1.72 mmol) was added and the 
reaction stirred for two hours.  The reaction mixture was filtered over Celite, washing 
with CH2Cl2, then concentrated under reduced pressure.  The intermediate aldehyde 
(~0.04 mmol) was taken up in 0.4 mL MeOH.  Sodium cyanide (0.010 g, 0.22 mmol) and 
acetic acid (0.005 mL, 0.09 mmol) were added.  After 2 hours of stirring at room 
temperature, the reaction was filtered over Celite, washing with ethyl acetate.  The 
organic layer was washed with brine, dried over Na2SO4, filtered, and concentrated 
under reduced pressure.  The crude product was purified by flash column 
chromatography (5-10% EtOAc/Hex) to give the product (0.0117 g, 78%) as a colorless 
oil.  1H NMR (500 MHz, CDCl3)  0.85 (d, J= 6.4 Hz, 3H), 0.90 (d, J= 7.1 Hz, 3H), 1.19-
1.48 (m, 4H), 1.61-1.84 (m, 4H), 1.88-2.06 (m, 2H), 2.16-2.31 (m, 4H), 2.35-2.44 (m, 
1H), 3.10 (dt, J= 9.4, 2.3 Hz, 1H), 3.69 (s, 3H), 4.87 (br. s., 1H) 5.03 (d, J= 10.8 Hz, 1H), 
5.09 (d, J= 17.6, 1H), 5.75 (s, 1H) 5.91-6.00 (m, 1H), 6.04 (dd, J= 15.9, 5.4 Hz, 1H), 6.29 
(d, J= 15.8 Hz, 1H); 13C NMR (125 MHz, CDCl3):  11.8, 13.9, 17.6, 22.5, 25.5, 29.4, 
31.7, 34.9, 36.5, 38.2, 51.2, 72.5, 78.5, 97.9, 116.2, 118.5, 132.9, 136.3, 136.7, 152.6, 
167.8; IR (film): 2949, 2874, 1717, 1614, 1437, 1235, 1157, 1022, 987 cm-1; ESI-MS: 
C21H32O4 [M+Na] calc. 371.22, found 371.22; []
25
D = +51.5° (c = 0.60, CH2Cl2). 
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Aldehyde 124: To a dry 10 mL round bottom flask under argon was added spiroketal 
122 (0.026 g, 0.075 mmol) in 0.6 mL degassed CH2Cl2 along with freshly distilled 
methacrolein (32 L, 0.37 mmol).  Grubbs 2nd generation catalyst (0.0032 g, 0.004 
mmol) was added in one portion to the solution.  The reaction was stirred at reflux for 3 
hours then cooled to room temperature and opened to air for 1 hour.  The mixture was 
concentrated under reduced pressure and the crude product was purified by flash 
column chromatography (5-10% EtOAc/Hex) to give the product (0.0216 g, 74%) as a 
colorless oil.  1H NMR (400 MHz, CDCl3)  0.77 (d, J= 7.2 Hz, 3H), 0.80 (d, J= 6.5 Hz, 
3H), 1.30-1.62 (m, 6H), 1.65-1.83 (m, 6H), 1.90 (m, 1H), 2.28 (s, 3H), 2.43-2.53 (m, 1H), 
2.54-2.65 (m, 1H), 3.58-3.65 (m, 1H), 3.71 (s, 3H), 4.18 (dd, J= 8.7, 4.9 Hz, 1H), 5.81 
(s,1H), 6.26 (d, J= 15.9 Hz, 1H), 6.44 (dd, J= 15.9, 9.1 Hz, 1H), 6.65 (t, J= 6.8 Hz, 1H), 
9.42 (s, 1H); 13C NMR (100 MHz, CDCl3):  9.6, 14.5, 16.8, 17.8, 24.3, 27.7, 32.7, 33.2, 
34.0, 35.3, 35.6, 51.2, 74.1, 78.4, 96.3, 119.3, 134.8, 136.4, 140.8, 150.8, 151.9, 167.6, 
195.3; IR (film): 2929, 2871, 1716, 1688, 1613, 1437, 1235, 1160, 1019, 987 cm-1; ESI-
MS: C23H34O5 [M+Na] calc. 413.23, found 413.23; []
25
D = 142.9° (c = 0.38, CH2Cl2). 
 
Aldehyde 125: To a dry 10 mL round bottom flask under argon was added spiroketal 
123 (0.024 g, 0.069 mmol) in 0.6 mL degassed CH2Cl2 along with freshly distilled 
methacrolein (30 L, 0.34 mmol).  Grubbs 2nd generation catalyst (0.003 g, 0.003 mmol) 
was added in one portion to the solution.  The reaction was stirred at reflux for 3 hours 
then cooled to room temperature and opened to air for 1 hour.  The mixture was 
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concentrated under reduced pressure and the crude product was purified by flash 
column chromatography (5-10% EtOAc/Hex) to give the product (0.0197 g, 74%) as a 
colorless oil.  1H NMR (400 MHz, CDCl3)  0.88 (d, J= 4.2, 3H), 0.90 (d, J= 3.4 Hz, 3H), 
1.21-1.52 (m, 4H), 1.58-1.91 (m, 8H), 2.01 (d, J= 14.4 Hz, 1H), 2.25 (s, 3H), 2.48-2.59 
(m, 1H), 2.62-2.72 (m, 1H), 3.26 (dt, J= 8.9, 2.7 Hz, 1H), 3.68 (s, 3H), 4.74 (br. s., 1H), 
5.75 (s, 1H), 6.01 (dd, J= 15.9, 4.9 Hz, 1H), 6.26 (d, J= 15.6 Hz, 1H), 6.67 (t, J= 6.6 Hz, 
1H), 9.44 (s, 1H); 13C NMR (125 MHz, CDCl3):  9.7, 11.8, 13.9, 17.7, 22.6, 25.7, 29.1, 
31.6, 33.4, 34.9, 36.4, 51.2, 72.7, 77.8, 98.1, 118.8, 133.0, 136.2, 140.5, 152.2, 152.4, 
167.8, 195.4; IR (film): 2951, 2870, 1715, 1687, 1614, 1439, 1236, 1158, 1082, 1020, 
987 cm-1; ESI-MS: C23H34O5 [M+Na] calc. 413.23, found 413.23; []
25
D = +108.5° (c = 
0.12, CH2Cl2). 
 
Diene 126: To a dry round-bottom flask, under argon, was added 
methylenetriphenylphosphine bromide (0.124 g, 0.347 mmol) in 0.3 mL THF. The 
mixture was cooled to 0 °C and potassium tert-butoxide (1 M in THF, 0.28 mL, 0.28 
mmol) was added. The bright yellow mixture was stirred 30 min at 0 °C upon which the 
aldehyde 124 (0.021 g, 0.052 mmol) was added in 0.3 mL THF. The reaction was stirred 
15 min at 0 °C then quenched with water. The layers were separated and the aqueous 
layer was extracted with ethyl acetate (2x). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude product was 
purified via flash column chromatography (2-5% EtOAc/Hex) to provide the product as a 
colorless oil (0.0175 g, 86%).  1H NMR (500 MHz, CDCl3)  0.76 (m, 6H), 1.32-1.55 (m, 
6H), 1.66-1.84 (m, 6H), 1.90 (br. s., 1H), 2.28 (s, 3H), 2.32 (m, 1H), 2.39 (m, 1H), 3.47 
(m, 1H), 3.71 (s, 3H), 4.16 (dd, J= 9.1, 5.2 Hz, 1H), 4.92 (d, J= 10.8 Hz, 1H), 5.08 (d, J= 
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17.2 Hz, 1H), 5.60 (t, J= 6.8 Hz, 1H), 5.80 (s, 1H), 6.23 (d, J= 15.6 Hz, 1H), 6.40 (dd, J= 
17.4, 10.8 Hz, 1H), 6.50 (dd, J= 15.6, 9.2 Hz, 1H); 13C NMR (100 MHz, CDCl3):  12.1, 
14.5, 17.1, 17.8, 24.1, 27.8, 32.1, 33.3, 33.8, 35.7, 36.2, 51.1, 74.7, 78.7, 95.9, 110.4, 
119.1, 128.8, 135.1, 135.2, 136.5, 141.9, 152.3, 167.6; IR (film): 2928, 2870, 1718, 
1612, 1436, 1235, 1159, 1019, 891 cm-1; ESI-MS: C24H36O4 [M+Na] calc. 411.25, found 
411.22; []24D = 154.0° (c = 0.29, CH2Cl2). 
 
Diene 127: To a dry round-bottom flask, under argon, was added 
methylenetriphenylphosphine bromide (0.102 g, 0.28 mmol) in 0.25 mL THF. The 
mixture was cooled to 0 °C and potassium tert-butoxide (1 M in THF, 0.23 mL, 0.23 
mmol) was added. The bright yellow mixture was stirred 30 min at 0 °C upon which the 
aldehyde 125 (0.018 g, 0.046 mmol) was added in 0.25 mL THF. The reaction was 
stirred 15 min at 0 °C then quenched with water. The layers were separated and the 
aqueous layer was extracted with ethyl acetate (2x). The combined organic layers were 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude 
product was purified via flash column chromatography (2% EtOAc/Hex) to provide the 
product (0.0134 g, 75%) as a colorless oil.  1H NMR (500 MHz, CDCl3)  0.86-0.92 (m, 
6H), 1.27-1.35 (m, 1H), 1.36-1.53 (m, 3H), 1.59-1.82 (m, 7H), 1.82 (m, 1H), 2.00 (m, 
1H), 2.25-2.34 (m, 4H), 2.51 (m, 1H), 3.13 (td, J= 8.8, 3.0 Hz, 1H), 3.70 (s, 3H), 4.82 (m, 
1H), 4.94 (d, J= 10.5 Hz, 1H), 5.09 (d, J= 17.4 Hz, 1H), 5.6 (t, J= 7.0 Hz, 1H), 5.75 (s, 
1H), 6.04 (dd, J= 15.8, 5.3 Hz, 1H), 6.28 (d, J= 15.8 Hz, 1H), 6.42 (dd, J= 17.3, 10.6 Hz, 
1H); 13C NMR (125 MHz, CDCl3):  11.8, 12.1, 13.9, 17.8, 22.9, 25.6, 29.0, 31.7, 32.6, 
34.6, 36.2, 51.2, 72.5, 78.7, 97.9, 110.7, 118.6, 130.4, 132.9, 135.0, 136.7, 141.8, 152.6, 
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167.8; IR (film): 2927, 2862, 1716, 1614, 1235, 1157, 1021, 968 cm-1; ESI-MS: C24H36O4 
[M+Na] calc. 411.25, found 411.22; []24D = +109.9° (c = 0.69, CH2Cl2). 
 
 
Cross metathesis product 128:  To a dry round bottom flask under argon was added 
diene 126 (0.018 g, 0.046 mmol) in 0.5 mL degassed CH2Cl2 along with alcohol 49 
(0.0128 g, 0.069 mmol).  A solution of Grubbs 2nd generation catalyst (0.008 g, 0.0092 
mmol) in 0.2 mL CH2Cl2 was added dropwise to the reaction over 6 hours.  Upon 
completion of catalyst addition, the reaction was stirred for 12 hours at room temperature 
then opened to air for 1 hour.  The mixture was concentrated under reduced pressure 
and the crude product was purified by flash column chromatography (4-20% EtOAc/Hex) 
to provide recovered diene 126 (0.0059 g, 33%) and the product (0.014 g, 55%) as 
colorless oils.  1H NMR (400 MHz, CDCl3)  0.70-0.80 (m, 6H), 1.09 (d, J= 6.5 Hz, 3H), 
1.29 (t, J= 7.2 Hz, 3H), 1.33-1.60 (m, 6H), 1.66-1.97 (m, 4H), 1.72 (s, 3H), 2.20-2.43 (m, 
2H), 2.26 (s, 3H), 2.57 (m, 1H), 3.45 (m, 1H) 3.72 (s, 3H) 4.08-4.23 (m, 5H), 5.51 (dd, J= 
15.75, 7.40 Hz, 1 H), 5.57 (t, J= 6.5 Hz, 1H), 5.80 (s, 1H), 5.87 (d, J= 15.9 Hz, 1H), 6.24 
(d, J= 15.9 Hz, 2H), 6.49 (dd, J= 15.6, 9.1 Hz, 1H), 7.01 (dd, J= 15.8, 7.4 Hz, 1H); 13C 
NMR (125 MHz, CDCl3):  13.0, 14.4, 14.5, 14.7, 17.4, 17.8, 23.9, 27.8, 32.5, 33.3, 34.2, 
35.9, 36.3, 42.7, 51.3, 60.5, 74.8, 76.3, 78.8, 95.9, 119.1, 122.0, 126.0, 130.0, 133.9, 
135.0, 136.7, 137.8, 150.6, 152.6, 166.8, 167.8; IR (film): 3422, 2927, 2862, 1715, 1650, 
1367, 1259, 1160, 1029 cm-1; ESI-MS: C32H48O7 [M+Na] calc. 567.33, found 567.30; 
[]24D = 73.0° (c = 0.19, CH2Cl2). 
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Cross metathesis product 129: To a dry round bottom flask under argon was added 
diene 127 (0.0287 g, 0.074 mmol) in 0.5 mL degassed CH2Cl2 along with alcohol 49 
(0.0204 g, 0.111 mmol).  A solution of Grubbs 2nd generation catalyst (0.0125 g, 0.015 
mmol) in 0.25 mL CH2Cl2 was added dropwise to the reaction over 6 hours.  Upon 
completion of catalyst addition, the reaction was stirred for 12 hours at room temperature 
then opened to air for 1 hour.  The mixture was concentrated under reduced pressure 
and the crude product was purified by flash column chromatography (4-20% EtOAc/Hex) 
to provide recovered diene 127 (0.005 g, 17%) and the product (0.0235 g, 58%) as 
colorless oils.  1H NMR (500 MHz, CDCl3)  0.88 (d, J= 6.6 Hz, 3H) 0.90, (d, J= 7.1 Hz, 
3H), 1.08 (d, J= 6.6 Hz, 3H), 1.29 (t, J= 7.1 Hz, 3H), 1.36-1.51 (m, 4H), 1.63 (td, J= 12.7, 
4.1 Hz, 1H), 1.67-1.84 (m, 7H), 1.85-1.96 (m, 1 H), 1.96-2.03 (m, 1H), 2.23-2.36 (m, 4H), 
2.46-2.54 (m, 1H), 2.54-2.63 (m, 1 H), 3.13 (td, J= 8.7, 2.8 Hz, 1H), 3.65-3.74 (m, 3H), 
4.12-4.24 (m, 3H), 4.82 (br. s., 1H), 5.52 (dd, J= 15.6, 7.1 Hz,1 H), 5.68 (t, J= 6.8 Hz, 
1H),  5.76 (s, 1H), 5.87 (d, J= 15.6 Hz, 1H), 6.04 (dd, J= 15.8, 5.3 Hz, 1H), 6.29 (d, J= 
15.8 Hz, 2H), 7.00 (dd, J= 15.8, 7.6 Hz, 1H); 13C NMR (125 MHz, CDCl3):  11.8, 13.0, 
13.9, 14.5, 14.6, 17.8, 22.9, 25.7, 29.0, 31.7, 32.7, 34.6, 36.2, 42.8, 51.2, 60.5, 72.5, 
76.2, 78.7, 98.9, 118.6, 122.1, 126.0, 131.1, 132.9, 133.7, 136.6, 137.6, 150.4, 152.6, 
166.7, 167.8; IR (film): 3477, 2928, 2862, 1716, 1650, 1453, 1236, 1158, 968 cm-1; ESI-
MS: C32H48O7 [M+Na] calc. 567.33, found 567.30; []
24
D = +139.3° (c = 0.08, CH2Cl2). 
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()-Spirofungin A (1): To a solution of diester 128 (0.0066 g, 0.012 mmol) in THF/H2O/ 
MeOH (300/150/150 L) was added LiOH (0.004 g, 0.10 mmol). The reaction mixture 
was stirred for 36 h. The reaction mixture was cooled to 0 °C, and quenched with 1 N 
HCl, aqueous NH4Cl, and diluted with ethyl acetate. The organic layer was washed with 
water then brine, dried over Na2SO4, and concentrated under reduced pressure.  The 
crude product was purified by flash column chromatography (Et2O: Hex 2:1, 1% AcOH) 
to give ()-spirofungin A (0.0053 g, 87%) as a colorless oil.  1H NMR (400 MHz, CDCl3) 
0.70-0.82 (m, 6H), 1.11 (d, J= 6.8 Hz, 3H), 1.35 (br. s., 2H), 1.39-1.63 (m, 6H), 1.64-
1.83 (m, 7H), 1.93 (br. s., 1H), 2.16-2.42 (m, 5H), 2.56-2.65 (m, 1H), 3.36-3.45 (m, 1H), 
4.11-4.21 (m, 2H), 5.46-5.54 (m, 2H), 5.82 (s, 1H), 5.87 (d, J= 15.6 Hz, 1H), 6.21 (d, J= 
15.6 Hz, 1H), 6.29 (d, J= 15.6 Hz, 1H), 6.56 (dd, J= 15.6, 9.5 Hz, 1H), 7.11 (dd, J= 15.6, 
7.2 Hz, 1H); 13C NMR (125 MHz, CDCl3):  12.9, 14.3, 14.8, 17.7, 17.8, 23.6, 28.0, 33.3, 
33.5, 35.3, 36.5, 36.6, 42.7, 75.0, 76.5, 78.7, 95.8, 118.7, 121.4, 125.5, 130.7, 133.5, 
135.6, 137.0, 138.0, 153.3, 154.8, 171.7, 172.2; IR (film): 3419, 2929, 2862, 1698, 1651, 
1455, 1380, 1260, 1157, 1020 cm-1; ESI-MS: C29H42O7 [M+Na] calc. 525.28, found 
525.25; []24D = 117.9° (c = 0.08, CH2Cl2). 
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(+)-Spirofungin B (2): To a solution of diester 129 (0.0078 g, 0.014 mmol) in THF/H2O/ 
MeOH (350/175/175 L) was added LiOH (0.0048 g, 0.11 mmol). The reaction mixture 
was stirred for 36 h. The reaction mixture was cooled to 0 °C, and quenched with 1 N 
HCl, aqueous NH4Cl, and diluted with ethyl acetate. The organic layer was washed with 
water then brine, dried over Na2SO4, and concentrated under reduced pressure.  The 
crude product was purified by flash column chromatography (Et2O: Hex 2:1, 1% AcOH) 
to give (+)-spirofungin B (0.0063 g, 88%) as a colorless oil.  1H NMR (500 MHz, CDCl3)  
0.85-0.94 (m, 6H), 1.10 (d, J= 6.6 Hz, 3H), 1.22-1.35 (m, 3H), 1.36-1.52, (m, 3H), 1.63 
(m, 1H), 1.67-1.85 (m, 7H) 1.93 (m, 2H), 2.26 (s, 3H), 2.29-2.41 (m, 1H) 2.45-2.52 (m, 
1H), 2.62 (m, 1H), 3.17 (td, J= 8.2, 2.5 Hz, 1H), 4.17 (t, J= 6.2 Hz, 1H), 4.79 (br. s., 1H), 
5.51 (dd, J= 15.5, 7.2 Hz, 1H), 5.65 (t, J= 6.9 Hz, 1H), 5.78 (s, 1H), 5.87 (d, J= 15.8 Hz, 
1H), 6.08 (dd, J= 15.8, 5.3 Hz, 1H), 6.30 (d, J= 15.6 Hz, 2H), 7.10 (dd, J= 15.7, 7.5 Hz, 
1H); 13C NMR (125 MHz, CDCl3):  11.8, 13.0, 14.1, 14.9, 17.8, 23.5, 25.7, 28.4, 31.7, 
32.6, 34.0, 35.8, 43.0, 72.5, 76.1, 78.6, 97.8, 118.1, 121.4, 125.7, 131.1, 132.9, 134.0, 
137.55, 137.64, 153.0, 155.0, 171.2, 171.9; IR (film): 3432, 2941, 2862, 1643, 1454, 
1367, 1259, 1020, 967 cm-1; ESI-MS: C29H42O7 [M+Na] calc. 525.28, found 525.25; []
24
D 
= +79.0° (c = 0.07, CH2Cl2). 
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CHAPTER SIX 
 
Experimental and NMR Spectra: (+)-Sorangicin A 
 
6.1 Materials and Methods 
  Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform 
infrared spectrometer and values reported in cm-1.  Proton and carbon nuclear magnetic 
resonance spectra were acquired on a Bruker model Avance 400 (1H at 400 MHz; 13C at 
100 MHz, CDCl3), Bruker model Avance 500 (
1H at 500 MHz; 13C at 125 MHz, CDCl3), or 
Bruker model Avance 600 (1H at 600 MHz; 13C at 150 MHz, CDCl3). Chemical shifts are 
reported relative to chloroform,  7.26 for 1H NMR spectra and  77.2 for 13C NMR 
spectra. Optical rotations were determined using a Jasco P1010 polarimeter. Mass 
spectra were obtained using a Bruker BioTOF II mass spectrometer with electrospray 
ionization (ESI).  Thin layer chromatography (TLC) was conducted on silica gel F254 
TLC plates purchased from Scientific Adsorbents, Inc.  Flash column chromatography 
was carried out using Ultra Pure Silica Gel Silia-P(40 to 63 m) purchased from SiliCycle 
Inc.  The second generation Grubbs precatalyst (G2) is defined as 
[Ru=CHPh(Cl)2(PCy3)(DHIMes)]. Diethyl ether (Et2O), tetrahydrofuran (THF), 
dichloromethane (CH2Cl2), and toluene were dried by being passed through a column of 
neutral alumina under nitrogen immediately prior to use.  Alkylamines were distilled from 
 
 
192 
 
 
calcium hydride immediately prior to use.  All other reagents and solvents were used as 
received from the manufacturer, unless otherwise specified.  All air and water sensitive 
reactions were performed in flasks flame dried under positive flow argon and conducted 
under an argon atmosphere. 
 
6.2 Experimental procedures 
 
p-Methoxy benzyl protected bicyclic ether 263:  
To a dry round bottom flask under argon was added bicyclic ether 227 (0.37 g, 1.41 
mmol) in 6.0 mL THF: DMF (1:1).  The reaction was cooled to 0 °C and sodium hydride 
(60% in mineral oil, 0.17 g, 4.24 mmol) was added in one portion.  The reaction was 
stirred for 30 minutes, then p-methoxybenzyl bromide (0.31 mL, 2.12 mmol) was added.  
After 2 hours stirring at 0 °C, the reaction mixture was diluted with ethyl acetate and 
quenched with water.  The layers were separated and the aqueous layer extracted three 
times with ethyl acetate.  The combined organic layers were dried over Na2SO4, filtered, 
and concentrated under reduced pressure.  The crude product was purified by flash 
column chromatography (10% EtOAc/Hex) to provide the product (0.506 g, 94%) as a 
colorless oil.  1H NMR (600 MHz, CDCl3)  7.38 (m, 2H), 7.28-7.34 (m, 4H), 7.21-7.26 
(m, 1H), 6.89 (d, J= 8.7, 2H), 6.52 (d, J= 15.8, 1H), 6.11 (dd, J= 15.6, 7.7 Hz, 1H), 4.59 
(d, J= 11.7 Hz, 1H), 4.56 (d, J= 11.7 Hz, 1H), 4.42 (br. s., 1H), 4.30 (d, J= 6.4 Hz, 1H), 
4.10-4.15 (m, 1H), 3.98 (t, J= 8.5 Hz, 1H), 3.84 (d, J= 6.0 Hz, 2H), 3.77-3.82 (m, 3H), 
2.05 (ddd, J= 11.5, 6.6, 2.6 Hz, 1H), 1.92 (d, J= 10.9 Hz, 1H), 1.47-1.54 (m, 1H), 0.92 (d, 
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J= 6.8 Hz, 3H); 13C NMR (150 MHz, CDCl3):  159.4, 136.7, 132.6, 130.5, 129.6, 129.3, 
128.7, 127.9, 126.7, 113.9, 81.9, 79.8, 79.1, 75.1, 73.1, 67.7, 55.4, 41.9, 38.9, 15.4; IR 
(film): 2961, 2933, 2873, 1612, 1513, 1451, 1248, 1075, 967, 820; ESI-MS: C24H28O4 
[M+Na] calc.403.19, found 403.2; []23D = 41.9 (c = 0.48, CH2Cl2). 
 
Bicyclic ether 264:  To a dry round bottom flask under argon was added PMB protected 
bicyclic ether 263 (0.400 g, 1.05 mmol) in 20 mL THF: pH 7 buffer (1:1).  Osmium 
tetraoxide (20 mg/mL in water, 1.34 mL, 0.11 mmol) was added dropwise followed by 
sodium periodate (0.449 g, 2.10 mmol).  The reaction was stirred for 2 hours then 
quenched with 1:1 NaHCO3:NaS2O3.  The layers were separated and the aqueous layer 
extracted three times with ethyl acetate.  The combined organic layers were dried over 
Na2SO4, filtered, and concentrated under reduced pressure.  The crude aldehyde was 
used immediately in the next reaction without further purification.   
To a dry round-bottom flask, under argon, was added 
methylenetriphenylphosphine bromide (1.88 g, 5.26 mmol) in 8.0 mL THF. The mixture 
was cooled to 0 °C and potassium tert-butoxide (1 M in THF, 4.20 mL, 4.20 mmol) was 
added. The bright yellow mixture was stirred 30 min at 0 °C at which time the aldehyde 
was added in 2.5 mL THF. The reaction was stirred 1 hour at 0 °C then quenched with 
water. The layers were separated and the aqueous layer was extracted with ethyl 
acetate (3x). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure. The crude product was purified via flash column 
chromatography (20% EtOAc/Hex) to provide the product as a colorless oil (0.278 g, 
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87% over 2 steps).  1H NMR (600 MHz, CDCl3)  7.29 (d, J= 8.7 Hz, 2H), 6.87 (d, J= 8.3 
Hz, 2H), 5.74 (ddd, J= 17.2, 10.1, 7.3 Hz, 1H), 5.19 (d, J= 17.0 Hz, 1H), 5.14 (d, J= 10.5 
Hz, 1H), 4.54 (q, J= 11.7 Hz, 2H), 4.38 (br. s., 1H), 4.25 (d, J= 6.4 Hz, 1H), 4.07-4.11 (m, 
1H), 3.77-3.82 (m, 6H), 2.01 (ddd, J= 11.6, 6.9, 2.6 Hz, 1H), 1.86 (d, J= 11.6 Hz, 1H), 
1.37-1.43 (m, 1H), 0.88 (d, 6.8 Hz, 3H); 13C NMR (150 MHz, CDCl3):  159.3, 138.1, 
130.5, 129.6, 117.3, 113.9, 81.9, 80.1, 79.0, 75.0, 73.1, 67.8, 55.4, 41.4, 38.8, 15.2; IR 
(film): 2934, 2874, 1613, 1514, 1302, 1248, 1076, 822; ESI-MS: C18H24O4 [M+Na]
 
calc.327.16, found 327.2;  []23D = 63.7° (c = 0.30, CH2Cl2). 
 
 
Aldehyde 278: 
To a dry round bottom flask under argon was added protected aldol adduct 240 (1.35 g, 
3.0 mmol) in 30 mL CH2Cl2.  The yellow solution was cooled to 78 °C and DIBAL (1M in 
hexanes) was added dropwise via syringe until the reaction mixture became colorless 
(6.0 mL, 6.0 mmol).  The reaction mixture was immediately quenched with saturated 
potassium sodium tartrate, warmed to room temperature, and vigorously stirred for 2 
hours.  The layers were separated and the aqueous layer extracted twice with CH2Cl2.  
The combined organic layers were dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography (5-
10% EtOAc/Hex) to provide the product (0.602 g, 83%) as a colorless oil.  1H NMR (600 
MHz, CDCl3)  9.56 (s, 1H), 5.75 (ddt, J= 17.2, 10.1, 7.3, 7.3 Hz, 1H), 5.04-5.13 (m, 2H), 
4.20 (td, J= 6.6, 3.8 Hz, 1H), 2.46 (qd, J= 6.8, 3.8 Hz, 1H), 2.29 (t, J= 7.0 Hz, 2H), 1.09 
(d, J= 7.2 Hz, 3H), 0.86 (s, 9H), 0.07 (s, 3H), 0.03 (s, 3H); 13C NMR (150 MHz, CDCl3):  
205.3, 134.3, 118.2, 71.5, 51.0, 39.7, 25.9, 18.2, 7.6, −4.0, −4.6; IR (film): 2955, 2930, 
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2858, 1730, 1472, 1036, 838, 776; ESI-MS: C13H26O2Si [M+H]
 calc. 243.17, found 243.2; 
[]23D = 29.1° (c = 0.95, CH2Cl2). 
 
 
Cross metathesis product 242: 
To a dry round bottom flask under argon was added aldehyde 278 (0.63 g, 2.60 mmol) in 
22 mL degassed toluene along with diacetate 274 (1.12 g, 6.50 mmol).  Grubbs 2nd 
generation catalyst (0.110 g, 0.13 mmol) was added in one portion to the solution.  The 
reaction was stirred at room temperature for 12 hours then opened to air for 1 hour.  The 
mixture was concentrated under reduced pressure and the crude product was purified by 
flash column chromatography (12-15% EtOAc/Hex) to give the product (0.544 g, 67%) 
as a colorless oil.  1H NMR (500 MHz, CDCl3)  9.74 (s, 1H), 5.67-5.73 (m, 1H), 5.60-
5.66 (m, 1H), 4.51 (d, J= 6.0 Hz, 2H), 4.18 (td, J= 6.4, 3.8 Hz, 1H), 2.44 (qd, J= 6.8, 3.8 
Hz, 1H), 2.26-2.31 (m, 2H), 2.06 (s, 3H), 1.08 (d, J= 7.2 Hz, 3H), 0.85 (s, 9H), 0.05 (s, 
3H), 0.03 (s, 3H); 13C NMR (125 MHz, CDCl3):  204.9, 170.8, 131.1, 127.3, 71.4, 64.7, 
51.0, 37.9, 25.7, 21.0, 18.0, 7.7, −4.3, −4.8. 
 
Cross metathesis product 281: 
To bicyclic ether 264 (0.126 g, 0.41 mmol) in 1.5 mL degassed toluene at room 
temperature was added tetrahydropyran 228 (0.154 g, 0.28 mmol) dropwise over 6 
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hours as a solution in 0.5 mL toluene via syringe pump. Grubbs 2nd generation catalyst 
(0.023 g, 0.028 mmol) was added in three portions as a solution in 0.3 mL toluene. Upon 
completion of addition of tetrahydropyran 228, the reaction was stirred for 12 hours at 
room temperature, then opened to air and stirred 1 hour.  The reaction mixture was 
concentrated under reduced pressure and the crude product was purified by flash 
column chromatography (10-20% EtOAc/Hex) to give the product (0.177 g, 77%) as a 
colorless oil.  1H NMR (600 MHz, CDCl3)  0.01 (s, 3H), 0.02 (s, 3H), 0.56-0.63 (m, 12H 
0.82-0.86 (m, 6H), 0.87 (s, 9 H), 0.95 (t, J= 7.9 Hz, 18 H), 1.34-1.41 (m, 2H), 1.42 - 1.49 
(m, 1H), 1.64-1.72 (m, 1H), 1.85 (d, J= 11.7 Hz, 1H), 1.95-2.06 (m, 2H), 2.23-2.31 (m, 
1H), 3.46 (dd, J= 10.2, 6.0 Hz, 1H), 3.57 (dd, J= 10.2, 5.7 Hz, 1H), 3.69 (q, J= 5.5 Hz, 
1H), 3.74-3.83 (m, 4H), 3.80 (s, 3H), 3.83-3.89 (m, 2H), 4.08 (td, J= 5.6, 1.7 Hz, 1H), 
4.24 (d, J= 6.8 Hz, 1H), 4.35 (br. s., 1H), 4.51 (d, J= 11.3 Hz, 1H), 4.56 (d, J= 11.7 Hz, 
1H), 5.41 (dd, J= 15.4, 7.9 Hz, 1H), 5.60 (ddd, J= 14.9, 9.2, 5.3 Hz, 1H), 6.87 (d, J= 8.3 
Hz, 2H), 7.29 (d, J= 8.3 Hz, 2H); 13C NMR (150 MHz, CDCl3):  159.4, 131.4, 131.2, 
130.5, 129.6, 113.9, 82.0, 80.0, 79.1, 76.1, 75.0, 73.6, 73.12, 73.05, 71.3, 68.1, 64.6, 
55.4, 41.7, 38.9, 38.4, 35.8, 28.9, 26.0, 18.3, 15.3, 10.8, 7.1, 7.0, 5.2, 4.5, 4.6, 4.8; IR 
(film): 2954, 2876, 1613, 1514, 1460, 1302, 1248, 1078; ESI-MS: C45H82O8Si3 [M+Na]
 
calc. 857.52, found 857.4; []23D = 7.2° (c = 0.29, CH2Cl2). 
 
Aldehyde 282: 
To a dry round bottom flask under argon was added freshly distilled oxalyl chloride (neat, 
41 L, 0.48 mmol) in 0.25 mL dichloromethane.  The solution was cooled to 78 °C and 
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DMSO (70 L, 0.97 mmol) in 0.25 mL CH2Cl2 was added dropwise.  After stirring 15 
minutes, bis-TES ether 281 (0.081 g, 0.10 mmol) in 0.25 mL CH2Cl2 was added 
dropwise.  The reaction mixture was stirred for 15 minutes at 78 °C then allowed to 
warm to 40 °C and stirred for 1 hour.  Upon recooling to 78 °C, triethylamine (0.24 mL, 
1.75 mmol) was added slowly.  The reaction was allowed to come to room temperature 
over two hours, then diluted with CH2Cl2 and quenched with water.  The aqueous layer 
was extracted twice with CH2Cl2, dried over magnesium sulfate, filtered, and 
concentrated under reduced pressure.  The crude product was purified via flash column 
chromatography (5-10-20% EA/Hex to give the product (0.054 g, 78%) as a colorless oil. 
1H NMR (500 MHz, CDCl3)  0.01 (s, 3H), 0.02 (s, 3H), 0.62 (q, J= 7.9 Hz, 6H), 0.83-
0.85 (m, 6H), 0.87 (s, 9H), 0.95 (t, J= 8.0 Hz, 9H), 1.31 (d, J= 13.6 Hz, 1H), 1.37 (dd, J= 
9.1, 6.9 Hz, 1H), 1.48 (d, J= 6.9 Hz, 1H), 1.78 (td, J= 13.4, 2.2 Hz, 1H), 1.84 (d, J= 11.4 
Hz, 1H), 1.95-2.06 (m, 2H), 2.23-2.31 (m, 1H), 3.76 (t, J= 8.5 Hz, 1H) 3.78-3.81 (m, 2H), 
3.79 (s, 3H), 3.83 - 3.87 (m, 1H), 3.90 (td, J= 7.3, 1.6 Hz, 1H), 3.95 (dd, J= 4.7, 1.0 Hz, 
1H), 4.02 (ddd, J= 11.7, 4.7, 1.9 Hz, 1H), 4.05-4.10 (m, 1H), 4.24 (d, J= 6.6 Hz, 1H), 
4.34 (br. s., 1H), 4.54 (q, J= 11.7 Hz, 2H), 5.40 (dd, J= 15.3, 7.7 Hz, 1H), 5.56 (ddd, J= 
14.8, 8.2, 5.4 Hz, 1H), 6.86 (d, J= 8.5 Hz, 2H), 7.28 (d, J= 8.5 Hz, 2H), 9.62 (d, J= 1.3 
Hz, 1H); 13C NMR (150 MHz, CDCl3):  203.3, 159.4, 131.7, 130.6, 130.5, 129.6, 113.9, 
82.0, 80.2, 79.8, 79.1, 75.0, 74.2, 73.9, 73.1, 70.8, 68.0, 55.5, 41.7, 38.9, 38.3, 35.5, 
30.0, 26.0, 18.2, 15.3, 10.8, 6.9, 5.0, 4.7, 4.8; IR (film): 2955, 2876, 1737, 1614, 1514, 
1302, 1250, 1077, 836, 775; ESI-MS: C39H66O8Si2 [M+Na]
 calc. 741.42, found 741.3; 
[]21D = 6.6° (c = 0.25, CH2Cl2). 
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Vinyl addition product 286: 
To a flame-dried round bottom flask under argon was added vinyl iodide (0.133 g, 0.41 
mmol) and 0.8 mL THF.  Upon cooling the solution to 78 °C, tert-butyllithium (1.7 M in 
pentane, 0.50 mL, 0.84 mmol) was added dropwise.  The reaction was stirred for 1.5 h 
then dimethyl zinc (1.0 M in heptanes, 0.61 mL, 0.61 mmol) was added dropwise and 
stirred an additional 15 minutes at 78 °C, at which time aldehyde 282 (0.098 g, 0.14 
mmol) in 0.6 mL THF was added dropwise.  After three hours stirring, the reaction was 
quenched with saturated ammonium chloride and diluted with ether.  The aqueous 
phase was extracted three times with ether, dried over magnesium sulfate, filtered, and 
concentrated under reduced pressure.  The crude product was purified via flash column 
chromatography (10-15% EA/Hex to give the product (0.103 g, 82%) as a colorless oil.  
1H NMR (600 MHz, CDCl3)  0.01 (s, 3H), 0.02 (s, 3H), 0.04 (s, 6H), 0.61 (q, J= 8.2 Hz, 
6H), 0.82-0.86 (m, 6H), 0.87 (s, 9H), 0.89 (s, 9H), 0.95 (t, J= 7.9 Hz, 9H), 1.34-1.42 (m, 
1H), 1.43-1.50 (m, 1H), 1.53-1.66 (m, 4H), 1.84 (d, J= 10.9 Hz, 1H), 1.96-2.02 (m, 1H), 
2.02-2.12 (m, 3H), 2.22-2.30 (m, 1H), 2.85 (d, J= 3.0 Hz, 1H), 3.55 (t, J= 5.7 Hz, 1H), 
3.61 (t, J= 6.4 Hz, 2H), 3.74-3.85 (m, 5H), 3.79 (s, 3H), 3.86-3.92 (m, 1H), 4.05-4.09 (m, 
1H), 4.10-4.15 (m, 1H), 4.23 (d, J= 6.8 Hz, 1H), 4.35 (br. s., 1H), 4.51 (d, J= 11.3 Hz, 
1H), 4.56 (d, J= 11.7 Hz, 1 H), 5.43 (dd, J= 15.3, 7.3 Hz, 1H), 5.51 (dd, J= 15.4, 7.2 Hz, 
1H), 5.57 (ddd, J= 14.7, 7.5, 5.7 Hz, 1H), 5.67-5.74 (m, 1H), 6.86 (d, J= 8.3 Hz, 2H), 
7.28 (d, J= 8.3 Hz, 2H); 13C NMR (150 MHz, CDCl3):  159.3, 133.0, 131.9, 130.5, 130.3, 
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129.6, 129.4, 113.9, 82.0, 79.7, 79.1, 77.7, 75.6, 75.01, 74.98, 73.8, 73.1, 71.0, 68.0, 
62.9, 55.4, 41.7, 38.9, 38.2, 35.7, 32.5, 30.7, 29.0, 26.1, 26.0, 18.5, 18.2, 15.4, 10.8, 7.2, 
5.4, −4.7, −4.8, −5.1; IR (film): 3436, 2954, 2931, 1614, 1514, 1251, 1099, 836, 775; 
ESI-MS: C50H90O9Si3 [M+Na]
 calc. 941.58, found 941.5; []23D = 9.9° (c = 1.68, CH2Cl2). 
 
Aldehyde 293: 
To a dry round bottom flask under argon was added mixed acetal 249 (0.208 g, 0.45 
mmol) and tert-butyldimethyl silyl vinyl ether (0.214 g, 1.35 mmol).  A solution of lithium 
perchlorate (3 M in ethyl acetate, 4.50 mL, 13.5 mmol) was added to the reaction.  The 
reaction was stirred at room temperature for two hours then quenched with water.  The 
layers were separated and the aqueous layer extracted three times with CH2Cl2.  The 
combined organic layers were washed with water then brine, dried over Na2SO4, filtered, 
and concentrated under reduced pressure.  The crude product was purified by flash 
column chromatography (15-30% EtOAc/Hex) to provide the product (0.169 g, 82%) as 
a colorless oil.  1H NMR (600 MHz, CDCl3)  0.92 (d, J= 6.4 Hz, 3H), 1.17-1.37 (m, 6H), 
1.55-1.62 (m, 2H), 1.67 (s, 3H), 2.33-2.44 (m, 1H), 2.54 (ddd, J= 16.4, 5.1, 1.5 Hz, 1H), 
2.79 (ddd, J= 16.5, 8.9, 2.6 Hz, 1H), 3.34 (s, 3H, 3.42 (t, J= 6.6 Hz, 2H), 3.76-3.83 (m, 
3H), 3.96 (dd, J= 5.3, 2.3 Hz, 1H), 4.06 (s, 1H), 4.42 (s, 2H), 4.58 (d, J= 6.8 Hz, 1H), 
4.68 (d, J= 6.8 Hz, 1 H), 4.93 (td, J= 5.6, 2.5 Hz, 1H), 5.34 (d, J= 9.4 Hz, 1H), 5.92 (dd, 
J= 10.2, 3.0 Hz, 1H), 6.09 (ddd, J= 10.0, 5.2, 2.1 Hz, 1H), 6.87 (d, J= 8.7 Hz, 2H), 7.26 
(d, J= 8.7 Hz, 3H), 9.79 (s, 1 H); 13C NMR (150 MHz, CDCl3):  200.7, 159.2, 133.4, 
131.7, 131.0, 129.40, 129.37, 126.3, 113.9, 96.1, 74.9, 72.7, 70.4, 68.8, 68.6, 55.7, 55.4, 
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46.2, 37.6, 32.1, 29.9, 27.5, 26.5, 21.0, 14.1; IR (film): 2929, 2854, 1726, 1613, 1513, 
1248, 1101, 1038; ESI-MS: C27H40O6 [M+Na]
 calc. 483.27, found 483.3; []23D = 92.0° (c 
= 0.70, CH2Cl2). 
 
Alcohol 294: 
To a dry round bottom flask under argon was added aldehyde 293 (0.375 g, 0.81 mmol) 
in 7 mL anhydrous methanol.  Sodium borohydride (0.037 g, 0.98 mmol) was added and 
the reaction stirred for 1 hour.  The reaction was quenched with sat. ammonium chloride 
and diluted with CH2Cl2.  The layers were separated and the aqueous layer extracted 
three times with CH2Cl2.  The combined organic layers were washed with saturated 
NaCl, dried over Na2SO4, filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography (30-50% EtOAc/Hex) to provide 
the product (0.365 g, 97%) as a colorless oil.  1H NMR (500 MHz, CDCl3)  0.95 (d, J= 
6.9 Hz, 3H), 1.19 - 1.39 (m, 6H), 1.54-1.65 (m, 2H), 1.70 (s, 3H), 1.97-2.09 (m, 1H), 
2.35-2.48 (m, 1H), 2.82 (dd, J= 9.1, 2.2 Hz, 1H), 3.36 (s, 3H), 3.44 (t, J= 6.6 Hz, 2H), 
3.74 - 3.85 (m, 1H), 3.82 (s, 3H), 3.85-3.94 (m, 1H), 3.99 (dd, J= 5.4, 1.9 Hz, 1H), 4.14 
(s, 1H), 4.44 (s, 2H), 4.59 (d, J= 6.9 Hz, 1H), 4.58-4.64 (m, 1H), 4.70 (d, J= 6.9 Hz, 1H), 
5.42 (d, J= 9.5 Hz, 1H), 5.92 (dd, J= 10.2, 3.2 Hz, 1H), 6.08 (ddd, J= 10.1, 5.4, 1.9 Hz, 
1H), 6.89 (d, J= 8.8 Hz, 2H), 7.28 (d, J= 8.2 Hz, 2H); 13C NMR (125 MHz, CDCl3):  
159.2, 133.2, 133.0, 131.0, 129.6, 129.4, 125.0, 113.9, 95.9, 74.5, 74.0, 72.6, 70.4, 67.8, 
62.2, 55.7, 55.4, 37.6, 33.2, 32.1, 29.9, 27.5, 26.5, 12.1, 14.3; IR (film): 3434, 2928, 
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1643, 1513, 1248, 1100, 1038; ESI-MS: C27H42O6 [M+Na]
 calc. 485.29, found 485.3; 
[]23D = 88.7° (c = 0.68, CH2Cl2). 
 
Diol: 
Alcohol 294 (0.040 g, 0.086 mmol) was taken up in 0.9 mL 15% HCl in tert-butyl alcohol 
at room temperature.  After two hours stirring, the reaction was diluted with diethyl ether 
and quenched with sat. sodium bicarbonate.  The layers were separated and the 
aqueous layer extracted three times with diethyl ether.  The combined organic layers 
were dried over MgSO4, filtered, and concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography (50-75% EtOAc/Hex) to provide 
the product (0.031 g, 86%) as a colorless oil.  1H NMR (600 MHz, CDCl3)  0.95 (d, J= 
6.8 Hz, 3H), 1.20-1.28 (m, 3H), 1.28-1.37 (m, 3H), 1.53-1.62 (m, 2H), 1.67 (s, 3H), 1.98-
2.06 (m, 1H), 2.39-2.48 (m, 1H), 2.62 (dd, J= 9.0, 2.6 Hz, 1H), 3.42 (t, J= 6.59 Hz, 2H), 
3.74-3.79 (m, 1H), 3.80 (s, 3H), 3.82-3.89 (m, 1H), 3.90-3.95 (m, 1H), 4.12 (s, 1H), 4.42 
(s, 2H), 4.52-4.58 (m, 1H), 5.41 (d, J= 9.8 Hz, 1H), 5.87 (dd, J= 10.0, 3.2 Hz, 1H), 6.09 
(ddd, J= 10.0, 5.7, 1.9 Hz, 1H), 6.87 (d, J= 8.7 Hz, 2H), 7.26 (d, J= 8.3 Hz, 2H); 13C NMR 
(150 MHz, CDCl3):  159.2, 133.4, 132.7, 131.0, 129.6, 129.4, 126.6, 113.9, 74.6, 73.9, 
72.6, 70.4, 62.13, 62.06, 55.5, 37.6, 33.1, 32.1, 29.9, 27.4, 26.5, 21.4, 14.4; IR (film): 
3418, 2928, 2856, 1613, 1513, 1248, 1089, 1035; ESI-MS: C25H38O5 [M+Na]
 calc. 
441.26, found 441.2; []23D = 77.8° (c = 0.19, CH2Cl2). 
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Bis-TBS dihydropyran 295: 
To a dry round bottom flask under argon was added the diol (0.031 g, 0.07 mmol) and 
1.5 mL CH2Cl2.  Upon cooling the solution to 78 °C, 2,6-lutidine (0.05 mL, 0.44 mmol) 
was added slowly, followed by TBSOTf (0.05 mL, 0.22 mmol).  The reaction was stirred 
1 hour at 78 °C then quenched with saturated sodium bicarbonate.  The layers were 
separated and the aqueous layer extracted three times with methylene chloride.  The 
combined organic layers were dried over Na2SO4, filtered, and concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography 
(hexanes to 5% EtOAc/Hex) to provide the product (0.048 g, 99%) as a colorless oil.  1H 
NMR (600 MHz, CDCl3)  0.03 (s, 3H), 0.04 (s, 9H), 0.88 (s, 9H), 0.86 (s, 9H), 0.92 (d, 
J= 6.8 Hz, 3H), 1.18-1.35 (m, 6H), 1.56-1.60 (m, 2H), 1.61-1.66 (m, 1H), 1.66 (s, 3H 
1.75-1.85 (m, 1H), 2.31-2.42 (m, 1H), 3.42 (t, J= 6.8 Hz, 2H), 3.67-3.77 (m, 2H), 3.80 (s, 
3H), 3.97 (br. s., 1H), 4.08 (t, J= 3.6 Hz, 1H), 4.34-4.40 (m, 1H), 4.43 (s, 2H),  5.34 (d, J= 
9.4 Hz, 1H)  5.78 (dd, J= 10.2, 2.6 Hz, 1H), 5.85 (ddd, J= 10.2, 4.5, 2.2 Hz, 1H), 6.87 (d, 
J= 8.3 Hz, 2H), 7.26 (d, J= 8.7 Hz, 2H); 13C NMR (150 MHz, CDCl3):  159.3, 133.2, 
132.4, 131.0, 130.2, 129.4, 127.3, 113.9, 76.2, 72.7, 70.4, 69.3, 65.6, 60.2, 55.5, 37.8, 
35.4, 32.1, 30.1, 27.6, 26.6, 26.2, 26.1, 21.1, 18.5, 18.4, 14.4, 3.9, 4.2, 5.1, 5.2; IR 
(film): 2928, 2856, 1613, 1514, 1463, 1360, 1302, 1250, 1172, 1099, 1039, 836, 775; 
ESI-MS: C37H66O5Si2 [M+Na]
 calc. 669.43, found 669.3; []23D = 68.7° (c = 0.50, CH2Cl2). 
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Alcohol: 
To a solution of bis-TBS dihydropyran 295 (0.152 g, 0.23 mmol) in CH2Cl2 (4.7 mL) and 
pH 7 buffer (0.6 mL) at 0 °C was added DDQ (0.133 g, 0.59 mmol).  After 1 hour, the 
reaction mixture was quenched with sat. NaHCO3, and diluted with water and CH2Cl2.  
The layers were separated and the aqueous layer extracted three times with methylene 
chloride.  The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (5-10% EtOAc/Hex) to provide 0.172 g of a mixture of the alcohol and 
4-methoxybenzaldehyde which was used in the next reaction without further purification.   
Further flash column chromatography afforded the clean product for characterization: 1H 
NMR (600 MHz, CDCl3)  0.03 (s, 3H), 0.04 (s, 9H), 0.85 (s, 9H), 0.88 (s, 9H), 0.93 (d, 
J= 6.8 Hz, 3H), 1.17-1.36 (m, 6H), 1.50-1.58 (m, 2H), 1.60-1.71 (m, 1H), 1.66 (s, 3H), 
1.75-1.86, (m, 1H), 2.34-2.44 (m, 1H), 3.57-3.66 (m, 2H), 3.66-3.78 (m, 2H) 3.97 (br. s., 
1H), 4.09 (t, J= 3.6 Hz, 1H), 4.33-4.40 (m, 1H), 5.35 (d, J= 9.4 Hz, 1H), 5.78 (dd, J= 
10.2, 3.0 Hz, 1H), 5.85 (ddd, J= 10.2, 4.5, 1.9 Hz, 1H); 13C NMR (150 MHz, CDCl3):  
133.1, 132.4, 130.1, 127.3, 76.2, 69.3, 65.5, 63.3, 60.2, 37.8, 35.4, 33.0, 32.1, 27.5, 
26.2, 26.13, 26.10, 18.5, 18.4, 14.4, −3.9, −4.3, −5.1, −5.2; IR (film): 3366, 2928, 2857, 
1471, 1389, 1361, 1254, 1100, 836, 775; ESI-MS: C29H58O4Si2 [M+Na]
 calc. 549.38, 
found 549.4; []23D = 72.0° (c = 0.41, CH2Cl2). 
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Aldehyde 296: 
To a dry round bottom flask under argon was added 0.172 g of the alcohol (as a 1:1 
mixture with 4-methoxybenzaldehyde) and 5.0 mL CH2Cl2.  Upon cooling to 0 °C, 
pyridine (0.10 mL, 1.30 mmol) and Dess-Martin periodinane (0.22 g, 0.52 mmol) were 
added successively.  The reaction was warmed to room temp.  After two hours stirring, 
an additional portion of Dess-Martin periodinane was introduced to the reaction mixture.  
The reaction was stirred at room temperature an additional two hours then quenched 
with sat. sodium bicarbonate.  The layers were separated and the aqueous layer 
extracted three times with methylene chloride.  The combined organic layers were dried 
over Na2SO4, filtered, and concentrated under reduced pressure.  The crude product 
was purified by flash column chromatography (3-5% EtOAc/Hex) to provide the product 
(0.118 g, 87% over 2 steps) as a colorless oil.  1H NMR (600 MHz, CDCl3) ; 0.02 (s, 
3H), 0.04 (s, 9H), 0.88 (s, 9H), 0.85 (s, 9H), 0.93 (d, J= 6.8 Hz, 3H), 1.20-1.34 (m, 4H), 
1.53-1.69 (m, 3H), 1.65 (s, 3H), 1.76-1.84 (m, 1H), 2.34-2.43 (m, 3H), 3.66-3.76 (m, 2H), 
3.96 (br. s., 1H), 4.09 (t, J= 3.6 Hz, 1H), 4.34-4.40 (m, 1H), 5.34 (d, J= 9.8 Hz, 1H), 5.78 
(dd, J= 10.2, 2.6 Hz, 1H), 5.85 (ddd, J= 10.2, 4.7, 2.1 Hz, 1H), 9.75 (s, 1H); 13C NMR 
(150 MHz, CDCl3):  203.0, 132.7, 132.4, 130.4, 127.3, 76.1, 69.3, 65.5, 60.2, 44.1, 
37.5, 35.4, 32.0, 27.3, 26.16, 26.12, 22.5, 21.1, 18.5, 18.4, 14.4, −3.8, −4.2, −5.1, −5.2; 
IR (film): 2954, 2857, 1729, 1463, 1389, 1254, 1100; ESI-MS: C29H56O4Si2 [M+Na]
 calc. 
547.36, found 547.4; []23D = 91.4° (c =0.14, CH2Cl2). 
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tert-Butyl ester 162: 
To a solution of aldehyde 296 (0.070 g, 0.13 mmol) in tert-butanol (1.2 mL) and pH 4 
phosphate buffer (0.67 mL) was added 2-methyl-2-butene (0.57 mL, 5.3 mmol) and 
sodium chlorite (0.060 g, 0.67 mmol) successively.  The reaction was stirred at room 
temperature for 2 hours then quenched with sat. ammonium chloride.  The layers were 
separated and the aqueous layer extracted three times with ethyl acetate.  The 
combined organic layers were dried over Na2SO4, filtered, and concentrated under 
reduced pressure to afford the crude carboxylic acid which was used in the next reaction 
without further purification.  
To a solution of the crude carboxylic acid in dichloromethane (0.5 mL) was added 
tert-butyl isourea 159 (0.13 g, 0.65 mmol, 5.0 equiv). After stirring at room temperature 
for 24 h an additional 5.0 equiv of isourea 159 were added.  The reaction was stirred an 
additional 12 h, then diluted with methylene chloride and quenched with water.  The 
layers were separated and the aqueous layer extracted three times with methylene 
chloride.  The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (10% EtOAc/Hex) to provide the product (0.066 g, 83%) as a pale 
yellow oil.  1H NMR (500 MHz, CDCl3)  0.03 (s, 3H), 0.04 (s, 3H), 0.05 (s, 6H), 0.86 (s, 
9H), 0.88 (s, 9H), 0.93 (d, J= 6.6 Hz, 3H), 1.19-1.33 (m, 4H), 1.44 (s, 9H), 1.50-1.59 (m, 
3H), 1.65 (s, 3H), 1.76-1.85 (m, 1H), 2.18 (t, J= 7.6 Hz, 2H), 2.34-2.43 (m, 1H), 3.66-
3.77 (m, 2H), 3.96 (br. s., 1H), 4.08 (t, J= 3.5 Hz, 1H), 4.36 - 4.40 (m, 1H), 5.34 (d, J= 
 
 
206 
 
 
9.1 Hz, 1H), 5.79 (dd, J= 10.4, 2.8 Hz, 1H), 5.85 (ddd, J= 10.1, 4.7, 1.9 Hz, 1H); 13C 
NMR (125 MHz, CDCl3):  173.5, 133.0, 132.4, 130.3, 127.3, 80.0, 76.2, 69.4, 65.5, 
60.2, 37.5, 35.8, 35.4, 32.0, 28.3, 27.2, 26.2, 26.1, 25.5, 21.1, 18.6, 18.4, 14.4, −3.8, 
−4.2, −5.1, −5.2; IR (film): 2928, 2857, 1732, 1643, 1461, 1390, 1366, 1254, 1099, 836, 
775; []23D = 74.4° (c = 0.12, CH2Cl2). 
 
Alcohol 297: 
To a solution of bis-TBS ester 162 (0.027 g, 0.05 mmol) in THF (0.90 mL) at 0 °C was 
added TBAF (1M in THF, 50 L, 0.05 mmol).  The reaction was stirred for 1 hour at 0 °C, 
at which time an additional 1.0 equiv TBAF were added (50 L).  After stirring for 2 hours 
at 0 °C, the reaction was diluted with methylene chloride and quenched with sat. sodium 
bicarbonate.  The layers were separated and the aqueous layer extracted 3x with 
methylene chloride.  The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (10-30% EtOAc/Hex) to provide the product (0.0166 g, 76%) as a 
colorless oil.  1H NMR (600 MHz, CDCl3)  0.04 (s, 3H), 0.05 (s, 3H), 0.86 (s, 9H), 0.93 
(d, J= 6.8 Hz, 3H), 1.20-1.34 (m, 4 H) 1.43 (s, 9H), 1.51-1.61 (m, 3H), 1.66 (s, 3H), 1.92-
1.99 (m, 1H), 2.18 (t, J= 7.5 Hz, 2H), 2.36-2.42 (m, 1H), 2.85 (dd, J= 8.7, 2.6 Hz, 1H), 
3.73-3.79 (m, 1H), 3.82-3.87 (m, 1H), 4.05 (s, 1H), 4.12-4.15 (m, 1H), 4.47 (dd, J= 10.9, 
2.3 Hz, 1H), 5.36 (d, J= 9.4 Hz, 1H), 5.74 (dd, J= 10.2, 3.0 Hz, 1H), 5.91 (ddd, J= 10.2, 
4.8, 1.9 Hz, 1H); 13C NMR (150 MHz, CDCl3):  173.5, 133.4, 131.3, 129.7, 127.7, 80.0, 
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75.9, 73.7, 64.7, 62.2, 37.4, 35.8, 33.7, 32.0, 28.3, 27.1, 26.1, 25.4, 21.0, 18.4, 14.5, 
−3.9, −4.3; IR (film): 3434, 2928, 2857, 1731, 1646, 1462, 1391, 1366, 1253, 1154, 
1113, 1065, 837, 775; ESI-MS: C27H50O5Si [M+Na]
 calc. 505.33, found 505.3; []23D = 
85.8° (c =0.09, CH2Cl2). 
 
Thioether 298: 
To a solution of alcohol 297 (0.025 g, 0.05 mmol), triphenylphosphine (0.027 g, 0.10 
mmol) and 1-phenyl-1H-tetrazole-5-thiol (0.037 g, 0.21 mmol) in THF (1.0 mL) was 
added diisopropylazodicarboxylate (DIAD, 40 L, 0.21 mmol). The reaction was stirred 
for 12 h at room temperature and then concentrated under reduced pressure.  The crude 
product was purified by flash column chromatography (5-10% EtOAc/Hex) to provide the 
product (0.029 g, 87%) as a pale yellow oil.1 H NMR (600 MHz, CDCl3)  0.03 (s, 3H), 
0.05 (s, 3H), 0.86 (s, 9H), 0.92 (d, J= 6.8 Hz, 3H), 1.17-1.32 (m, 4H) 1.43 (s, 9H), 1.49-
1.57 (m, 2H), 1.66 (s, 3H), 2.01-2.12 (m, 2H), 2.16 (t, J= 7.5 Hz, 4H), 2.35-2.41 (m, 1H), 
3.40 (ddd, J= 13.2, 7.9, 7.9 Hz, 1H) 3.53 (ddd, J= 13.2, 7.9, 4.9 Hz, 1H), 4.01 (br. s., 
1H), 4.12 (t, J= 3.6 Hz, 1H), 4.36-4.40 (m, 1H), 5.36 (d, J= 9.4 Hz, 1H), 5.74 (dd, J= 
10.2, 2.6 Hz, 1H), 5.90 (ddd, J= 10.2, 4.5, 1.9 Hz, 1H), 7.49-7.62 (m, 5H); 13C NMR (150 
MHz, CDCl3):  173.4, 154.6, 133.9, 133.5, 130.7, 130.3, 130.0, 129.8, 128.5, 124.0, 
80.1, 76.4, 70.7, 65.3, 37.4, 35.8, 32.0, 31.9, 30.1, 28.3, 27.2, 26.1, 25.5, 21.0, 18.4, 
14.4, −3.9, −4.3; IR (film): 2956, 2928, 2856, 1728, 1598, 1500, 1110, 837; ESI-MS: 
C34H54N4O4SSi [M+H]
 calc. 643.36, found 643.3; []23D = 65.2° (c =0.14, CH2Cl2). 
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Sulfone 132: 
To a solution of thioether 298 (0.025 g, 0.04 mmol) in EtOH (4 mL) at 0 °C was added a 
pre-mixed solution of (NH4)6Mo7O24•4H2O (0.012 g, 0.01 mmol) in H2O2 (30% aq, 60 L, 
0.58 mmol) via a glass pipette.  The resulting yellow solution was allowed to warm to 
room temperature and stirred for 12 hours.  The reaction was diluted with diethyl ether 
and quenched with sat. sodium bicarbonate and water.  The layers were separated and 
the aqueous layer extracted 3x with diethyl ether.  The combined organic layers were 
washed with sat. sodium sulfite, dried over MgSO4, filtered, and concentrated under 
reduced pressure.  The crude product was purified by flash column chromatography (5% 
EtOAc/Hex) to provide the product (0.021 g, 78%) as a pale yellow oil.  1H NMR (600 
MHz, CDCl3)  0.04 (s, 3H), 0.06 (s, 3H), 0.86 (s, 9H), 0.93 (d, J= 6.8 Hz, 3H), 1.18-1.35 
(m, 4H), 1.43 (s, 9H), 1.51-1.56 (m, 2H), 1.68 (s, 3H), 2.09-2.18 (m, 3H), 2.21-2.27 (m, 
1H), 2.35-2.44 (m, 1H), 3.79 (ddd, J= 15.4, 11.1, 5.1 Hz, 1H), 3.92 (ddd, J= 15.0, 11.0, 
4.5 Hz, 1H), 4.05 (d, J= 2.6 Hz, 1H), 4.17 (t, J= 3.8 Hz, 1H), 4.29-4.34 (m, 1H), 5.39 (d, 
J= 9.4 Hz, 1H), 5.70 (dd, J= 10.2, 2.1 Hz, 1 H), 5.94 (ddd, J= 10.2, 4.2, 2.3 Hz, 1H), 
7.58-7.63 (m, 3H), 7.68-7.70 (m, 2H); 13C NMR (150 MHz, CDCl3):  173.4, 153.6, 134.4, 
133.2, 131.6, 129.9, 129.8, 129.3, 129.1, 125.3, 80.0, 76.7, 69.8, 65.2, 53.4, 37.4, 35.8, 
32.1, 28.3, 27.2, 26.0, 25.8, 25.4, 21.0, 18.3, 14.4, 4.1, 4.4; IR (film): 2928, 2857, 
1728, 1462, 1340, 1252, 1156, 1111, 838, 775; ESI-MS: C34H54N4O6SSi [M+Na]
 
calc.697.34, found 697.3; []21D = 77.5° (c = 1.2, CH2Cl2). 
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Tetraol 299: 
To a dry 10 mL round bottom flask was added vinyl addition product 286 (0.064 g, 0.070 
mmol) and 0.7 mL THF.  The reaction mixture was cooled to 0 °C, and 
tetrabutylammonium fluoride (1M in THF, 0.70 mL, 0.70 mmol) was added dropwise.  
Upon completion of addition, the reaction was allowed to come to room temperature.   
After 12 hours stirring, additional tetrabutylammonium fluoride (0.35 mL, 0.35 mmol) was 
added and the reaction was stirred for another 12 hours.  The reaction was diluted with 
CH2Cl2 and quenched with water.  The aqueous layer was extracted 3x with CH2Cl2, 
dried over sodium sulfate, filtered, and concentrated under reduced pressure.  The crude 
product was purified via flash column chromatography (100% EA to 50% acetone/EA) to 
give the product (0.030 g, 75%) as a white solid.  1H NMR (600 MHz, CDCl3)  0.84 (d, 
J= 6.4 Hz, 3H), 0.89 (d, J= 7.2 Hz, 3H), 1.34-1.43 (m, 1H), 1.57-1.63 (m, 1H), 1.63-1.71 
(m, 2H), 1.71-1.81 (m, 2H), 1.84 (d, J= 11.3 Hz, 1H), 1.96-2.02 (m, 1H), 2.02-2.09 (m, 
1H), 2.13-2.23 (m, 2H), 2.23-2.36 (m, 1H), 2.59 (br. s, 1 H), 3.16 (br. s., 1 H), 3.48 (t, J= 
6.4 Hz, 1H), 3.65 (t, J= 5.8 Hz, 2H), 3.71-3.85 (m, 4H), 3.80 (s, 3H), 3.90-3.97 (m, 2H), 
4.06-4.09 (m, 1H), 4.20 (t, J= 6.4 Hz, 1H), 4.24 (d, J= 6.4 Hz, 1H), 4.35 (br. s., 1H), 4.54 
(q, J= 10.9 Hz, 2H), 5.44 (dd, J= 15.1, 7.5 Hz, 1H), 5.52-5.61 (m, 2H), 5.76-5.83 (m, 1H), 
6.87 (d, J= 8.7 Hz, 2H), 7.29 (d, J= 8.7 Hz, 2H); 13C NMR (150 MHz, CDCl3):  159.3, 
134.6, 132.3, 130.5, 130.2, 129.6, 129.2, 114.0, 81.9, 79.7, 79.0, 75.5, 75.0, 74.65, 
74.63, 74.2, 73.0, 70.3, 67.8, 62.5, 55.5, 41.7, 38.9, 37.7, 35.7, 31.9, 30.5, 29.5, 15.4, 
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10.8; IR (film): 3418, 2958, 2933, 2871, 1613, 1513, 1376, 11248, 1074; ESI-MS: 
C32H48O9 [M+Na]
 calc. 599.32, found 599.31; []25D = 19.8° (c = 0.25, CH2Cl2). 
 
Acetonide 300: 
To tetraol 299 (0.020 g, 0.035 mmol) in 1.0 mL dimethoxypropane in a dry vial under 
argon was added camphorsulfonic acid (1.0 mg, 0.003 mmol) at room temperature.  
After 12 hours stirring, the reaction mixture was diluted with CH2Cl2 and 10% HCl and 
stirred for 10 minutes.  The layers were separated and the aqueous layer was extracted 
three times with CH2Cl2, dried over sodium sulfate, filtered, and concentrated under 
reduced pressure.  The crude product was purified via flash column chromatography 
(100% EA) to give the product (0.020 g, 95%) as a colorless oil.  1H NMR (600 MHz, 
CDCl3)  0.84 (d, J= 6.8 Hz, 3H), 0.90 (d, J= 7.2 Hz, 3H), 1.35 (s, 3H), 1.36-1.43 (m, 
2H), 1.46 (s, 3H), 1.64-1.69 (m, 2H), 1.69-1.71 (m, 1H), 1.71-1.77 (m, 1H), 1.78 (br. s., 
1H), 1.84 (d, J= 12.8 Hz, 1H), 2.00 (ddd, J= 11.4, 6.7, 2.3 Hz, 1H), 2.07-2.14 (m, 1H), 
2.18 (q, J= 7.2 Hz, 2H), 2.23-2.30 (m, 1H), 3.62-3.66 (m, 2H), 3.72-3.85 (m, 5H), 3.81 (s, 
3H), 3.94-4.02 (m, 2H), 4.08 (td, J= 5.7, 1.9 Hz, 1H), 4.24 (d, J= 6.8 Hz, 1H), 4.35 (br. s., 
1H), 4.54 (q, J= 11.7 Hz, 2H), 4.65 (t, J= 6.8 Hz, 1H), 5.43 (dd, J= 15.3, 7.7 Hz, 1H), 
5.53 (ddd, J= 13.9, 7.7, 6.2 Hz, 1H), 5.58 (dd, J= 15.3, 7.0 Hz, 1H), 5.73-5.80 (m, 1H), 
6.88 (d, J= 8.7 Hz, 2H), 7.29 (d, J= 8.7 Hz, 2H); 13C NMR (150 MHz, CDCl3):  159.3, 
133.5, 132.3, 130.5, 130.2, 129.6, 126.7, 114.0, 108.5, 81.8, 80.0, 79.7, 79.0, 78.7, 75.0, 
73.5, 73.0, 71.2, 70.5, 67.7, 62.2, 55.5, 41.7, 38.9, 37.6, 35.9, 32.2, 30.9, 28.9, 27.8, 
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25.5, 15.4, 10.8; IR (film): 3429, 2933, 1642, 1514, 1248, 1064; ESI-MS: C35H52O9 
[M+Na] calc.639.35, found 639.3; []23D = 23.0° (c = 0.25, CH2Cl2). 
 
TBS protected acetonide: 
To acetonide 300 (0.020 g, 0.03 mmol) in a dry 1 dram vial under argon was added 
imidazole (0.005 g, 0.06 mmol) and TBSCl (0.005 g, 0.06 mmol) successively.  The 
reaction was stirred for 12 hours at room temperature, then quenched with sat. sodium 
bicarbonate.  The aqueous layer was extracted three times with CH2Cl2, dried over 
sodium sulfate, and concentrated under reduced pressure.  The crude product was 
purified via flash column chromatography (30-50% EA/Hex) to give the product (0.017 g, 
72%) as a colorless oil.  1H NMR (600 MHz, CDCl3)  0.05 (s, 6H), 0.83 (d, J= 6.4 Hz, 
3H), 0.86-0.94 (m, 12H), 1.35 (s, 3H), 1.35-1.41 (m, 1H), 1.45 (s, 3H), 1.54-1.65 (m, 2H), 
1.66-1.77 (m, 2H), 1.84 (d, J= 10.9 Hz, 1H), 2.00 (ddd, J= 11.4, 6.7, 2.3 Hz, 1H), 2.07-
2.17 (m, 4H), 2.24-2.31 (m, 1H), 3.62 (t, J= 6.4 Hz, 2H), 3.74 (t, J= 8.7 Hz, 1H), 3.76-
3.86 (m, 4H), 3.80 (s, 3H), 3.92-3.99 (m, 2H), 4.05-4.10 (m, 1H), 4.24 (d, J= 6.8 Hz, 1H), 
4.35 (br. s., 1H), 4.54 (q, J= 12.0 Hz, 2H), 4.63 (t, J= 7.0 Hz, 1H), 5.43 (dd, J= 15.4, 7.5 
Hz, 1 H), 5.50 (dd, J= 8.5, 5.8 Hz, 1H), 5.54 (dd, J= 15.4, 7.5 Hz, 1H), 5.75-5.83 (m, 1H), 
6.87 (d, J= 8.7 Hz, 2H), 7.29 (d, J= 8.7 Hz, 2H); 13C NMR (150 MHz, CDCl3):  159.3, 
134.1, 132.4, 130.6, 129.8, 129.6, 126.0, 114.0, 108.5, 81.9, 80.0, 79.6, 78.99, 78.95, 
75.0, 73.2, 73.1, 71.2, 70.5, 67.9, 62.8, 55.5, 41.8, 38.9, 37.3, 35.8, 32.5, 31.2, 29.0, 
27.9, 26.2, 25.6, 18.5, 15.5, 10.7, 5.0; IR (film): 3445, 2931, 1613, 1514, 1378, 1248, 
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1065, 836, 775; ESI-MS: C41H66O9Si [M+Na]
 calc. 797.46, found 797.44; []20D = 22.7° 
(c = 0.23, CH2Cl2). 
 
Methoxy methyl ether 301: 
To a dry round bottom flask was added the secondary alcohol (0.023 g, 0.031 mmol) in 
0.8 mL CH2Cl2.  Dimethylaminopyridine (1 equiv), sodium iodide (1 equiv) and di-iso-
propylethyl amine (0.28 mL, 1.6 mmol) were added successively.  The reaction mixture 
was cooled to 0 °C at which time methoxymethyl chloride (60 L, 0.79 mmol) was added 
dropwise.  The reaction mixture was allowed to come to room temperature and stirred 
for 12 hours.  The reaction was quenched with sat. ammonium chloride and diluted with 
ethyl acetate.  The aqueous layer was extracted twice with ethyl acetate, dried over 
sodium sulfate, filtered, and concentrated under reduced pressure.  The crude product 
was purified via flash column chromatography (25% EA/Hex) to give the product (0.022 
g, 85%) as a colorless oil.   1H NMR (600 MHz, CDCl3)  0.04 (s, 6H), 0.84 (d, J= 6.8 Hz, 
3H), 0.87-0.93 (m, 12H), 1.35 (s, 3H), 1.35-1.41 (m, 1H), 1.45 (s, 3H), 1.59-1.67 (m, 3H), 
1.70 (d, J= 7.2 Hz, 1H), 1.77 (d, J= 14.3 Hz, 1H), 1.84 (d, J= 11.3 Hz, 1H), 1.99 (ddd, J= 
11.3, 6.8, 2.3 Hz, 1H), 2.06-2.16 (m, 3H), 2.23-2.29 (m, 1H), 3.35 (s, 3H), 3.62 (t, J= 6.4 
Hz, 2H), 3.71-3.84 (m, 6H), 3.80 (s, 3H), 3.95 (t, J= 7.0 Hz, 1H), 4.07 (t, J= 4.9 Hz, 1H), 
4.24 (d, J= 6.4 Hz, 1H), 4.35 (br. s., 1H), 4.50 (d, J= 11.7 Hz, 1H), 4.55 (d, J= 11.3 Hz, 
1H), 4.63 (t, J= 6.8 Hz, 1H), 4.66 (q, J= 6.8 Hz, 2H), 5.43 (dd, J= 15.3, 7.7 Hz, 1H), 5.50-
 
 
213 
 
 
5.58 (m, 2H), 5.75-5.83 (m, 1H), 6.87 (d, J= 8.3 Hz, 2H), 7.28 (d, J= 8.3 Hz, 2H); 13C 
NMR (150 MHz, CDCl3):  159.4, 134.2, 132.4, 130.5, 129.9, 129.6, 126.0, 113.9, 108.4, 
95.0, 82.0, 80.1, 79.7, 79.0, 78.9, 75.4, 75.0, 73.8, 73.1, 71.8, 68.0, 62.8, 55.6, 55.5, 
41.8, 38.9, 35.9, 35.1, 32.5, 29.0, 28.7, 27.8, 26.2, 25.6, 18.5, 15.4, 10.8, −5.1; IR (film): 
2931, 1642, 1514, 1248, 1099, 1038, 836; ESI-MS: C43H70O10Si [M+Na]
 calc. 797.46, 
found 797.4; []23D = 14.3° (c = 0.35, CH2Cl2). 
 
Alcohol 302:  To a dry 10 mL round bottom flask containing p-methoxybenzyl ether 301 
(0.019 g, 0.025 mmol) was added 1.2 mL CH2Cl2 and 60 L pH 7 buffer.  The solution 
was cooled to 0 °C, and DDQ (0.009 g, 0.038 mmol) was added in one portion.  After 1 
hour at 0 °C, a second portion of DDQ (0.009 g, 0.038 mmol) was added.  The reaction 
was stirred an additional hour then diluted with CH2Cl2 and quenched with sat. sodium 
bicarbonate.  The aqueous layer was extracted 3x with CH2Cl2, dried over Na2SO4, 
filtered, and concentrated under reduced pressure.  The crude product was purified via 
flash column chromatography (25-50% EA/Hex) to give the product (0.014 g, 84%) as a 
light yellow oil.  1H NMR (600 MHz, CDCl3)  0.05 (s, 6H), 0.85 (d, J= 6.4 Hz, 3H), 0.87-
0.92 (m, 12H), 1.34 (s, 3H), 1.37-1.43 (m, 1H), 1.44 (s, 3H), 1.58-1.71 (m, 4H), 1.77 (d, 
J= 13.9 Hz, 1H), 1.86 (d, J= 11.3 Hz, 1H), 1.99-2.11 (m, 2H), 2.13 (q, J= 7.2 Hz, 2H), 
2.21-2.28 (m, 1H), 3.35 (s, 3H), 3.64 (t, J= 6.2 Hz, 2H), 3.70-3.77 (m, 3H), 3.82-3.91 (m, 
2H), 3.93 (t, J= 7.0 Hz, 1H), 3.96-4.05 (m, 2H), 4.27 (d, J= 6.4 Hz, 1H), 4.36 (br. s., 1H), 
 
 
214 
 
 
4.62 (t, J= 6.8 Hz, 1H), 4.66 (q, J= 7.2 Hz, 2H), 5.42 (dd, J= 15.3, 7.7 Hz, 1H), 5.50-5.63 
(m, 2H), 5.75-5.83 (m, 1H); 13C NMR (150 MHz, CDCl3):   134.3, 132.2, 130.6, 125.8, 
108.4, 94.8, 83.0, 80.0, 79.8, 79.0, 78.9, 75.2, 74.5, 73.2, 71.6, 62.9, 61.0, 55.6, 41.6, 
39.0, 36.0, 35.3, 32.5, 29.0, 28.6, 27.9, 26.1, 25.6, 18.5, 15.4, 10.8, −5.1; IR (film): 3457, 
2958, 2931, 1462, 1380, 1274, 1100, 1071, 837; []23D = 9.3° (c = 0.18, CH2Cl2). 
 
Aldehyde 303:   
To alcohol 302 (0.029 g, 0.044 mmol) in 2.20 mL CH2Cl2 was added Dess-Martin 
periodinane (0.038 g, 0.089 mmol) at room temperature.  After stirring for 30 minutes, 
the reaction was quenched with 5:1 Na2S2O3: NaHCO3 and diluted with CH2Cl2.  The 
aqueous layer was extracted 3x with CH2Cl2, dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified via flash column 
chromatography (30-40% EA/Hex) to give the product (0.024 g, 83%) as a colorless oil, 
which was used immediately in the next reaction.  1H NMR (600 MHz, CDCl3)  0.05 (s, 
6H), 0.86-0.92 (m, 12H), 0.95 (d, J= 6.8 Hz, 3H), 1.34 (s, 3H), 1.44 (s, 3H), 1.45-1.51 (m, 
2H), 1.58-1.65 (m, 3H), 1.66-1.71 (m, 1H), 1.76 (d, J=,14.3 Hz, 1H), 1.95-2.02 (m, 2H), 
2.06-2.15 (m, 3H), 2.20-2.27 (m, 1H), 3.35 (s, 3H), 3.48 (t, J= 8.5 Hz, 1H), 3.63 (t, J= 6.4 
Hz, 2H), 3.70-3.78 (m, 3H), 3.94 (t, J= 7.0 Hz, 1H), 4.37-4.42 (m, 2H), 4.62 (t, J= 6.8 Hz, 
1H), 4.66 (q, J= 7.2 Hz, 2H), 4.81 (br. s., 1H), 5.41 (dd, J= 15.3, 7.3 Hz, 1H), 5.49-5.59 
(m, 2H), 5.75-5.83 (m, 1H), 9.95 (s, 1H); 13C NMR (150 MHz, CDCl3):   198.6, 134.3, 
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131.2, 130.7, 125.9, 108.4, 95.0, 87.5, 80.8, 80.3, 80.1, 79.0, 76.3, 75.4, 73.7, 71.8, 
62.9, 55.6, 41.5, 38.9, 35.9, 35.2, 32.5, 29.0, 28.6, 27.8, 26.2, 25.6, 18.5, 15.2, 10.8, 
−5.1.   
 
E-vinyl iodide 172:   
Chromium (II) chloride (0.056 g, 0.46 mmol) was heated with a heat gun under vacuum, 
then refilled with argon and allowed to cool to room temperature.  Degassed THF (0.46 
mL) was added to the flask, and the resulting suspension cooled to 0 °C and wrapped in 
aluminum foil and placed in the dark.  Aldehyde 303 (0.030 g, 0.046 mmol) and iodoform 
(0.054 g, 0.14 mmol) in 1.40 mL dioxane were added by syringe pump over 1 hour, the 
flask was rinsed with dioxane (2 x 0.20 mL) to ensure complete transfer of the aldehyde.  
The reaction was allowed to come to room temperature and stirred for 12 hours at which 
time the suspension was quenched with brine and diluted with diethyl ether.  The 
aqueous layer was extracted 3x with diethyl ether, dried over MgSO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified via flash column 
chromatography (hex-15-30% EA/Hex) to give E-vinyl iodide 172 (0.0144 g, 40%) and Z-
vinyl iodide 304 (0.004 g, 11%) as pale yellow oils. 1H NMR (600 MHz, C6D6)  0.09 (s, 
6H), 0.79-0.83 (m, 6H), 1.00 (s, 9H), 1.05-1.10 (m, 1H), 1.32 (s, 3H), 1.39 (ddd, J= 11.7, 
6.4, 2.6 Hz, 1H), 1.44 (d, J= 10.9 Hz, 1H), 1.51 (s, 3H), 1.60-1.76 (m, 4H), 2.00-2.08 (m, 
2H), 2.22 (q, J=6.90 Hz, 2H), 2.35 (ddd, J= 13.9, 6.6, 6.6 Hz, 1H), 3.19 (s, 3H), 3.61 (t, 
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J= 6.4 Hz, 2H), 3.66 (m, 1H), 3.82-3.85 (m, 1H), 3.87 (br. s., 1H), 3.91 (d, J= 6.0 Hz, 
1H), 3.97 (td, J= 7.2, 1.9 Hz, 1H), 4.00 (dd, J= 8.9, 7.7 Hz, 1H), 4.04-4.09 (m, 2H), 4.48-
4.53 (m, 2H), 4.78 (t, J= 5.7 Hz, 1H), 5.45 (dd, J= 15.1, 7.2 Hz, 1H), 5.68 (ddd, J= 14.7, 
7.5, 7.5 Hz, 1H), 5.83 (dd, J= 15.4, 6.4 Hz, 1H), 5.94 (ddd, J= 15.4, 6.4, 6.4 Hz, 1H), 
6.44 (dd, J= 14.7, 1.5 Hz, 1H), 6.82 (dd, J= 14.5, 4.7 Hz, 1H); 13C NMR (150 MHz, 
C6D6):   142.0, 132.7, 132.6, 129.2, 127.5, 108.4, 95.1, 83.6, 80.6, 79.4, 79.2, 79.0, 
78.6, 75.8, 75.5, 73.9, 72.0, 62.7, 55.2, 41.7, 38.7, 36.3, 35.6, 33.0, 29.6, 29.2, 28.2, 
26.2, 25.7, 18.5, 15.2, 10.8, −5.1; IR (film): 2931, 2857, 1602, 1462, 1380, 1254, 1217, 
1143, 1099, 1067, 1038; ESI-MS: C36H61IO8Si [M+Na]
 calc. 799.31, found 799.28; []24D 
= 19.6° (c = 0.72, C6H6). 
 
Alcohol 305:  
To TBS ether 172 (0.0105 g, mmol) in 0.5 mL THF at 20 °C in the dark was added 
TBAF (1M in THF, 20 L, mmol).  After 30 minutes stirring, the reaction was warmed to 
room temperature and stirred an additional 2 hours, at which time additional TBAF (20 
L) was added.  The reaction was stirred an additional hour and diluted with saturated 
NaHCO3 (3 mL), water (10 mL) and EtOAc (15 mL).  The aqueous layer was extracted 
3x with ethyl acetate, and the combined organic layers were dried over MgSO4, filtered, 
and concentrated under reduced pressure.  The crude product was purified by flash 
column chromatography (50-70-100% EtOAc/Hex) to give the product (0.0085 g, 95%) 
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as a light yellow oil.  1H NMR (600 MHz, C6D6)  0.78-0.83 (m, 6H), 1.04-1.10 (m, 1H), 
1.32 (s, 3H), 1.39 (ddd, J= 11.3, 6.6, 2.8 Hz, 1H), 1.46 (d, J= 11.3 Hz, 1H), 1.51 (s, 3H), 
1.56-1.60 (m, 2H), 1.64-1.70 (m, 1H), 1.70-1.76 (m, 1H), 2.00-2.07 (m, 2H), 2.14 (q, J= 
7.2 Hz, 2H), 2.32 (ddd, J= 14.1, 6.9, 6.9 Hz, 1H), 3.19 (s, 3H), 3.48 (t, J= 6.4 Hz, 2H), 
3.63-3.66 (m, 1H), 3.79-3.82 (m, 1H), 3.87 (br. s, 1H), 3.89 (d, J= 6.4 Hz, 1H), 3.96 (ddd, 
J= 7.0, 7.0, 1.9 Hz, 1H), 4.01 (dd, J=9.0, 7.5 Hz, 1H), 4.04-4.10 (m, 2H), 4.50 (br. s., 
2H), 4.77 (t, J= 5.7 Hz, 1H), 5.46 (dd, J= 15.1, 7.2 Hz, 1H), 5.70 (ddd, J= 14.7, 6.8, 6.8 
Hz, 1H), 5.81 (dd, J= 15.4, 6.0 Hz, 1H), 5.85-5.93 (m, 1H), 6.43 (dd, J= 14.5, 1.7 Hz, 
1H), 6.83 (dd, J= 14.3, 4.9 Hz, 1H); 13C NMR (150 MHz, C6D6)  141.9, 132.6, 132.4, 
129.7, 127.6, 108.4, 95.2, 83.5, 80.5, 79.4, 79.2, 79.1, 78.7, 76.0, 75.5, 74.1, 72.0, 62.1, 
55.3, 41.7, 38.7, 36.4, 35.7, 32.8, 29.6, 29.1, 28.1, 25.6, 15.2, 10.9; IR (film): 3458, 
2931, 2870, 1671, 1603, 1456, 1380, 1217, 1144, 1098, 1066, 1037; ESI-MS: 
C30H47IO8Si [M+Na]
 calc. 685.22, found 685.20; []23D = 29.8° (c = 0.35, C6H6). 
 
 
Aldehyde 173:  
To alcohol 305 (0.007 g, 0.011 mmol) and sodium bicarbonate (0.011 g, 0.132 mmol) in 
0.6 mL CH2Cl2 at room temperature was added Dess-Martin periodinane (0.013 g, 0.032 
mmol).  The reaction mixture was stirred for 2 hours, at which time 2 mL diethyl ether 
and 3 mL of 1:1:1 sat. NaCO3/brine/Na2S2O3 was added to the flask and stirred for 20 
minutes until the aqueous layer became homogeneous.  The layers were separated and 
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the aqueous layer extracted 3x with diethyl ether.  The combined organic extracts were 
dried over Na2SO4, filtered over a plug of silica gel (washing with ether), and 
concentrated under reduced pressure.  The crude product was purified by flash column 
chromatography (50% EA/Hex) to deliver the product (0.005 g, 72%) as a colorless oil.   
1H NMR (600 MHz, C6D6)  0.76-0.83 (m, 6H), 1.04-1.10 (m, 1H), 1.30 (s, 3H), 1.36-1.46 
(m, 3H), 1.50 (s, 3H), 1.60-1.69 (m, 1H), 1.70-1.76 (m, 1H), 1.96-2.06 (m, 4H), 2.18-2.25 
(m, 1H), 2.27-2.33 (m, 1H), 3.19 (s, 3H), 3.63-3.67 (m, 1H), 3.80-3.83 (m, 1H), 3.86 (br. 
s., 1H), 3.89 (d, J= 5.7 Hz, 1H), 3.95 (m, 1H), 3.98-4.06 (m, 3H), 4.52 (s, 2H), 4.71 (t, J= 
5.8 Hz, 1H), 5.46 (dd, J= 15.3, 7.0 Hz, 1H), 5.70 (ddd, J= 14.9, 14.9, 7.9 Hz, 1H), 5.75 
(d, J= 6.0 Hz, 1H), 5.80 (ddd, J= 13.6, 6.4, 6.4 Hz, 1H), 6.43 (dd, J= 14.5, 1.7 Hz, 1H), 
6.80 (dd, J= 14.5, 4.7 Hz, 1 H), 9.37 (s, 1H); 13C NMR (150 MHz, C6D6):  200.3, 142.0, 
132.6, 130.7, 129.2, 127.6, 108.4, 95.2, 83.6, 80.5, 79.4, 78.9, 78.8, 78.4, 75.7, 75.5, 
73.9, 71.9, 55.2, 43.2, 41.8, 38.7, 36.4, 35.8, 29.7, 28.1, 25.6, 25.2, 15.2, 10.8.     
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C1-C38 fragment 174:   
To a flame-dried 5 mL round bottom flask in the dark was added sulfone 132 (0.008 g, 
0.012 mmol) and 0.12 mL DME.  The solution was cooled to 78 °C, at which time 
KHMDS (0.5 M in toluene, 24 L, mmol) was added dropwise via syringe.  After stirring 
for 15 minutes, aldehyde 173 (0.004 g, 0.006 mmol) in 0.12 mL DME was added 
dropwise via syringe to the yellow solution.  The reaction mixture was warmed to room 
temperature over 2 hours then diluted with ether and quenched with sat. NH4Cl.  The 
aqueous layer was extracted 3x with diethyl ether, dried over Na2SO4, filtered, and 
concentrated under reduced pressure.  The crude product was purified via flash column 
chromatography (5-30% EA/Hex, silica gel pretreated with 0.5% Et3N) to give the 
product (0.0053 g, 79%) as a light yellow oil, along with 2.4 mg sulfone (58%).  1H NMR 
(600 MHz, C6D6)  0.08 (s, 3H), 0.11 (s, 3H), 0.81 (d, J= 6.8 Hz, 3H), 0.82 (d, J= 7.2 Hz, 
3H), 0.99 (s, 9H), 1.04 (d, J= 6.4 Hz, 3H), 1.06-1.10 (m, 1H), 1.23-1.31 (m, 4H), 1.33 (s, 
3H), 1.41 (s, 9H), 1.43-1.51 (m, 2H), 1.53 (s, 3H), 1.61-1.69 (m, 3H), 1.69-1.76 (m, 1H), 
1.83 (s, 3H), 1.99-2.06 (m, 2H), 2.14-2.27 (m, 7H), 2.30-2.37 (m, 1H), 2.39-2.45 (m, 2H), 
3.20 (s, 3H), 3.65-3.69 (m, 1H), 3.83-3.86 (m, 1H), 3.89 (br. s., 1H), 3.92 (d, J= 6.0 Hz, 
1H), 3.98 (ddd, J= 7.9, 7.9, 1.9 Hz, 1H), 4.01 (dd, J= 8.7, 7.9 Hz, 1H), 4.04-4.09 (m, 3H), 
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4.11 (br. s., 1H), 4.27 (t, J= 7.2 Hz, 1H), 4.52-4.55 (m, 2H), 4.79 (t, J= 5.5 Hz, 1H), 5.45 
(dd, J= 15.4, 7.2 Hz, 1H), 5.49-5.59 (m, 3H), 5.70 (ddd, J= 14.6, 7.2, 7.2 Hz, 1H), 5.75 
(dd, J= 10.4, 2.5 Hz, 1H), 5.82 (dd, J= 14.7, 6.4 Hz, 1H), 5.87 (ddd, J= 10.2, 4.7, 2.1 Hz, 
1H), 5.92-5.99 (m, 1H), 6.45 (dd, J= 14.7, 1.5 Hz, 1H), 6.83 (dd, J= 14.5, 4.7 Hz, 1H); 
13C NMR (150 MHz, C6D6):  172.5, 142.0, 133.1, 132.6, 132.5, 132.4, 132.1, 131.2, 
129.5, 127.6, 127.0, 108.4, 95.1, 83.6, 80.6, 79.4, 79.3, 79.1, 79.0, 78.5, 76.7, 75.8, 
75.5, 74.0, 72.7, 71.9, 66.0, 55.2, 41.8, 38.8, 37.8, 36.9, 36.4, 35.79, 35.76, 33.0, 32.9, 
32.2, 29.6, 28.2, 27.5, 26.2, 25.74, 25.68, 21.3, 18.4, 15.2, 14.5, 10.8, 3.7, 4.2; IR 
(film): 2928, 2857, 1729, 1461, 1367, 1100, 1067, 1038, 837, 775; ESI-MS: C57H93IO11Si 
[M+Na] calc. 1131.54, found 1131.50; []24D = +45.0° (c = 0.27, C6H6). 
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13C NMR SPECTRUM OF 263 (150 MHz, CDCl3) 
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1H NMR SPECTRUM OF 264 (600 MHz, CDCl3) 
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13C NMR SPECTRUM OF 264 (150 MHz, CDCl3) 
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1H NMR SPECTRUM OF 278 (600 MHz, CDCl3) 
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13C NMR SPECTRUM OF 278 (150 MHz, CDCl3) 
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1H NMR SPECTRUM OF 281 (600 MHz, CDCl3)  
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1H NMR SPECTRUM OF 286 (600 MHz, CDCl3)  
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13C NMR SPECTRUM OF 286 (150 MHz, CDCl3)  
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1H NMR SPECTRUM OF 293 (600 MHz, CDCl3) 
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13C NMR SPECTRUM OF 293 (150 MHz, CDCl3) 
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1H NMR SPECTRUM OF 294 (500 MHz, CDCl3) 
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13C NMR SPECTRUM OF 294 (125 MHz, CDCl3) 
 
 
 
 
2
3
7
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13C NMR SPECTRUM OF THE DIOL (150 MHz, CDCl3) 
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1H NMR SPECTRUM OF 295 (600 MHz, CDCl3) 
 
 
 
 
2
4
0
 
13C NMR SPECTRUM OF 295 (150 MHz, CDCl3) 
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1H NMR SPECTRUM OF THE ALCOHOL (600 MHz, CDCl3) 
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13C NMR SPECTRUM OF THE ALCOHOL (150 MHz, CDCl3) 
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1H NMR SPECTRUM OF 296 (600 MHz, CDCl3) 
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13C NMR SPECTRUM OF 296 (150 MHz, CDCl3) 
 
 
 
 
2
4
5
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13C NMR SPECTRUM OF 162 (125 MHz, CDCl3) 
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1H NMR SPECTRUM OF 297 (600 MHz, CDCl3) 
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13C NMR SPECTRUM OF 297 (150 MHz, CDCl3) 
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1H NMR SPECTRUM OF 298 (600 MHz, CDCl3) 
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13C NMR SPECTRUM OF 298 (150 MHz, CDCl3) 
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13C NMR SPECTRUM OF 132 (150 MHz, CDCl3) 
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1H NMR SPECTRUM OF 299 (600 MHz, CDCl3) 
 
 
 
 
2
5
4
 
13C NMR SPECTRUM OF 299 (150 MHz, CDCl3) 
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1H NMR SPECTRUM OF 300 (600 MHz, CDCl3) 
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13C NMR SPECTRUM OF 300 (150 MHz, CDCl3) 
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13C NMR SPECTRUM OF 302 (150 MHz, CDCl3) 
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